Other appendicitis

K11_APPENDOTH

appendicitis: Acute inflammation of the vermiform appendix.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K36, K37 Hospital discharge: ICD-9 — 541\|542 Hospital discharge: ICD-8 — 541\|542 Cause of death: ICD-10 — K36, K37 Cause of death: ICD-9 — 541\|542 Cause of death: ICD-8 — 541\|542 2 out of 7 registries used, show all original rules.	3754
4. Check minimum number of events None	3754
5. Include endpoints None	3754
6. Filter based on genotype QC (FinnGen only)	3635

Control definitions (FinnGen only)

Control exclude: K11_APPENDIX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_APPENDOTH
CONTROL_EXCLUDE	K11_APPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K3[6-7]
HD_ICD_9	541\|542
HD_ICD_8	541\|542
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K3[6-7]
COD_ICD_9	541\|542
COD_ICD_8	541\|542
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other appendicitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30807	15923	14710
Only index persons	27597	14579	13018
Unadjusted period prevalence (%)
Whole population	0.43	0.46	0.41
Only index persons	0.52	0.54	0.50
Median age at first event (years)
Whole population	26.65	26.67	26.39
Only index persons	25.39	25.68	25.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3635	2144	1491
Unadjusted period prevalence (%)	0.73	0.76	0.68
Median age at first event (years)	28.95	27.81	30.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3754: Matched controls
37540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K37

ICD-10 Finland

Unspecified appendicitis

787.9

307.7

944

6421

FHL

Appendicectomy

29.6

307.7

783

331

JEA01

NOMESCO Finland

Laparoscopic appendectomy

99.6

307.7

770

K36

ICD-10 Finland

Other appendicitis

1908.7

307.7

334

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

397.5

307.7

629

5410X

ICD-9 Finland

Appendicitis, unqualified[APPENDICITIS NUD]

+∞

307.7

659

54199

ICD-8 Finland

Appendicitis, unqualified

+∞

307.7

1286

54200

ICD-8 Finland

Other appendicitis, Appendicitis chronica

+∞

232.8

221

JEA00

NOMESCO Finland

Appendectomy

6.7

141.5

233

369

54208

ICD-8 Finland

Other appendicitis

+∞

113.1

108

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

+∞

111.0

106

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

109.9

668

2729

5428X

ICD-9 Finland

Other appendicitis[APPENDICITIS ALIA DEFINITA]

+∞

107.8

103

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

87.7

1533

9635

K35.0

ICD-10 Finland

Acute appendicitis with generalized peritonitis

+∞

82.6

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

66.4

422

1738

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

64.3

994

5863

P01AB01

ATC

metronidazole; oral, rectal

1.8

59.0

1564

10834

5420A

ICD-9 Finland

Other appendicitis[APPENDICITIS CHRONICA]

+∞

49.1

54003

ICD-8 Finland

Acute appendicitis, Cum abscessu

+∞

49.1

WX402

NOMESCO Finland

General anaesthesia

1.7

42.1

890

5673

5409X

ICD-9 Finland

Acute appendicitis, Without mention of peritonitis

+∞

39.6

54099

ICD-8 Finland

Acute appendicitis, Without mention of peritonitis

+∞

39.6

ZXD05

NOMESCO Finland

Urgent procedure

1.7

39.3

1041

7031

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

33.5

892

5992

WX704

NOMESCO Finland

Intubation

2.1

30.5

318

1601

N02BE01

ATC

paracetamol; systemic, rectal

1.7

26.8

3270

29918

A02BC05

ATC

esomeprazole; systemic

1.5

26.1

1424

11067

N02AX02

ATC

tramadol; systemic, rectal

1.5

25.7

1487

11676

R10.0

ICD-10 Finland

Acute abdomen

2.7

25.1

133

497

5401A

ICD-9 Finland

Acute appendicitis, With peritoneal abscess

+∞

25.0

J01DB01

ATC

cefalexin; oral

1.6

24.8

3004

27048

D88

ICPC

Appendicitis

84.0

22.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

21.7

637

4328

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

21.1

447

2804

D01

ICPC

Abdominal pain/cramps general

1.7

21.0

435

2711

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.7

20.9

115

439

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

19.9

1522

12385

54201

ICD-8 Finland

Other appendicitis, Appendicitis recidivans

+∞

19.8

K35

ICD-10 Finland

Acute appendicitis

22.7

19.0

M01AB05

ATC

diclofenac; systemic, rectal

1.4

18.9

2356

20664

UJF32

NOMESCO Finland

Coloscopy

1.4

18.2

824

6100

J01AA02

ATC

doxycycline; systemic

1.4

17.7

2754

24887

N03AX16

ATC

[U] pregabalin

1.5

17.2

753

5532

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

17.2

914

6957

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

16.9

1177

9370

JAH01

NOMESCO Finland

Laparoscopy

2.1

16.1

158

777

A02BC02

ATC

pantoprazole; systemic

1.3

16.1

2366

21002

ZXE00

NOMESCO Finland

One hour or less

1.4

15.7

1238

10022

M03BX02

ATC

tizanidine; oral

1.3

15.6

2216

19524

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

15.0

699

5183

SPAT1263

SPAT

Sampling

1.3

14.6

1309

10770

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

14.3

175

933

H02AB06

ATC

prednisolone; systemic

1.3

13.9

1564

13260

99850

ICD-8 Finland

Other complications of surgical procedures, Postoperative wound infection

5.3

13.7

M79.6

ICD-10 Finland

Pain in limb

1.3

13.6

1506

12724

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

13.6

535

3840

J01MA02

ATC

ciprofloxacin; systemic

1.3

13.5

1215

9973

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

13.4

345

2262

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

12.9

112

527

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

12.8

1485

12598

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

12.6

601

4462

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

12.3

3283

31087

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

12.0

2520

22964

M01AE02

ATC

naproxen; oral, rectal

1.3

12.0

1910

16812

M54.5

ICD-10 Finland

Low back pain

1.3

11.9

1235

10298

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

11.8

1775

15507

J01MA12

ATC

levofloxacin; systemic

1.4

11.7

542

4002

A02BC01

ATC

omeprazole; systemic

1.3

11.6

813

6415

5421A

ICD-9 Finland

Other appendicitis[APPENDICITIS RECIDIVANS]

+∞

11.5

R51.80

ICD-10 Finland

Headache

1.4

11.4

515

3785

R03AC02

ATC

salbutamol; inhalant

1.3

11.2

1855

16350

D06

ICPC

Abdominal pain localized other

1.6

11.2

283

1847

A02BC03

ATC

lansoprazole; oral

1.3

11.2

871

6975

A03FA02

ATC

cisapride; oral, rectal

1.7

11.1

208

1259

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

11.1

1455

12462

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

11.0

1082

8936

AA1AD

NOMESCO Finland

CT of head and brain

1.3

10.7

837

6703

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

10.0

10.5

54191, ,

ICD-8 Finland

+∞

10.4

Y0599

ICD-8 Finland

Investigation of digestive system

2.8

10.3

186

M01AH05

ATC

etoricoxib; oral

1.3

10.0

2185

19775

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

9.8

828

6690

R06.0

ICD-10 Finland

Dyspnoea

1.3

9.6

804

6486

M01AH01

ATC

celecoxib; oral

1.4

9.6

527

3997

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

9.2

282

1921

UKC02

NOMESCO Finland

Cystoscopy

1.4

9.2

417

3061

B01AB05

ATC

enoxaparin; parenteral

1.3

9.2

925

7634

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

9.1

864

7077

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

9.1

675

5352

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

9.0

718

5750

N05BA04

ATC

oxazepam; oral

1.3

8.9

798

6487

G44.2

ICD-10 Finland

Tension-type headache

1.4

8.8

431

3205

R51

ICD-10 Finland

Headache

1.6

8.8

183

1142

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.7

777

6312

J01EA01

ATC

trimethoprim; systemic

1.3

8.7

748

6047

H57.1

ICD-10 Finland

Ocular pain

1.8

8.6

128

728

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

8.6

354

2554

N05BA01

ATC

diazepam; systemic, rectal

1.4

8.5

378

2763

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

8.5

165

1012

J02AC01

ATC

fluconazole; systemic

1.2

8.5

1279

11047

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

8.4

400

2962

J01MA14

ATC

moxifloxacin; systemic

1.5

8.4

262

1794

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

8.4

1746

15594

54091

ICD-8 Finland

Acute appendicitis, Gangraenosa, peritonitide non indicata

+∞

8.3

54100, ,

ICD-8 Finland

+∞

8.3

K30

ICD-10 Finland

Functional dyspepsia

1.4

8.3

352

2554

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.7

8.2

156

R50.9

ICD-10 Finland

Fever, unspecified

1.4

8.2

448

3392

N06AX21

ATC

duloxetine; oral

1.4

8.2

382

2818

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

8.1

170

1064

J01FA10

ATC

azithromycin; systemic

1.2

8.1

1933

17477

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.8

8.1

141

N06AX11

ATC

mirtazapine; oral

1.2

8.0

1075

9152

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.0

344

2502

N06AA09

ATC

amitriptyline; systemic

1.5

8.0

266

1844

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

8.0

121

693

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

7.9

395

2946

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

7.9

589

4667

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.9

810

6688

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

7.8

335

2434

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.4

7.8

208

S06.0

ICD-10 Finland

Concussion

1.4

7.8

316

2275

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

7.8

453

XKD00

NOMESCO Finland

Uroflowmetry

1.4

7.7

379

2818

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.7

293

2083

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

7.6

1869

16896

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

7.6

310

2236

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

7.5

283

2008

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.4

822

6838

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

7.4

915

7708

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

7.4

309

2236

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

7.4

387

2909

J01DA01

ATC

[U] cefalexin

1.2

7.4

2024

18474

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

7.4

585

4672

R52.9

ICD-10 Finland

Pain, unspecified

1.4

7.4

312

2264

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.3

616

4958

N06AB10

ATC

escitalopram; oral

1.3

7.2

645

5228

J01FF01

ATC

clindamycin; systemic

1.3

7.2

821

6851

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

3.1

7.2

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.8

7.1

100

561

A02BA04

ATC

nizatidine; systemic

1.5

7.1

195

1300

J01DA06

ATC

[U] cefuroxime

1.3

7.0

417

3200

N03AX12

ATC

[U] gabapentin; oral

1.3

7.0

471

3679

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

6.9

108

625

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.9

844

7099

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.8

406

3111

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.6

6.8

154

983

1220

FHL

Arthroscopy

1.7

6.8

111

651

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.0

6.8

K38.9

ICD-10 Finland

Disease of appendix, unspecified

40.1

6.8

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

2.7

6.8

126

C01CA24

ATC

epinephrine; parenteral

1.5

6.7

193

1299

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.2

6.7

236

N05AH04

ATC

quetiapine; oral

1.3

6.7

535

4274

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.7

2283

21172

G47.3

ICD-10 Finland

Sleep apnoea

1.3

6.6

723

5997

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.2

6.6

231

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

6.6

324

2410

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

6.6

296

2171

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

6.6

430

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

6.5

245

1739

R03BA05

ATC

fluticasone; inhalant

1.3

6.5

530

4245

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.5

244

1734

K66.0

ICD-10 Finland

Peritoneal adhesions

3.7

6.5

J01FA06

ATC

roxithromycin; oral

1.2

6.4

1237

10875

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.1

6.4

274

R42

ICD-10 Finland

Dizziness and giddiness

1.3

6.4

645

5301

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

6.4

556

4489

M02AA07

ATC

piroxicam; topical

1.2

6.4

1035

8952

R52.2

ICD-10 Finland

Other chronic pain

1.7

6.4

115

694

S83.2

ICD-10 Finland

Tear of meniscus, current

1.5

6.3

209

1449

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.0

6.3

330

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

6.3

400

C07AB07

ATC

bisoprolol; oral

1.2

6.3

1392

12396

K38.8

ICD-10 Finland

Other specified diseases of appendix

+∞

6.2

54190, ,

ICD-8 Finland

+∞

6.2

C10AX09

ATC

ezetimibe; oral

1.3

6.2

478

3798

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

6.2

107

638

A02BA02

ATC

ranitidine; systemic

1.3

6.2

519

4169

M01AX17

ATC

nimesulide; oral

1.3

6.1

660

5467

C01DA14

ATC

isosorbide mononitrate; oral

1.4

6.1

324

2443

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

6.1

306

2287

EB1VA, ,

NOMESCO Finland

1.3

6.1

574

4682

N03AE01

ATC

clonazepam; systemic

1.5

6.0

160

1060

J01FA09

ATC

clarithromycin; systemic

1.2

6.0

973

8403

A01AB09

ATC

miconazole; local oral

1.4

6.0

218

1538

N06AB04

ATC

citalopram; systemic

1.3

6.0

613

5043

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Inpatient Visit
IP [9201]

1.0e-01

4.4e-01

1.6e+00

6.9e+00

2.2e+00

6.3e-01

4.7e-01

cases:17.25%

controls:15.86%

cases:7.77%

controls:5.15%

cases:2.41%

controls:0.50%

cases:31.54%

controls:0.05%

cases:4.52%

controls:0.54%

cases:7.99%

controls:4.42%

cases:16.64%

controls:11.11%

344

3035

1650

16100

155

985

1839

18150

1946

19039

629

1365

19126

103

1899

19012

156

829

1796

17944

289

1825

1448

14605

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

1.3e-01

7.2e-01

1.9e+00

6.1e+00

2.0e+00

5.1e-01

3.6e-01

cases:8.68%

controls:7.73%

cases:7.87%

controls:4.00%

cases:4.76%

controls:0.73%

cases:16.30%

controls:0.04%

cases:4.63%

controls:0.68%

cases:6.61%

controls:4.08%

cases:12.20%

controls:8.86%

173

1479

1821

17656

157

765

1837

18370

140

1899

18995

325

1669

19127

130

1897

18985

129

766

1823

18007

212

1455

1525

14975

Other and unspecified abdominal pain
R10.4 [45568113]

6.6e-01

1.4e+00

3.5e+00

—

3.4e+00

1.3e+00

8.2e-01

cases:7.32%

controls:3.91%

cases:5.67%

controls:1.41%

cases:5.12%

controls:0.17%

—

cases:3.52%

controls:0.13%

cases:4.35%

controls:1.24%

cases:8.46%

controls:3.91%

146

748

1848

18387

113

270

1881

18865

102

1892

19103

—

1919

19091

232

1867

18541

147

643

1590

15787

Pathology report gross observation
24419-4 [3002256]

-6.2e-02

8.8e-01

3.1e+00

—

5.4e+00

1.6e+00

2.6e-01

cases:1.50%

controls:1.60%

cases:1.30%

controls:0.54%

cases:0.90%

controls:0.04%

—

cases:11.11%

controls:0.06%

cases:2.00%

controls:0.40%

cases:1.96%

controls:1.51%

306

1964

18829

104

1968

19031

1976

19127

—

221

1768

19104

1913

18698

248

1703

16182

metronidazole; oral, rectal
P01AB01 [21604857]

4.3e-01

1.5e+00

2.6e+00

1.0e+50

5.1e+00

7.1e-01

5.1e-01

cases:7.37%

controls:4.91%

cases:5.97%

controls:1.41%

cases:2.01%

controls:0.15%

cases:1.00%

controls:0.00%

cases:15.23%

controls:0.10%

cases:3.13%

controls:1.56%

cases:8.12%

controls:5.05%

147

939

1847

18196

119

269

1875

18866

1954

19106

1974

19135

303

1686

19095

292

1891

18481

141

829

1596

15601

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

6.9e-02

3.1e-01

1.3e+00

5.8e+00

2.7e+00

3.9e-01

2.0e-01

cases:25.28%

controls:23.99%

cases:18.86%

controls:14.59%

cases:9.43%

controls:2.65%

cases:32.55%

controls:0.15%

cases:27.50%

controls:2.50%

cases:19.72%

controls:14.28%

cases:31.32%

controls:27.28%

504

4590

1490

14545

376

2792

1618

16343

188

507

1806

18628

649

1345

19106

547

477

1442

18638

385

2681

1567

16092

544

4482

1193

11948

Abdominal CT examination
JN3AD [2001305554]

-1.8e-01

1.6e+00

3.6e+00

—

4.0e+00

1.4e+00

4.0e-01

cases:0.50%

controls:0.60%

cases:1.35%

controls:0.28%

cases:1.35%

controls:0.04%

—

cases:1.46%

controls:0.03%

cases:1.18%

controls:0.30%

cases:1.78%

controls:1.21%

115

1984

19020

1967

19082

1967

19128

—

1960

19110

1929

18716

198

1706

16232

Pain localized to other parts of lower abdomen
R10.3 [45534426]

6.0e-01

1.4e+00

3.5e+00

1.0e+50

3.3e+00

1.1e+00

7.5e-01

cases:4.96%

controls:2.80%

cases:3.51%

controls:0.93%

cases:3.56%

controls:0.11%

cases:8.58%

controls:0.00%

cases:2.16%

controls:0.08%

cases:3.13%

controls:1.04%

cases:6.22%

controls:3.05%

535

1895

18600

178

1924

18957

1923

19113

171

1823

19135

1946

19099

196

1891

18577

108

501

1629

15929

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

-2.4e-02

3.9e-01

1.5e+00

5.8e+00

1.9e+00

5.3e-01

2.6e-01

cases:8.73%

controls:8.92%

cases:6.57%

controls:4.55%

cases:2.46%

controls:0.56%

cases:9.58%

controls:0.03%

cases:3.37%

controls:0.50%

cases:6.81%

controls:4.13%

cases:13.24%

controls:10.55%

174

1706

1820

17429

131

871

1863

18264

108

1945

19027

191

1803

19129

1922

19020

133

775

1819

17998

230

1734

1507

14696

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

2.4e-02

3.3e-01

1.8e+00

6.1e+00

1.8e+00

4.2e-01

2.0e-01

cases:12.84%

controls:12.57%

cases:8.07%

controls:5.95%

cases:4.36%

controls:0.77%

cases:17.00%

controls:0.05%

cases:4.37%

controls:0.76%

cases:7.89%

controls:5.33%

cases:15.54%

controls:13.07%

256

2405

1738

16730

161

1139

1833

17996

148

1907

18987

339

1655

19126

145

1902

18970

154

1001

1798

17772

270

2147

1467

14283

Leukocytes [#/volume] in Urine
30405-5 [3018095]

6.9e-03

4.5e-01

1.9e+00

5.9e+00

1.6e+00

4.5e-01

2.5e-01

cases:5.27%

controls:5.23%

cases:4.36%

controls:2.83%

cases:2.56%

controls:0.40%

cases:10.48%

controls:0.03%

cases:2.11%

controls:0.41%

cases:4.25%

controls:2.75%

cases:8.81%

controls:6.97%

105

1001

1889

18134

542

1907

18593

1943

19059

209

1785

19129

1947

19036

516

1869

18257

153

1145

1584

15285

Upper gastrointestinal surgery
106 [44777669]

2.6e-01

1.2e+00

2.5e+00

—

3.9e+00

1.9e+00

7.9e-01

cases:7.07%

controls:5.56%

cases:6.87%

controls:2.24%

cases:3.96%

controls:0.32%

—

cases:14.23%

controls:0.33%

cases:10.91%

controls:1.86%

cases:10.65%

controls:5.14%

141

1064

1853

18071

137

428

1857

18707

1915

19073

—

283

1706

19052

213

349

1739

18424

185

844

1552

15586

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

-2.9e-02

2.1e-01

1.2e+00

5.6e+00

2.5e+00

2.6e-01

8.5e-02

cases:23.42%

controls:23.95%

cases:19.96%

controls:16.83%

cases:9.23%

controls:3.04%

cases:30.99%

controls:0.17%

cases:25.94%

controls:2.73%

cases:21.00%

controls:17.02%

cases:31.15%

controls:29.36%

467

4583

1527

14552

398

3221

1596

15914

184

581

1810

18554

618

1376

19102

516

521

1473

18594

410

3195

1542

15578

541

4824

1196

11606

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

-2.7e-02

1.8e-01

1.2e+00

5.6e+00

2.5e+00

2.4e-01

8.0e-02

cases:23.72%

controls:24.21%

cases:19.86%

controls:17.10%

cases:9.23%

controls:3.10%

cases:30.64%

controls:0.16%

cases:25.94%

controls:2.75%

cases:21.00%

controls:17.28%

cases:31.26%

controls:29.56%

473

4633

1521

14502

396

3273

1598

15862

184

593

1810

18542

611

1383

19104

516

526

1473

18589

410

3244

1542

15529

543

4857

1194

11573

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

4.4e-02

4.2e-01

1.3e+00

5.6e+00

1.4e+00

3.0e-01

2.4e-01

cases:14.99%

controls:14.44%

cases:12.24%

controls:8.42%

cases:5.82%

controls:1.64%

cases:16.75%

controls:0.07%

cases:5.33%

controls:1.37%

cases:11.17%

controls:8.50%

cases:20.09%

controls:16.53%

299

2764

1695

16371

244

1611

1750

17524

116

313

1878

18822

334

1660

19121

106

261

1883

18854

218

1595

1734

17178

349

2716

1388

13714

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]

8.1e-02

1.1e+00

3.0e+00

1.0e+50

2.9e+00

1.2e+00

8.0e-01

cases:1.45%

controls:1.34%

cases:1.65%

controls:0.56%

cases:1.20%

controls:0.06%

cases:3.51%

controls:0.00%

cases:0.96%

controls:0.05%

cases:1.59%

controls:0.50%

cases:3.11%

controls:1.42%

257

1965

18878

107

1961

19028

1970

19123

1924

19135

1970

19105

1921

18679

234

1683

16196

INR in Blood by Coagulation assay
34714-6 [3032080]

2.5e-02

5.2e-01

1.1e+00

5.1e+00

1.6e+00

6.0e-01

2.9e-01

cases:6.47%

controls:6.32%

cases:5.57%

controls:3.40%

cases:2.76%

controls:0.96%

cases:9.48%

controls:0.06%

cases:4.63%

controls:0.96%

cases:5.69%

controls:3.20%

cases:8.87%

controls:6.79%

129

1209

1865

17926

111

651

1883

18484

183

1939

18952

189

1805

19123

184

1897

18931

111

600

1841

18173

154

1115

1583

15315

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

8.3e-02

3.1e-01

1.1e+00

5.8e+00

1.3e+00

3.7e-01

1.9e-01

cases:11.23%

controls:10.43%

cases:8.58%

controls:6.44%

cases:4.21%

controls:1.48%

cases:16.00%

controls:0.06%

cases:5.23%

controls:1.48%

cases:8.66%

controls:6.14%

cases:13.93%

controls:11.76%

224

1996

1770

17139

171

1233

1823

17902

283

1910

18852

319

1675

19124

104

282

1885

18833

169

1152

1783

17621

242

1932

1495

14498

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

5.9e-02

1.8e-01

9.4e-01

5.3e+00

2.2e+00

2.5e-01

1.8e-01

cases:21.16%

controls:20.19%

cases:17.75%

controls:15.31%

cases:8.17%

controls:3.38%

cases:24.07%

controls:0.15%

cases:22.47%

controls:3.12%

cases:19.31%

controls:15.73%

cases:29.30%

controls:25.75%

422

3864

1572

15271

354

2929

1640

16206

163

646

1831

18489

480

1514

19106

447

596

1542

18519

377

2953

1575

15820

509

4231

1228

12199

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

4.5e-02

1.7e-01

9.4e-01

5.2e+00

2.2e+00

2.4e-01

9.4e-02

cases:19.66%

controls:18.97%

cases:16.80%

controls:14.56%

cases:6.87%

controls:2.79%

cases:22.12%

controls:0.15%

cases:19.71%

controls:2.62%

cases:18.65%

controls:15.33%

cases:27.23%

controls:25.40%

392

3629

1602

15506

335

2787

1659

16348

137

534

1857

18601

441

1553

19106

392

500

1597

18615

364

2878

1588

15895

473

4174

1264

12256

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

-3.1e-02

3.2e-01

1.3e+00

5.4e+00

1.2e+00

3.4e-01

2.2e-01

cases:13.09%

controls:13.45%

cases:8.43%

controls:6.28%

cases:3.11%

controls:0.87%

cases:9.78%

controls:0.05%

cases:2.77%

controls:0.85%

cases:8.25%

controls:6.00%

cases:16.75%

controls:13.85%

261

2574

1733

16561

168

1202

1826

17933

166

1932

18969

195

1799

19126

163

1934

18952

161

1126

1791

17647

291

2276

1446

14154

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

-3.1e-02

1.5e-01

9.9e-01

5.3e+00

2.3e+00

1.7e-01

7.2e-02

cases:26.73%

controls:27.34%

cases:23.02%

controls:20.47%

cases:10.08%

controls:4.01%

cases:30.99%

controls:0.21%

cases:26.29%

controls:3.58%

cases:23.87%

controls:20.87%

cases:34.89%

controls:33.28%

533

5231

1461

13904

459

3916

1535

15219

201

768

1793

18367

618

1376

19094

523

685

1466

18430

466

3917

1486

14856

606

5468

1131

10962

General anesthesia, balanced
WX408 [2001310808]

1.8e-01

2.1e+00

1.0e+50

3.6e+00

1.6e+00

1.1e+00

cases:3.01%

controls:2.52%

cases:0.70%

controls:0.59%

cases:0.30%

controls:0.04%

cases:7.32%

controls:0.00%

cases:2.51%

controls:0.07%

cases:1.84%

controls:0.38%

cases:2.94%

controls:0.96%

482

1934

18653

112

1980

19023

1988

19128

146

1848

19135

1939

19102

1916

18702

157

1686

16273

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

-6.3e-02

1.4e-01

8.9e-01

5.3e+00

2.1e+00

1.4e-01

4.6e-02

cases:30.29%

controls:31.64%

cases:27.08%

controls:24.40%

cases:11.79%

controls:5.19%

cases:32.25%

controls:0.23%

cases:29.36%

controls:4.77%

cases:27.72%

controls:25.01%

cases:39.15%

controls:38.06%

604

6055

1390

13080

540

4668

1454

14467

235

993

1759

18142

643

1351

19091

584

912

1405

18203

541

4696

1411

14077

680

6254

1057

10176

Platelets [#/volume] in Blood
26515-7 [3007461]

-6.8e-02

1.4e-01

9.0e-01

5.3e+00

2.1e+00

1.4e-01

4.6e-02

cases:30.09%

controls:31.53%

cases:26.88%

controls:24.26%

cases:11.79%

controls:5.16%

cases:32.20%

controls:0.24%

cases:29.36%

controls:4.76%

cases:27.56%

controls:24.86%

cases:38.98%

controls:37.89%

600

6034

1394

13101

536

4642

1458

14493

235

987

1759

18148

642

1352

19090

584

909

1405

18206

538

4667

1414

14106

677

6226

1060

10204

MCH [Entitic mass]
28539-5 [3035941]

-5.9e-02

1.4e-01

9.0e-01

5.3e+00

2.1e+00

1.4e-01

4.8e-02

cases:30.29%

controls:31.55%

cases:26.93%

controls:24.29%

cases:11.79%

controls:5.16%

cases:32.20%

controls:0.24%

cases:29.36%

controls:4.76%

cases:27.66%

controls:24.89%

cases:39.09%

controls:37.95%

604

6038

1390

13097

537

4648

1457

14487

235

987

1759

18148

642

1352

19090

584

909

1405

18206

540

4673

1412

14100

679

6236

1058

10194

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

-6.1e-02

1.4e-01

9.0e-01

5.3e+00

2.1e+00

1.4e-01

4.7e-02

cases:30.29%

controls:31.60%

cases:26.93%

controls:24.31%

cases:11.79%

controls:5.16%

cases:32.20%

controls:0.24%

cases:29.36%

controls:4.76%

cases:27.66%

controls:24.91%

cases:39.09%

controls:37.97%

604

6047

1390

13088

537

4652

1457

14483

235

987

1759

18148

642

1352

19090

584

910

1405

18205

540

4677

1412

14096

679

6239

1058

10191

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

-5.9e-02

1.4e-01

9.0e-01

5.3e+00

2.1e+00

1.4e-01

4.7e-02

cases:30.34%

controls:31.60%

cases:26.98%

controls:24.31%

cases:11.79%

controls:5.16%

cases:32.20%

controls:0.24%

cases:29.36%

controls:4.76%

cases:27.66%

controls:24.95%

cases:39.09%

controls:37.99%

605

6047

1389

13088

538

4652

1456

14483

235

988

1759

18147

642

1352

19090

584

910

1405

18205

540

4683

1412

14090

679

6241

1058

10189

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

-6.1e-02

1.4e-01

9.0e-01

5.3e+00

2.1e+00

1.4e-01

4.6e-02

cases:30.29%

controls:31.59%

cases:26.98%

controls:24.32%

cases:11.79%

controls:5.16%

cases:32.20%

controls:0.24%

cases:29.36%

controls:4.78%

cases:27.66%

controls:24.95%

cases:39.09%

controls:37.99%

604

6045

1390

13090

538

4653

1456

14482

235

987

1759

18148

642

1352

19090

584

913

1405

18202

540

4683

1412

14090

679

6242

1058

10188

Leukocytes [#/volume] in Blood
26464-8 [3010813]

-6.1e-02

1.4e-01

9.0e-01

5.3e+00

2.1e+00

1.4e-01

4.4e-02

cases:30.29%

controls:31.60%

cases:27.03%

controls:24.35%

cases:11.84%

controls:5.18%

cases:32.25%

controls:0.24%

cases:29.36%

controls:4.80%

cases:27.66%

controls:24.98%

cases:39.09%

controls:38.04%

604

6047

1390

13088

539

4660

1455

14475

236

992

1758

18143

643

1351

19090

584

917

1405

18198

540

4690

1412

14083

679

6250

1058

10180

CBC panel - Blood by Automated count
58410-2 [40761511]

-4.5e-02

1.8e-01

9.4e-01

5.1e+00

2.2e+00

1.7e-01

9.7e-02

cases:25.98%

controls:26.86%

cases:19.16%

controls:16.48%

cases:7.02%

controls:2.87%

cases:18.15%

controls:0.14%

cases:19.11%

controls:2.56%

cases:18.24%

controls:15.84%

cases:31.49%

controls:29.43%

518

5140

1476

13995

382

3154

1612

15981

140

549

1854

18586

362

1632

19109

380

490

1609

18625

356

2974

1596

15799

547

4836

1190

11594

General Surgery
2 [38004447]

2.2e-01

1.1e+00

2.5e+00

—

3.0e+00

9.6e-01

6.0e-01

cases:14.04%

controls:11.58%

cases:9.43%

controls:3.34%

cases:4.16%

controls:0.35%

—

cases:7.74%

controls:0.42%

cases:8.20%

controls:3.31%

cases:19.17%

controls:11.49%

280

2216

1714

16919

188

640

1806

18495

1911

19068

—

154

1835

19034

160

621

1792

18152

333

1888

1404

14542

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

-6.7e-02

1.8e-01

8.7e-01

5.2e+00

2.1e+00

1.7e-01

-5.8e-04

cases:22.82%

controls:24.02%

cases:19.16%

controls:16.50%

cases:7.97%

controls:3.51%

cases:21.82%

controls:0.15%

cases:20.76%

controls:3.21%

cases:19.52%

controls:17.05%

cases:28.61%

controls:28.62%

455

4597

1539

14538

382

3158

1612

15977

159

671

1835

18464

435

1559

19106

413

613

1576

18502

381

3200

1571

15573

497

4703

1240

11727

pH of Urine
2756-5 [3015736]

6.8e-02

4.4e-01

1.3e+00

5.1e+00

1.1e+00

2.7e-01

2.3e-02

cases:6.67%

controls:6.26%

cases:4.41%

controls:2.87%

cases:1.50%

controls:0.41%

cases:4.86%

controls:0.03%

cases:1.16%

controls:0.38%

cases:4.05%

controls:3.13%

cases:9.27%

controls:9.08%

133

1198

1861

17937

550

1906

18585

1964

19056

1897

19129

1966

19042

588

1873

18185

161

1492

1576

14938

Obstetrics / Gynecology
16 [38004461]

8.9e-02

4.0e-01

6.6e-01

5.1e+00

1.1e+00

4.3e-01

2.4e-01

cases:16.40%

controls:15.21%

cases:8.38%

controls:5.75%

cases:2.11%

controls:1.10%

cases:4.11%

controls:0.03%

cases:2.92%

controls:0.98%

cases:8.35%

controls:5.60%

cases:17.85%

controls:14.66%

327

2911

1667

16224

167

1101

1827

18034

210

1952

18925

1912

19130

187

1931

18928

163

1052

1789

17721

310

2408

1427

14022

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

-3.0e-02

2.7e-01

1.2e+00

5.4e+00

1.3e+00

1.7e-01

2.0e-01

cases:12.84%

controls:13.17%

cases:7.62%

controls:5.95%

cases:2.26%

controls:0.72%

cases:5.62%

controls:0.03%

cases:2.11%

controls:0.59%

cases:7.22%

controls:6.14%

cases:18.31%

controls:15.53%

256

2521

1738

16614

152

1138

1842

17997

137

1949

18998

112

1882

19130

113

1947

19002

141

1153

1811

17620

318

2551

1419

13879

General anaesthesia
WX402 [2001310806]

8.0e-02

6.0e-01

2.6e+00

—

3.6e+00

1.1e+00

5.5e-01

cases:1.91%

controls:1.76%

cases:1.55%

controls:0.86%

cases:1.05%

controls:0.08%

—

cases:2.71%

controls:0.08%

cases:2.41%

controls:0.78%

cases:4.32%

controls:2.53%

337

1956

18798

164

1963

18971

1973

19120

—

1935

19100

147

1905

18626

415

1662

16015

Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]

6.2e-02

4.3e-01

1.4e+00

5.0e+00

1.0e+00

1.8e-01

2.5e-02

cases:7.12%

controls:6.72%

cases:4.51%

controls:2.99%

cases:1.60%

controls:0.41%

cases:5.87%

controls:0.04%

cases:1.01%

controls:0.37%

cases:3.74%

controls:3.13%

cases:8.81%

controls:8.61%

142

1286

1852

17849

572

1904

18563

1962

19057

117

1877

19127

1969

19044

588

1879

18185

153

1414

1584

15016

Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]

2.2e-02

3.7e-01

1.3e+00

5.1e+00

9.9e-01

2.7e-01

5.2e-02

cases:7.92%

controls:7.77%

cases:5.62%

controls:3.95%

cases:2.06%

controls:0.54%

cases:7.07%

controls:0.05%

cases:1.46%

controls:0.55%

cases:5.53%

controls:4.28%

cases:12.20%

controls:11.66%

158

1486

1836

17649

112

755

1882

18380

104

1953

19031

141

1853

19126

105

1960

19010

108

803

1844

17970

212

1916

1525

14514

Ketones [Presence] in Urine by Test strip
2514-8 [3035350]

1.6e-02

3.8e-01

1.4e+00

5.1e+00

9.5e-01

2.7e-01

4.5e-02

cases:8.02%

controls:7.91%

cases:5.72%

controls:4.00%

cases:2.11%

controls:0.55%

cases:7.17%

controls:0.05%

cases:1.46%

controls:0.57%

cases:5.58%

controls:4.33%

cases:12.32%

controls:11.84%

160

1513

1834

17622

114

765

1880

18370

105

1952

19030

143

1851

19126

109

1960

19006

109

813

1843

17960

214

1945

1523

14485

Glucose [Presence] in Urine by Test strip
25428-4 [3009261]

1.5e-02

3.8e-01

1.3e+00

5.1e+00

9.5e-01

2.5e-01

3.6e-02

cases:8.17%

controls:8.06%

cases:5.77%

controls:4.03%

cases:2.06%

controls:0.56%

cases:7.22%

controls:0.05%

cases:1.46%

controls:0.57%

cases:5.58%

controls:4.41%

cases:12.20%

controls:11.83%

163

1543

1831

17592

115

771

1879

18364

107

1953

19028

144

1850

19126

109

1960

19006

109

828

1843

17945

212

1943

1525

14487

Coloscopy
UJF32 [2001305029]

3.3e-01

9.6e-01

2.4e+00

1.0e+50

1.6e+00

1.8e+00

6.4e-01

cases:3.01%

controls:2.19%

cases:1.65%

controls:0.64%

cases:0.60%

controls:0.06%

cases:0.40%

controls:0.00%

cases:0.45%

controls:0.09%

cases:3.07%

controls:0.53%

cases:3.51%

controls:1.87%

419

1934

18716

123

1961

19012

1982

19124

1986

19135

1980

19098

100

1892

18673

308

1676

16122

Abdominal pain/cramps general
D01 [2002000300]

2.8e-01

6.9e-01

3.0e+00

1.0e+50

2.7e+00

8.8e-01

7.1e-01

cases:1.60%

controls:1.22%

cases:0.90%

controls:0.45%

cases:0.65%

controls:0.03%

cases:1.76%

controls:0.00%

cases:0.55%

controls:0.04%

cases:1.08%

controls:0.45%

cases:2.42%

controls:1.20%

234

1962

18901

1976

19048

1981

19129

1959

19135

1978

19108

1931

18689

197

1695

16233

Specific gravity of Urine by Refractometry
5810-7 [3019150]

-5.1e-02

3.1e-01

1.2e+00

4.8e+00

1.2e+00

-1.7e-02

-3.2e-01

cases:3.61%

controls:3.79%

cases:2.36%

controls:1.74%

cases:0.90%

controls:0.28%

cases:3.01%

controls:0.03%

cases:0.75%

controls:0.23%

cases:1.90%

controls:1.93%

cases:4.20%

controls:5.70%

726

1922

18409

333

1947

18802

1976

19081

1934

19130

1974

19071

362

1915

18411

937

1664

15493

Blood type and Crossmatch panel - Blood
34531-4 [3044640]

-4.7e-02

6.3e-01

2.1e+00

—

3.0e+00

9.3e-01

4.0e-01

cases:4.76%

controls:4.98%

cases:3.61%

controls:1.96%

cases:2.16%

controls:0.26%

—

cases:5.28%

controls:0.28%

cases:3.74%

controls:1.51%

cases:6.39%

controls:4.38%

953

1899

18182

376

1922

18759

1951

19086

—

105

1884

19061

284

1879

18489

111

720

1626

15710

Normoblasts [#/volume] in Blood
715-3 [3021589]

7.1e-02

1.2e-01

6.7e-01

4.8e+00

1.6e+00

2.0e-01

1.3e-01

cases:8.07%

controls:7.56%

cases:6.52%

controls:5.80%

cases:2.31%

controls:1.20%

cases:5.82%

controls:0.05%

cases:5.33%

controls:1.12%

cases:7.17%

controls:5.92%

cases:11.28%

controls:10.01%

161

1447

1833

17688

130

1110

1864

18025

229

1948

18906

116

1878

19125

106

215

1883

18900

140

1112

1812

17661

196

1645

1541

14785

Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]

5.3e-01

7.6e-01

3.0e+00

1.0e+50

2.7e+00

6.7e-01

3.8e-01

cases:2.66%

controls:1.58%

cases:1.35%

controls:0.64%

cases:0.80%

controls:0.04%

cases:0.35%

controls:0.00%

cases:0.55%

controls:0.04%

cases:1.28%

controls:0.66%

cases:3.22%

controls:2.22%

303

1941

18832

122

1967

19013

1978

19127

1987

19135

1978

19108

124

1927

18649

365

1681

16065

Prothrombin time (PT) actual/Normal
5894-1 [3033658]

7.2e-02

5.9e-01

2.1e+00

—

2.9e+00

7.8e-01

5.6e-01

cases:4.16%

controls:3.88%

cases:3.36%

controls:1.89%

cases:1.81%

controls:0.22%

—

cases:3.92%

controls:0.21%

cases:3.33%

controls:1.56%

cases:6.33%

controls:3.71%

743

1911

18392

362

1927

18773

1958

19092

—

1911

19074

293

1887

18480

110

610

1627

15820

Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]

3.2e-01

1.0e+00

2.5e+00

—

2.7e+00

7.3e-01

3.1e-01

cases:6.02%

controls:4.45%

cases:4.41%

controls:1.68%

cases:2.46%

controls:0.21%

—

cases:2.41%

controls:0.16%

cases:3.53%

controls:1.74%

cases:6.85%

controls:5.12%

120

851

1874

18284

321

1906

18814

1945

19095

—

1941

19084

326

1883

18447

119

842

1618

15588

Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]

2.1e-01

5.7e-01

1.5e+00

4.9e+00

9.4e-01

3.3e-01

2.3e-01

cases:5.62%

controls:4.58%

cases:3.36%

controls:1.93%

cases:1.10%

controls:0.25%

cases:4.51%

controls:0.04%

cases:0.65%

controls:0.26%

cases:2.82%

controls:2.05%

cases:7.20%

controls:5.82%

112

877

1882

18258

369

1927

18766

1972

19087

1904

19128

1976

19066

385

1897

18388

125

957

1612

15473

Bacteria identified in Blood by Culture
600-7 [3023368]

1.2e-01

7.6e-01

2.0e+00

—

3.3e+00

7.5e-01

3.7e-01

cases:3.41%

controls:3.04%

cases:2.76%

controls:1.31%

cases:1.86%

controls:0.25%

—

cases:4.02%

controls:0.15%

cases:2.46%

controls:1.18%

cases:5.12%

controls:3.60%

582

1926

18553

251

1939

18884

1957

19088

—

1909

19086

222

1904

18551

592

1648

15838

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

3.6e-02

3.2e-01

1.0e+00

3.1e+00

2.3e+00

4.7e-01

2.6e-01

cases:6.27%

controls:6.06%

cases:4.56%

controls:3.36%

cases:1.40%

controls:0.52%

cases:0.55%

controls:0.03%

cases:4.63%

controls:0.49%

cases:5.43%

controls:3.46%

cases:9.21%

controls:7.29%

125

1160

1869

17975

643

1903

18492

1966

19036

1983

19130

1897

19021

106

649

1846

18124

160

1197

1577

15233

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

-5.9e-02

9.7e-02

8.0e-01

5.1e+00

9.0e-01

7.0e-02

5.4e-02

cases:25.13%

controls:26.25%

cases:19.81%

controls:18.31%

cases:7.07%

controls:3.29%

cases:16.65%

controls:0.13%

cases:6.84%

controls:2.89%

cases:20.18%

controls:19.09%

cases:33.74%

controls:32.54%

501

5022

1493

14113

395

3503

1599

15632

141

630

1853

18505

332

1662

19111

136

552

1853

18563

394

3583

1558

15190

586

5346

1151

11084

Laboratory Visit
OMOP4822461 [32036]

-7.2e-02

4.9e-02

6.0e-01

4.6e+00

1.6e+00

8.5e-02

9.9e-03

cases:34.20%

controls:35.84%

cases:33.15%

controls:32.08%

cases:16.50%

controls:9.76%

cases:34.35%

controls:0.52%

cases:32.63%

controls:9.22%

cases:34.99%

controls:33.09%

cases:42.89%

controls:42.65%

682

6858

1312

12277

661

6138

1333

12997

329

1868

1665

17267

685

1309

19036

649

1762

1340

17353

683

6212

1269

12561

745

7007

992

9423

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

-2.2e-02

6.3e-01

2.3e+00

—

2.8e+00

8.8e-01

3.4e-01

cases:3.26%

controls:3.33%

cases:2.76%

controls:1.48%

cases:1.91%

controls:0.20%

—

cases:3.87%

controls:0.24%

cases:2.82%

controls:1.19%

cases:4.89%

controls:3.52%

637

1929

18498

284

1939

18851

1956

19097

—

1912

19070

224

1897

18549

579

1652

15851

Emergency Room Visit
ER [9203]

2.2e-01

7.4e-01

2.1e+00

—

2.6e+00

5.8e-01

3.9e-01

cases:25.88%

controls:21.89%

cases:13.24%

controls:6.79%

cases:6.17%

controls:0.82%

—

cases:9.15%

controls:0.76%

cases:10.19%

controls:5.97%

cases:21.99%

controls:16.03%

516

4189

1478

14946

264

1299

1730

17836

123

157

1871

18978

—

182

145

1807

18970

199

1121

1753

17652

382

2633

1355

13797

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

-5.9e-03

5.1e-01

2.2e+00

—

2.8e+00

7.8e-01

3.0e-01

cases:7.57%

controls:7.61%

cases:5.22%

controls:3.19%

cases:3.16%

controls:0.37%

—

cases:6.23%

controls:0.41%

cases:5.43%

controls:2.57%

cases:9.33%

controls:7.08%

151

1457

1843

17678

104

611

1890

18524

1931

19064

—

124

1865

19036

106

482

1846

18291

162

1164

1575

15266

Albumin [Presence] in Urine by Test strip
50949-7 [3029937]

-1.4e-01

6.8e-02

1.4e+00

5.0e+00

9.4e-01

2.4e-01

4.3e-02

cases:4.11%

controls:4.68%

cases:2.46%

controls:2.30%

cases:1.10%

controls:0.28%

cases:3.91%

controls:0.03%

cases:0.65%

controls:0.26%

cases:2.82%

controls:2.22%

cases:6.04%

controls:5.81%

896

1912

18239

440

1945

18695

1972

19081

1916

19130

1976

19066

417

1897

18356

105

954

1632

15476

More than one and less than three hours
ZXE10 [2001311401]

1.2e-01

-8.8e-02

1.6e+00

—

4.2e+00

1.2e+00

9.7e-01

cases:4.11%

controls:3.68%

cases:0.75%

controls:0.82%

cases:0.35%

controls:0.07%

—

cases:1.66%

controls:0.03%

cases:1.43%

controls:0.45%

cases:3.51%

controls:1.36%

704

1912

18431

157

1979

18978

1987

19121

—

1956

19110

1924

18688

224

1676

16206

ciprofloxacin; oral, parenteral
J01MA02 [21603009]

3.6e-01

7.3e-01

1.5e+00

—

2.8e+00

6.6e-01

5.0e-01

cases:4.71%

controls:3.33%

cases:2.06%

controls:1.00%

cases:0.60%

controls:0.14%

—

cases:1.76%

controls:0.10%

cases:1.79%

controls:0.94%

cases:4.84%

controls:2.98%

638

1900

18497

192

1953

18943

1982

19108

—

1954

19095

176

1917

18597

490

1653

15940

Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]

1.1e-01

8.7e-01

2.4e+00

1.0e+50

2.0e+00

8.1e-01

4.6e-01

cases:1.76%

controls:1.57%

cases:1.50%

controls:0.64%

cases:0.80%

controls:0.07%

cases:1.71%

controls:0.00%

cases:0.70%

controls:0.10%

cases:1.49%

controls:0.67%

cases:2.53%

controls:1.62%

300

1959

18835

122

1964

19013

1978

19121

1960

19135

1975

19096

125

1923

18648

266

1693

16164

ibuprofen
R02AX02 [1588667]

1.1e-01

2.4e-01

4.8e-01

2.3e+00

2.8e+00

3.5e-01

2.7e-01

cases:28.89%

controls:26.78%

cases:14.74%

controls:11.94%

cases:2.51%

controls:1.57%

cases:0.45%

controls:0.05%

cases:20.11%

controls:1.45%

cases:16.09%

controls:11.86%

cases:32.07%

controls:26.46%

576

5124

1418

14011

294

2284

1700

16851

301

1944

18834

1985

19126

400

277

1589

18838

314

2227

1638

16546

557

4348

1180

12082

ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]

1.1e-01

2.4e-01

4.8e-01

2.3e+00

2.8e+00

3.5e-01

2.7e-01

cases:28.89%

controls:26.78%

cases:14.74%

controls:11.94%

cases:2.51%

controls:1.57%

cases:0.45%

controls:0.05%

cases:20.11%

controls:1.45%

cases:16.09%

controls:11.86%

cases:32.07%

controls:26.46%

576

5124

1418

14011

294

2284

1700

16851

301

1944

18834

1985

19126

400

277

1589

18838

314

2227

1638

16546

557

4348

1180

12082

cefalexin; oral
J01DB01 [21602870]

1.4e-01

5.6e-01

1.0e+00

—

3.6e+00

4.3e-01

3.7e-01

cases:21.77%

controls:19.45%

cases:10.58%

controls:6.32%

cases:1.96%

controls:0.73%

—

cases:17.60%

controls:0.59%

cases:8.81%

controls:5.94%

cases:26.25%

controls:19.78%

434

3721

1560

15414

211

1210

1783

17925

139

1955

18996

—

350

112

1639

19003

172

1115

1780

17658

456

3250

1281

13180

Outpatient Hospital
22 [8756]

2.5e-02

4.5e-01

1.3e+00

—

2.9e+00

8.1e-01

4.3e-01

cases:14.54%

controls:14.24%

cases:5.52%

controls:3.57%

cases:1.55%

controls:0.43%

—

cases:6.13%

controls:0.37%

cases:6.76%

controls:3.13%

cases:15.54%

controls:10.66%

290

2724

1704

16411

110

684

1884

18451

1963

19052

—

122

1867

19044

132

587

1820

18186

270

1752

1467

14678

Essential (primary) hypertension
I10 [45591453]

-2.1e-02

1.6e-01

4.5e-01

4.8e+00

1.0e+00

-7.2e-02

6.8e-02

cases:7.92%

controls:8.08%

cases:5.02%

controls:4.31%

cases:1.25%

controls:0.80%

cases:3.16%

controls:0.03%

cases:2.11%

controls:0.78%

cases:4.46%

controls:4.77%

cases:10.65%

controls:10.02%

158

1546

1836

17589

100

825

1894

18310

154

1969

18981

1931

19130

149

1947

18966

896

1865

17877

185

1647

1552

14783

Intubation
WX704 [2001310820]

1.7e-01

2.6e-01

—

1.0e+50

3.3e+00

1.6e+00

7.9e-01

cases:0.70%

controls:0.59%

cases:0.25%

controls:0.19%

—

cases:5.62%

controls:0.00%

cases:1.16%

controls:0.04%

cases:1.02%

controls:0.21%

cases:1.32%

controls:0.60%

113

1980

19022

1989

19098

—

112

1882

19135

1966

19107

1932

18734

1714

16331

Outpatient Visit
OP [9202]

6.7e-02

1.5e-01

2.6e-01

4.5e+00

8.1e-01

3.4e-01

1.4e-01

cases:54.76%

controls:53.10%

cases:38.21%

controls:34.76%

cases:9.28%

controls:7.32%

cases:22.52%

controls:0.33%

cases:13.62%

controls:6.53%

cases:41.75%

controls:33.87%

cases:58.55%

controls:55.16%

1092

10160

902

8975

762

6651

1232

12484

185

1400

1809

17735

449

1545

19071

271

1249

1718

17866

815

6358

1137

12415

1017

9062

720

7368

paracetamol; oral, parenteral, rectal
N02BE01 [21604344]

6.6e-02

2.1e-01

3.9e-01

2.1e+00

2.7e+00

3.7e-01

cases:25.18%

controls:23.96%

cases:14.39%

controls:12.02%

cases:2.71%

controls:1.86%

cases:0.75%

controls:0.09%

cases:24.94%

controls:2.11%

cases:16.60%

controls:12.03%

cases:32.12%

controls:24.56%

502

4584

1492

14551

287

2300

1707

16835

355

1940

18780

1979

19117

496

404

1493

18711

324

2259

1628

16514

558

4035

1179

12395

Supplier / Service Provider
OMOP5117446 [33004]

-1.2e+00

-1.1e+00

-7.1e-01

—

2.7e+00

2.3e+00

2.9e+00

cases:11.99%

controls:31.09%

cases:4.06%

controls:11.63%

cases:0.60%

controls:1.22%

—

cases:0.90%

controls:0.06%

cases:3.89%

controls:0.40%

cases:11.23%

controls:0.71%

239

5949

1755

13186

2226

1913

16909

233

1982

18902

—

1971

19103

1876

18698

195

116

1542

16314

Emergency Room and Inpatient Visit
ERIP [262]

6.4e-02

6.7e-01

1.8e+00

—

3.1e+00

4.1e-01

2.2e-01

cases:3.81%

controls:3.59%

cases:3.81%

controls:2.00%

cases:1.65%

controls:0.28%

—

cases:5.38%

controls:0.27%

cases:3.33%

controls:2.24%

cases:7.54%

controls:6.13%

686

1918

18449

382

1918

18753

1961

19081

—

107

1882

19064

420

1887

18353

131

1007

1606

15423

Emergency Medicine
93 [38004510]

1.7e-01

6.4e-01

2.0e+00

—

2.1e+00

4.6e-01

2.8e-01

cases:12.69%

controls:10.89%

cases:10.58%

controls:5.89%

cases:5.02%

controls:0.72%

—

cases:5.33%

controls:0.70%

cases:9.12%

controls:5.98%

cases:18.88%

controls:15.02%

253

2084

1741

17051

211

1127

1783

18008

100

137

1894

18998

—

106

134

1883

18981

178

1122

1774

17651

328

2468

1409

13962

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

5.6e-02

5.5e-01

1.9e+00

—

1.9e+00

6.1e-01

4.2e-01

cases:4.16%

controls:3.95%

cases:3.56%

controls:2.10%

cases:1.91%

controls:0.28%

—

cases:1.91%

controls:0.28%

cases:3.23%

controls:1.77%

cases:6.91%

controls:4.65%

755

1911

18380

401

1923

18734

1956

19081

—

1951

19061

333

1889

18440

120

764

1617

15666

Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]

2.8e-01

7.1e-01

2.0e+00

—

2.3e+00

4.9e-01

4.4e-01

cases:2.36%

controls:1.80%

cases:2.26%

controls:1.12%

cases:1.05%

controls:0.15%

—

cases:1.46%

controls:0.15%

cases:1.84%

controls:1.14%

cases:4.20%

controls:2.74%

344

1947

18791

214

1949

18921

1973

19107

—

1960

19086

214

1916

18559

450

1664

15980

Inpatient Hospital
21 [8717]

2.5e-02

7.0e-01

1.2e+00

—

2.6e+00

5.4e-01

2.2e-01

cases:20.46%

controls:20.06%

cases:11.28%

controls:5.92%

cases:2.51%

controls:0.73%

—

cases:8.60%

controls:0.70%

cases:9.58%

controls:5.84%

cases:21.53%

controls:18.06%

408

3838

1586

15297

225

1132

1769

18003

140

1944

18995

—

171

133

1818

18982

187

1096

1765

17677

374

2968

1363

13462

Bacteria [Presence] in Urine
87829-8 [36304419]

4.8e-02

5.1e-01

1.9e+00

—

1.9e+00

5.7e-01

4.0e-01

cases:4.06%

controls:3.88%

cases:3.26%

controls:1.98%

cases:1.76%

controls:0.28%

—

cases:1.71%

controls:0.25%

cases:2.92%

controls:1.67%

cases:6.51%

controls:4.44%

742

1913

18393

378

1929

18757

1959

19082

—

1955

19067

314

1895

18459

113

729

1624

15701

Bacteria identified in Isolate by Culture
43409-2 [3042936]

3.0e-02

6.4e-01

1.9e+00

—

3.4e+00

3.8e-01

1.7e-01

cases:1.91%

controls:1.85%

cases:1.20%

controls:0.64%

cases:0.70%

controls:0.11%

—

cases:3.37%

controls:0.12%

cases:0.87%

controls:0.60%

cases:2.30%

controls:1.94%

354

1956

18781

122

1970

19013

1980

19114

—

1922

19093

112

1935

18661

319

1697

16111

Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]

4.7e-01

9.6e-01

1.6e+00

—

2.1e+00

1.5e+00

7.4e-01

cases:2.01%

controls:1.26%

cases:1.15%

controls:0.44%

cases:0.40%

controls:0.08%

—

cases:0.75%

controls:0.09%

cases:2.00%

controls:0.46%

cases:2.88%

controls:1.39%

242

1954

18893

1971

19050

1986

19119

—

1974

19097

1913

18686

229

1687

16201

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

2.5e-02

4.9e-01

1.9e+00

—

1.9e+00

5.5e-01

3.6e-01

cases:4.61%

controls:4.50%

cases:3.76%

controls:2.33%

cases:2.16%

controls:0.32%

—

cases:2.11%

controls:0.32%

cases:3.64%

controls:2.14%

cases:7.60%

controls:5.44%

862

1902

18273

446

1919

18689

1951

19074

—

1947

19054

401

1881

18372

132

894

1605

15536

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

7.1e-02

3.6e-01

6.0e-01

3.7e+00

7.8e-01

3.4e-01

2.4e-01

cases:9.53%

controls:8.93%

cases:7.07%

controls:5.02%

cases:1.55%

controls:0.86%

cases:1.05%

controls:0.03%

cases:2.06%

controls:0.95%

cases:6.71%

controls:4.88%

cases:11.86%

controls:9.61%

190

1709

1804

17426

141

961

1853

18174

165

1963

18970

1973

19130

182

1948

18933

131

917

1821

17856

206

1579

1531

14851

Monocytes/Leukocytes in Blood
26485-3 [3019069]

9.0e-02

3.7e-01

5.6e-01

3.7e+00

7.4e-01

3.3e-01

2.2e-01

cases:9.33%

controls:8.60%

cases:6.92%

controls:4.89%

cases:1.50%

controls:0.86%

cases:1.00%

controls:0.03%

cases:1.96%

controls:0.94%

cases:6.56%

controls:4.80%

cases:11.28%

controls:9.28%

186

1645

1808

17490

138

935

1856

18200

165

1964

18970

1974

19130

180

1950

18935

128

902

1824

17871

196

1524

1541

14906

Cathetrisation of vein
TPH04 [2001309597]

3.4e-01

8.8e-01

1.3e+00

1.0e+50

2.5e+00

1.2e+00

5.2e-01

cases:2.71%

controls:1.94%

cases:1.50%

controls:0.63%

cases:0.40%

controls:0.10%

cases:4.16%

controls:0.00%

cases:1.26%

controls:0.10%

cases:2.00%

controls:0.63%

cases:2.88%

controls:1.73%

371

1940

18764

120

1964

19015

1986

19115

1911

19135

1964

19095

118

1913

18655

284

1687

16146

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

1.0e-01

3.8e-01

5.6e-01

3.6e+00

7.5e-01

3.4e-01

2.2e-01

cases:9.33%

controls:8.51%

cases:6.97%

controls:4.87%

cases:1.50%

controls:0.86%

cases:0.95%

controls:0.03%

cases:1.96%

controls:0.94%

cases:6.56%

controls:4.78%

cases:11.23%

controls:9.25%

186

1629

1808

17506

139

931

1855

18204

165

1964

18970

1975

19130

179

1950

18936

128

897

1824

17876

195

1520

1542

14910

Infection following a procedure, not elsewhere classified
T81.4 [45575538]

8.7e-02

5.8e-01

—

3.3e+00

1.6e+00

6.8e-01

cases:0.75%

controls:0.69%

cases:0.40%

controls:0.22%

—

cases:1.76%

controls:0.06%

cases:0.87%

controls:0.17%

cases:1.04%

controls:0.53%

132

1979

19003

1986

19092

—

1954

19103

1935

18741

1719

16343

Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]

2.2e-01

7.8e-01

1.9e+00

—

2.3e+00

5.1e-01

3.6e-01

cases:2.16%

controls:1.73%

cases:2.46%

controls:1.14%

cases:1.15%

controls:0.18%

—

cases:1.51%

controls:0.16%

cases:1.95%

controls:1.18%

cases:4.43%

controls:3.13%

331

1951

18804

219

1945

18916

1971

19100

—

1959

19085

221

1914

18552

514

1660

15916

One hour or less
ZXE00 [2001311394]

2.7e-01

4.0e-01

1.3e+00

—

3.2e+00

1.0e+00

6.3e-01

cases:5.42%

controls:4.19%

cases:1.35%

controls:0.91%

cases:0.35%

controls:0.09%

—

cases:1.81%

controls:0.08%

cases:1.49%

controls:0.54%

cases:3.68%

controls:1.99%

108

802

1886

18333

175

1967

18960

1987

19117

—

1953

19100

101

1923

18672

327

1673

16103

Sampling
SPAT1263 [2001700364]

1.2e-01

-9.4e-02

6.3e-01

3.5e+00

9.7e-01

3.6e-01

3.7e-01

cases:8.17%

controls:7.35%

cases:2.41%

controls:2.64%

cases:0.70%

controls:0.38%

cases:1.00%

controls:0.03%

cases:1.11%

controls:0.42%

cases:3.33%

controls:2.35%

cases:8.46%

controls:6.02%

163

1406

1831

17729

505

1946

18630

1980

19063

1974

19129

1967

19034

441

1887

18332

147

989

1590

15441

Eosinophils [#/volume] in Blood
26449-9 [3013115]

5.4e-02

3.2e-01

4.4e-01

3.4e+00

7.6e-01

3.2e-01

1.4e-01

cases:9.83%

controls:9.36%

cases:7.42%

controls:5.50%

cases:1.65%

controls:1.08%

cases:0.90%

controls:0.03%

cases:2.21%

controls:1.05%

cases:7.27%

controls:5.41%

cases:12.20%

controls:10.79%

196

1791

1798

17344

148

1052

1846

18083

206

1961

18929

1976

19129

201

1945

18914

142

1015

1810

17758

212

1772

1525

14658

Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]

1.7e-01

7.0e-01

1.5e+00

—

1.9e+00

6.8e-01

4.1e-01

cases:4.51%

controls:3.82%

cases:2.26%

controls:1.13%

cases:0.65%

controls:0.15%

—

cases:0.55%

controls:0.08%

cases:2.00%

controls:1.02%

cases:4.49%

controls:3.03%

731

1904

18404

217

1949

18918

1981

19106

—

1978

19099

191

1913

18582

498

1659

15932

Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]

1.7e-01

7.0e-01

1.7e+00

—

3.0e+00

7.0e-01

9.8e-02

cases:1.40%

controls:1.19%

cases:1.10%

controls:0.55%

cases:0.40%

controls:0.07%

—

cases:1.81%

controls:0.09%

cases:1.28%

controls:0.64%

cases:2.25%

controls:2.04%

228

1966

18907

105

1972

19030

1986

19121

—

1953

19098

120

1927

18653

335

1698

16095

Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]

-1.1e-01

3.3e-01

1.7e+00

—

2.1e+00

9.1e-01

6.1e-01

cases:0.95%

controls:1.06%

cases:0.90%

controls:0.65%

cases:0.80%

controls:0.15%

—

cases:0.85%

controls:0.10%

cases:1.49%

controls:0.60%

cases:2.01%

controls:1.11%

203

1975

18932

124

1976

19011

1978

19107

—

1972

19095

113

1923

18660

182

1702

16248

ABO and Rh group [Type] in Blood
882-1 [3003694]

-1.3e-01

3.0e-01

1.9e+00

1.0e+50

2.8e+00

-2.5e-01

-1.5e-01

cases:4.81%

controls:5.44%

cases:2.51%

controls:1.87%

cases:1.20%

controls:0.18%

cases:7.87%

controls:0.00%

cases:2.06%

controls:0.13%

cases:1.08%

controls:1.38%

cases:3.80%

controls:4.41%

1040

1898

18095

357

1944

18778

1970

19100

157

1837

19135

1948

19090

259

1931

18514

724

1671

15706

levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]

4.5e-01

1.0e+00

—

3.6e+00

9.7e-01

5.4e-01

cases:1.81%

controls:1.16%

cases:0.90%

controls:0.33%

—

cases:1.51%

controls:0.04%

cases:0.77%

controls:0.29%

cases:1.84%

controls:1.08%

222

1958

18913

1976

19071

—

1959

19107

1937

18718

178

1705

16252

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

4.6e-02

3.0e-01

5.2e-01

3.4e+00

8.1e-01

3.3e-01

1.6e-01

cases:9.83%

controls:9.43%

cases:7.22%

controls:5.48%

cases:1.71%

controls:1.02%

cases:0.95%

controls:0.03%

cases:2.21%

controls:1.00%

cases:7.17%

controls:5.28%

cases:12.32%

controls:10.68%

196

1805

1798

17330

144

1048

1850

18087

195

1960

18940

1975

19129

191

1945

18924

140

991

1812

17782

214

1754

1523

14676

Physiotherapist
Z3226 [2001311560]

2.3e-01

—

-1.0e+50

—

2.1e+00

1.5e+00

8.8e-01

cases:1.71%

controls:1.36%

—

cases:0.00%

controls:0.06%

—

cases:0.35%

controls:0.04%

cases:0.56%

controls:0.13%

cases:1.15%

controls:0.48%

261

1960

18874

—

1994

19124

—

1982

19107

1941

18749

1717

16351

Medical doctor
Z2221 [2001311556]

2.8e-01

1.5e+00

1.0e+50

2.3e+00

1.3e+00

8.8e-01

cases:4.06%

controls:3.10%

cases:1.00%

controls:0.76%

cases:0.25%

controls:0.06%

cases:0.40%

controls:0.00%

cases:0.65%

controls:0.06%

cases:1.90%

controls:0.54%

cases:2.71%

controls:1.14%

593

1913

18542

145

1974

18990

1989

19124

1986

19135

1976

19103

101

1915

18672

188

1690

16242

Case Management Agency
251B00000X [38004193]

-1.1e-01

-2.7e-02

2.8e-01

3.7e+00

4.8e-01

5.1e-02

1.3e-02

cases:49.25%

controls:52.06%

cases:43.73%

controls:44.40%

cases:23.07%

controls:18.52%

cases:32.05%

controls:1.11%

cases:27.15%

controls:18.72%

cases:46.57%

controls:45.30%

cases:53.60%

controls:53.27%

982

9961

1012

9174

872

8495

1122

10640

460

3543

1534

15592

639

213

1355

18922

540

3578

1449

15537

909

8505

1043

10268

931

8752

806

7678

SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]

6.3e-02

2.0e-01

3.8e-01

4.5e+00

9.7e-02

1.5e-01

4.8e-02

cases:11.28%

controls:10.67%

cases:7.32%

controls:6.10%

cases:1.60%

controls:1.10%

cases:2.26%

controls:0.03%

cases:1.11%

controls:1.00%

cases:7.38%

controls:6.40%

cases:15.89%

controls:15.26%

225

2042

1769

17093

146

1167

1848

17968

211

1962

18924

1949

19130

192

1967

18923

144

1202

1808

17571

276

2508

1461

13922

Basophils [#/volume] in Blood
26444-0 [3006315]

7.2e-02

2.9e-01

5.1e-01

3.3e+00

7.5e-01

3.2e-01

1.7e-01

cases:9.58%

controls:8.97%

cases:6.97%

controls:5.32%

cases:1.65%

controls:1.00%

cases:0.85%

controls:0.03%

cases:2.06%

controls:0.98%

cases:7.07%

controls:5.21%

cases:12.09%

controls:10.40%

191

1717

1803

17418

139

1018

1855

18117

192

1961

18943

1977

19129

188

1948

18927

138

979

1814

17794

210

1708

1527

14722

Oncology Clinic/Center
261QX0200X [38004268]

3.5e-02

5.9e-02

1.9e+00

—

2.4e+00

4.0e-01

2.7e-01

cases:3.06%

controls:2.96%

cases:0.95%

controls:0.90%

cases:0.40%

controls:0.06%

—

cases:1.01%

controls:0.09%

cases:1.02%

controls:0.69%

cases:3.17%

controls:2.45%

566

1933

18569

172

1975

18963

1986

19124

—

1969

19098

129

1932

18644

402

1682

16028

General Practice
1 [38004446]

3.0e-01

5.6e-01

1.5e+00

—

1.6e+00

4.2e-01

2.7e-01

cases:10.38%

controls:7.93%

cases:4.86%

controls:2.83%

cases:1.86%

controls:0.42%

—

cases:1.81%

controls:0.37%

cases:4.56%

controls:3.05%

cases:10.31%

controls:8.06%

207

1518

1787

17617

542

1897

18593

1957

19055

—

1953

19044

572

1863

18201

179

1325

1558

15105

Monocytes [#/volume] in Blood
26484-6 [3001604]

7.3e-02

2.8e-01

5.1e-01

3.3e+00

7.5e-01

3.2e-01

1.6e-01

cases:9.58%

controls:8.97%

cases:6.92%

controls:5.33%

cases:1.65%

controls:1.00%

cases:0.85%

controls:0.03%

cases:2.06%

controls:0.98%

cases:7.02%

controls:5.21%

cases:12.03%

controls:10.40%

191

1716

1803

17419

138

1020

1856

18115

192

1961

18943

1977

19129

188

1948

18927

137

978

1815

17795

209

1708

1528

14722

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

1.9e-01

6.9e-01

—

1.0e+50

2.3e+00

9.0e-01

5.1e-01

cases:3.26%

controls:2.71%

cases:1.55%

controls:0.79%

—

cases:0.25%

controls:0.00%

cases:0.40%

controls:0.04%

cases:1.43%

controls:0.59%

cases:3.63%

controls:2.20%

519

1929

18616

151

1963

18984

—

1989

19135

1981

19107

110

1924

18663

362

1674

16068

enoxaparin; parenteral
B01AB05 [21600976]

2.3e-01

2.6e-01

5.8e-01

—

3.0e+00

7.8e-01

5.3e-01

cases:3.96%

controls:3.19%

cases:1.25%

controls:0.97%

cases:0.25%

controls:0.14%

—

cases:2.26%

controls:0.11%

cases:1.84%

controls:0.85%

cases:3.68%

controls:2.20%

610

1915

18525

186

1969

18949

1989

19108

—

1944

19094

160

1916

18613

362

1673

16068

Pain localized to upper abdomen
R10.1 [45568111]

-6.3e-03

1.2e+00

2.5e+00

—

1.4e+00

4.2e-01

5.5e-01

cases:1.60%

controls:1.61%

cases:1.71%

controls:0.51%

cases:0.65%

controls:0.05%

—

cases:0.35%

controls:0.09%

cases:0.92%

controls:0.61%

cases:2.94%

controls:1.72%

309

1962

18826

1960

19037

1981

19125

—

1982

19098

114

1934

18659

282

1686

16148

Noninvasive ventilation
WX725 [2001310828]

6.1e-01

9.3e-01

—

2.9e+00

1.4e+00

7.2e-01

cases:0.65%

controls:0.36%

cases:0.25%

controls:0.10%

—

cases:0.45%

controls:0.03%

cases:0.56%

controls:0.14%

cases:0.81%

controls:0.40%

1981

19067

1989

19116

—

1980

19110

1941

18747

1723

16365

Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]

-1.9e-01

7.2e-01

2.3e+00

—

2.0e+00

5.9e-01

5.4e-01

cases:0.95%

controls:1.15%

cases:1.00%

controls:0.49%

cases:0.30%

controls:0.03%

—

cases:0.45%

controls:0.06%

cases:0.82%

controls:0.46%

cases:1.96%

controls:1.15%

220

1975

18915

1974

19041

1988

19129

—

1980

19103

1936

18687

189

1703

16241

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

3.3e-01

7.6e-01

1.9e+00

—

1.5e+00

5.9e-01

1.8e-01

cases:3.26%

controls:2.37%

cases:2.06%

controls:0.97%

cases:0.85%

controls:0.13%

—

cases:0.55%

controls:0.12%

cases:1.90%

controls:1.05%

cases:3.40%

controls:2.85%

453

1929

18682

186

1953

18949

1977

19111

—

1978

19092

198

1915

18575

469

1678

15961

Extensive abdominal CT
JN3BD [2001305556]

2.9e-01

2.5e+00

—

1.0e+50

—

1.7e+00

8.0e-01

cases:1.10%

controls:0.83%

cases:1.55%

controls:0.14%

—

cases:6.62%

controls:0.00%

—

cases:0.51%

controls:0.09%

cases:0.63%

controls:0.29%

158

1972

18977

1963

19109

—

132

1862

19135

—

1942

18756

1726

16383

Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]

1.1e-01

3.3e-01

2.0e+00

—

2.1e+00

7.8e-01

3.8e-01

cases:1.20%

controls:1.08%

cases:0.60%

controls:0.43%

cases:0.40%

controls:0.05%

—

cases:0.30%

controls:0.04%

cases:0.82%

controls:0.38%

cases:1.73%

controls:1.19%

206

1970

18929

1982

19052

1986

19125

—

1983

19108

1936

18702

196

1707

16234

Gastroenterology
10 [38004455]

2.4e-01

5.7e-01

1.1e+00

—

1.2e+00

7.4e-01

4.8e-01

cases:4.61%

controls:3.66%

cases:2.96%

controls:1.69%

cases:1.00%

controls:0.33%

—

cases:1.01%

controls:0.29%

cases:3.59%

controls:1.75%

cases:5.93%

controls:3.76%

701

1902

18434

324

1935

18811

1974

19071

—

1969

19059

328

1882

18445

103

617

1634

15813

Tissue Pathology biopsy report
66121-5 [40768804]

-2.9e-02

1.5e-02

1.1e+00

—

2.5e+00

5.1e-01

2.3e-01

cases:6.37%

controls:6.54%

cases:2.51%

controls:2.47%

cases:0.65%

controls:0.22%

—

cases:2.92%

controls:0.24%

cases:3.02%

controls:1.83%

cases:6.79%

controls:5.50%

127

1252

1867

17883

473

1944

18662

1981

19092

—

1931

19070

344

1893

18429

118

903

1619

15527

Intravenous general anesthesia
WX404 [2001310807]

-1.3e-02

3.0e-01

—

2.8e+00

1.3e+00

3.9e-01

cases:2.16%

controls:2.18%

cases:0.65%

controls:0.49%

—

cases:0.65%

controls:0.04%

cases:1.08%

controls:0.29%

cases:1.09%

controls:0.74%

418

1951

18717

1981

19042

—

1976

19107

1931

18718

122

1718

16308

Other and unspecified ventral hernia without obstruction or gangrene
K43.9 [45533594]

5.4e-01

1.2e+00

—

2.2e+00

1.9e+00

cases:0.40%

controls:0.24%

cases:0.25%

controls:0.08%

—

cases:0.56%

controls:0.06%

cases:1.09%

controls:0.17%

1986

19090

1989

19120

—

1941

18761

1718

16402

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

1.7e-01

4.0e-01

1.6e+00

—

1.8e+00

5.1e-01

2.7e-01

cases:5.52%

controls:4.68%

cases:3.31%

controls:2.25%

cases:1.15%

controls:0.24%

—

cases:1.26%

controls:0.20%

cases:3.48%

controls:2.12%

cases:7.48%

controls:5.81%

110

896

1884

18239

430

1928

18705

1971

19090

—

1964

19076

398

1884

18375

130

954

1607

15476

Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]

2.4e-01

7.3e-01

—

1.0e+50

2.7e+00

1.2e+00

6.7e-02

cases:0.55%

controls:0.43%

cases:0.40%

controls:0.19%

—

cases:0.60%

controls:0.00%

cases:0.75%

controls:0.05%

cases:0.72%

controls:0.21%

cases:0.75%

controls:0.70%

1983

19052

1986

19098

—

1982

19135

1974

19105

1938

18734

115

1724

16315

Abdominal ultrasound examination
JN3AE [2001305555]

7.4e-01

1.2e+00

—

1.0e+50

2.1e+00

1.1e+00

7.6e-01

cases:2.16%

controls:1.05%

cases:1.10%

controls:0.33%

—

cases:3.41%

controls:0.00%

cases:0.25%

controls:0.03%

cases:0.92%

controls:0.30%

cases:1.55%

controls:0.73%

200

1951

18935

1972

19071

—

1926

19135

1984

19109

1934

18716

120

1710

16310

Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]

5.0e-01

7.2e-01

1.9e+00

—

1.9e+00

5.0e-01

1.0e-01

cases:1.30%

controls:0.79%

cases:0.80%

controls:0.39%

cases:0.35%

controls:0.05%

—

cases:0.35%

controls:0.05%

cases:0.67%

controls:0.40%

cases:1.67%

controls:1.51%

152

1968

18983

1978

19060

1987

19125

—

1982

19105

1939

18697

248

1708

16182

Observation for suspected disease or condition, unspecified
Z03.9 [45552062]

2.7e-01

5.6e-01

1.8e+00

1.0e+50

1.9e+00

7.2e-01

3.6e-01

cases:2.41%

controls:1.84%

cases:0.90%

controls:0.52%

cases:0.35%

controls:0.06%

cases:0.60%

controls:0.00%

cases:0.40%

controls:0.06%

cases:1.23%

controls:0.60%

cases:2.42%

controls:1.70%

352

1946

18783

1976

19036

1987

19124

1982

19135

1981

19104

113

1928

18660

280

1695

16150

Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]

-1.6e-01

6.7e-01

—

2.5e+00

1.2e+00

-1.7e-01

cases:0.50%

controls:0.59%

cases:0.50%

controls:0.26%

—

cases:0.55%

controls:0.05%

cases:0.67%

controls:0.21%

cases:0.69%

controls:0.82%

112

1984

19023

1984

19086

—

1978

19106

1939

18734

135

1725

16295

Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]

6.3e-01

9.9e-01

2.6e+00

1.0e+50

1.9e+00

4.3e-01

-2.7e-02

cases:1.05%

controls:0.56%

cases:0.75%

controls:0.28%

cases:0.35%

controls:0.03%

cases:1.35%

controls:0.00%

cases:0.30%

controls:0.05%

cases:0.41%

controls:0.27%

cases:1.21%

controls:1.24%

108

1973

19027

1979

19081

1987

19130

1967

19135

1983

19106

1944

18723

204

1716

16226

Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]

5.9e-02

3.6e-01

1.8e+00

—

1.8e+00

3.4e-01

3.2e-01

cases:5.67%

controls:5.36%

cases:3.71%

controls:2.61%

cases:2.11%

controls:0.37%

—

cases:2.01%

controls:0.35%

cases:3.43%

controls:2.48%

cases:7.83%

controls:5.84%

113

1026

1881

18109

500

1920

18635

1952

19065

—

1949

19048

465

1885

18308

136

959

1601

15471

Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]

3.4e-01

5.3e-01

—

1.0e+50

2.6e+00

9.4e-01

7.3e-03

cases:1.20%

controls:0.86%

cases:0.60%

controls:0.36%

—

cases:0.70%

controls:0.00%

cases:0.75%

controls:0.06%

cases:0.92%

controls:0.36%

cases:1.32%

controls:1.31%

165

1970

18970

1982

19067

—

1980

19135

1974

19104

1934

18705

216

1714

16214

Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]

5.9e-02

5.3e-01

—

2.5e+00

1.0e+00

-6.1e-02

cases:0.90%

controls:0.85%

cases:0.60%

controls:0.36%

—

cases:0.75%

controls:0.06%

cases:0.92%

controls:0.34%

cases:1.15%

controls:1.22%

163

1976

18972

1982

19067

—

1974

19103

1934

18710

201

1717

16229

Abdominal pain localized other
D06 [2002000305]

5.9e-01

5.1e-01

2.4e+00

1.0e+50

—

1.0e+00

4.7e-01

cases:1.35%

controls:0.76%

cases:0.50%

controls:0.30%

cases:0.35%

controls:0.03%

cases:1.45%

controls:0.00%

—

cases:0.77%

controls:0.28%

cases:1.21%

controls:0.76%

145

1967

18990

1984

19077

1987

19129

1965

19135

—

1937

18720

125

1716

16305

Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]

-2.9e-01

6.3e-01

—

2.3e+00

1.1e+00

-2.0e-01

cases:0.45%

controls:0.60%

cases:0.50%

controls:0.27%

—

cases:0.55%

controls:0.06%

cases:0.67%

controls:0.22%

cases:0.69%

controls:0.85%

115

1985

19020

1984

19084

—

1978

19104

1939

18732

139

1725

16291

Bacteria identified in Urine by Culture
630-4 [3026008]

3.8e-02

2.0e-01

1.8e+00

—

1.6e+00

4.2e-01

2.4e-01

cases:4.01%

controls:3.87%

cases:2.21%

controls:1.81%

cases:1.10%

controls:0.19%

—

cases:1.06%

controls:0.21%

cases:2.46%

controls:1.64%

cases:6.04%

controls:4.82%

740

1914

18395

347

1950

18788

1972

19098

—

1968

19075

307

1904

18466

105

792

1632

15638

Oxygen saturation in Arterial blood
2708-6 [3016502]

6.5e-02

4.7e-01

—

2.3e+00

1.0e+00

-3.3e-02

cases:0.95%

controls:0.89%

cases:0.60%

controls:0.38%

—

cases:0.75%

controls:0.07%

cases:0.97%

controls:0.36%

cases:1.27%

controls:1.31%

171

1975

18964

1982

19063

—

1974

19101

1933

18706

215

1715

16215

Other symptoms involving abdomen and pelvis, Abdominal pain
7890A [2000407034]

1.1e+00

2.3e+00

—

1.0e+50

—

1.4e+00

9.5e-01

cases:0.80%

controls:0.28%

cases:0.60%

controls:0.06%

—

cases:0.25%

controls:0.00%

—

cases:0.26%

controls:0.06%

cases:0.52%

controls:0.20%

1978

19082

1982

19123

—

1989

19135

—

1947

18761

1728

16397

Epithelial cells [#/volume] in Urine
30383-4 [3000850]

-6.0e-02

1.3e-01

1.9e+00

—

1.4e+00

4.8e-01

2.8e-01

cases:2.96%

controls:3.14%

cases:1.45%

controls:1.28%

cases:1.20%

controls:0.18%

—

cases:0.65%

controls:0.17%

cases:1.64%

controls:1.02%

cases:3.80%

controls:2.88%

600

1935

18535

244

1965

18891

1970

19100

—

1976

19083

191

1920

18582

474

1671

15956

clidinium and psycholeptics
A03CA02 [21600204]

9.4e-01

9.0e-01

—

1.4e+00

9.1e-01

cases:1.20%

controls:0.48%

cases:0.60%

controls:0.25%

—

cases:0.72%

controls:0.18%

cases:1.38%

controls:0.56%

1970

19044

1982

19088

—

1938

18740

1713

16338

Office Visit
OMOP4822458 [581477]

1.5e-01

1.2e-01

1.2e+00

—

2.1e+00

4.0e-01

3.0e-01

cases:6.07%

controls:5.29%

cases:1.65%

controls:1.47%

cases:0.70%

controls:0.22%

—

cases:1.46%

controls:0.18%

cases:1.79%

controls:1.21%

cases:4.72%

controls:3.55%

121

1012

1873

18123

282

1961

18853

1980

19093

—

1960

19080

227

1917

18546

583

1655

15847

pH of Arterial blood
2744-1 [3019977]

-2.8e-02

5.4e-01

—

2.3e+00

9.8e-01

-8.8e-03

cases:1.10%

controls:1.13%

cases:0.75%

controls:0.44%

—

cases:0.85%

controls:0.09%

cases:1.02%

controls:0.39%

cases:1.38%

controls:1.39%

217

1972

18918

1979

19051

—

1972

19098

1932

18700

229

1713

16201

Choriogonadotropin [Presence] in Serum or Plasma
2118-8 [3003191]

-4.2e-02

8.4e-01

2.4e+00

1.0e+50

1.6e+00

9.7e-01

8.0e-01

cases:0.75%

controls:0.78%

cases:0.60%

controls:0.26%

cases:0.45%

controls:0.04%

cases:2.51%

controls:0.00%

cases:0.25%

controls:0.05%

cases:0.61%

controls:0.23%

cases:1.50%

controls:0.68%

150

1979

18985

1982

19085

1985

19127

1944

19135

1984

19105

1940

18729

111

1711

16319

Base excess in Arterial blood by calculation
1925-7 [3003396]

-2.3e-02

5.4e-01

—

2.3e+00

9.0e-01

-4.3e-02

cases:1.10%

controls:1.13%

cases:0.75%

controls:0.44%

—

cases:0.90%

controls:0.09%

cases:0.97%

controls:0.40%

cases:1.32%

controls:1.38%

216

1972

18919

1979

19051

—

1971

19097

1933

18698

227

1714

16203

tramadol; oral, parenteral, rectal
N02AX02 [21604298]

2.4e-01

2.9e-01

4.1e-01

—

1.9e+00

7.3e-01

4.8e-01

cases:5.72%

controls:4.55%

cases:2.26%

controls:1.70%

cases:0.50%

controls:0.33%

—

cases:2.11%

controls:0.31%

cases:3.28%

controls:1.61%

cases:6.51%

controls:4.11%

114

870

1880

18265

326

1949

18809

1984

19071

—

1947

19056

302

1888

18471

113

675

1624

15755

Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]

-3.7e-02

5.4e-01

—

2.2e+00

9.4e-01

1.9e-02

cases:1.10%

controls:1.14%

cases:0.75%

controls:0.44%

—

cases:0.85%

controls:0.09%

cases:0.97%

controls:0.38%

cases:1.44%

controls:1.41%

219

1972

18916

1979

19051

—

1972

19097

1933

18701

232

1712

16198

Removal of sutures
SPAT1153 [2001700254]

-8.6e-02

2.7e-01

—

3.1e+00

6.6e-01

3.2e-01

cases:3.31%

controls:3.60%

cases:1.10%

controls:0.85%

—

cases:1.91%

controls:0.09%

cases:1.33%

controls:0.69%

cases:3.17%

controls:2.32%

688

1928

18447

162

1972

18973

—

1951

19098

130

1926

18643

381

1682

16049

12 lead EKG panel
34534-8 [3044889]

-3.4e-02

2.2e-02

3.2e-01

3.1e+00

6.4e-01

1.5e-01

9.8e-02

cases:12.09%

controls:12.45%

cases:6.42%

controls:6.29%

cases:0.95%

controls:0.70%

cases:0.55%

controls:0.03%

cases:1.16%

controls:0.61%

cases:6.86%

controls:5.94%

cases:16.06%

controls:14.78%

241

2382

1753

16753

128

1203

1866

17932

133

1975

19002

1983

19130

117

1966

18998

134

1116

1818

17657

279

2429

1458

14001

Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]

3.1e-02

3.0e-01

1.4e+00

1.0e+50

1.6e+00

2.1e-01

2.3e-01

cases:1.45%

controls:1.41%

cases:1.00%

controls:0.74%

cases:0.50%

controls:0.12%

cases:1.05%

controls:0.00%

cases:0.55%

controls:0.11%

cases:0.97%

controls:0.79%

cases:3.05%

controls:2.44%

270

1965

18865

142

1974

18993

1984

19112

1973

19135

1978

19094

148

1933

18625

401

1684

16029

Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]

-4.6e-01

—

2.0e+00

—

9.5e-01

9.4e-01

cases:0.25%

controls:0.40%

—

cases:0.35%

controls:0.05%

—

cases:0.56%

controls:0.22%

cases:1.09%

controls:0.43%

1989

19059

—

1987

19126

—

1941

18732

1718

16359

Protein [Presence] in Urine by Test strip
20454-5 [3014051]

2.6e-01

7.2e-01

1.2e+00

—

1.0e+00

3.1e-01

8.6e-02

cases:4.36%

controls:3.40%

cases:3.36%

controls:1.66%

cases:0.90%

controls:0.27%

—

cases:0.80%

controls:0.29%

cases:2.87%

controls:2.11%

cases:6.79%

controls:6.27%

650

1907

18485

317

1927

18818

1976

19083

—

1973

19059

397

1896

18376

118

1030

1619

15400

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

9.7e-03

8.7e-02

9.3e-01

—

1.3e+00

3.8e-01

3.2e-01

cases:7.27%

controls:7.21%

cases:3.96%

controls:3.64%

cases:1.30%

controls:0.52%

—

cases:1.76%

controls:0.48%

cases:5.12%

controls:3.55%

cases:11.11%

controls:8.34%

145

1379

1849

17756

697

1915

18438

1968

19036

—

1954

19023

100

667

1852

18106

193

1370

1544

15060

Treatment of chronic ulcer or burn
SPAT1148 [2001700249]

-3.4e-01

3.3e-01

—

1.9e+00

1.1e+00

3.4e-01

cases:0.70%

controls:0.98%

cases:0.40%

controls:0.29%

—

cases:0.40%

controls:0.06%

cases:0.87%

controls:0.30%

cases:1.21%

controls:0.86%

188

1980

18947

1986

19080

—

1981

19103

1935

18717

142

1716

16288

amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]

1.5e-01

2.7e-01

—

2.9e+00

4.0e-01

9.0e-02

cases:6.67%

controls:5.81%

cases:2.11%

controls:1.61%

—

cases:2.16%

controls:0.13%

cases:2.41%

controls:1.62%

cases:5.64%

controls:5.18%

133

1111

1861

18024

309

1952

18826

—

1946

19091

305

1905

18468

851

1639

15579

Laceration/cut
S18 [2002000983]

-4.7e-02

8.0e-02

3.2e-01

—

2.8e+00

4.8e-01

1.5e-01

cases:5.07%

controls:5.29%

cases:1.91%

controls:1.76%

cases:0.30%

controls:0.22%

—

cases:3.32%

controls:0.20%

cases:2.66%

controls:1.66%

cases:6.56%

controls:5.70%

101

1013

1893

18122

337

1956

18798

1988

19093

—

1923

19077

312

1900

18461

114

937

1623

15493

Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]

-2.6e-01

-1.4e-01

—

1.0e+50

2.8e+00

5.2e-01

2.0e-01

cases:1.15%

controls:1.49%

cases:0.50%

controls:0.57%

—

cases:0.55%

controls:0.00%

cases:0.80%

controls:0.05%

cases:0.77%

controls:0.46%

cases:1.32%

controls:1.08%

285

1971

18850

110

1984

19025

—

1983

19135

1973

19106

1937

18687

178

1714

16252

Malignant neoplasm of prostate
C61 [45547509]

4.8e-01

3.6e-01

3.9e-01

2.8e+00

2.6e-01

5.2e-01

2.9e-01

cases:1.20%

controls:0.75%

cases:0.95%

controls:0.67%

cases:0.30%

controls:0.20%

cases:0.50%

controls:0.03%

cases:0.25%

controls:0.19%

cases:1.08%

controls:0.64%

cases:0.92%

controls:0.69%

143

1970

18992

128

1975

19007

1988

19096

1984

19129

1984

19078

121

1931

18652

113

1721

16317

oxycodone and naloxone; oral
N02AA55 [21604265]

4.1e-01

3.9e-01

—

2.6e+00

5.7e-01

3.9e-01

cases:1.65%

controls:1.10%

cases:0.85%

controls:0.58%

—

cases:1.31%

controls:0.09%

cases:0.87%

controls:0.50%

cases:2.59%

controls:1.77%

211

1961

18924

111

1977

19024

—

1963

19097

1935

18680

290

1692

16140

Thorax X-ray examination
GD1AA [2001303617]

1.1e-01

4.9e-01

1.1e+00

—

1.2e+00

5.4e-01

4.6e-01

cases:5.57%

controls:5.02%

cases:2.96%

controls:1.83%

cases:0.75%

controls:0.24%

—

cases:0.60%

controls:0.19%

cases:2.66%

controls:1.58%

cases:6.97%

controls:4.52%

111

960

1883

18175

351

1935

18784

1979

19089

—

1977

19079

296

1900

18477

121

743

1616

15687

saccharomyces boulardii; oral
A07FA02 [21600670]

2.7e-01

7.7e-01

—

2.6e+00

4.4e-02

4.6e-04

cases:0.85%

controls:0.65%

cases:0.45%

controls:0.21%

—

cases:0.35%

controls:0.03%

cases:0.26%

controls:0.25%

cases:0.63%

controls:0.63%

125

1977

19010

1985

19095

—

1982

19110

1947

18727

104

1726

16326

Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]

—

2.6e+00

1.3e+00

—

cases:0.56%

controls:0.04%

cases:0.40%

controls:0.12%

—

1941

18765

1730

16411

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

2.2e-03

4.0e-01

1.6e+00

—

1.0e+00

4.3e-01

1.1e-01

cases:5.57%

controls:5.56%

cases:3.61%

controls:2.45%

cases:1.20%

controls:0.26%

—

cases:0.85%

controls:0.31%

cases:3.74%

controls:2.48%

cases:7.48%

controls:6.74%

111

1063

1883

18072

469

1922

18666

1970

19086

—

1972

19056

465

1879

18308

130

1107

1607

15323

Laparoscopic repair of incisional hernia
JAD11 [2001304419]

—

2.5e+00

—

cases:0.46%

controls:0.04%

—

1729

16424

Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]

5.6e-01

5.8e-01

—

2.4e+00

3.5e-01

3.4e-01

cases:0.95%

controls:0.55%

cases:0.55%

controls:0.31%

—

cases:0.30%

controls:0.03%

cases:0.46%

controls:0.32%

cases:1.09%

controls:0.78%

105

1975

19030

1983

19076

—

1983

19110

1943

18712

128

1718

16302

Scheduled procedure
ZXD10 [2001311387]

3.6e-01

1.5e-01

—

1.4e+00

9.9e-01

cases:5.07%

controls:3.60%

cases:1.05%

controls:0.90%

—

cases:1.90%

controls:0.46%

cases:3.74%

controls:1.43%

101

689

1893

18446

173

1973

18962

—

1915

18687

235

1672

16195

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]

-2.8e-01

1.5e-01

1.6e+00

—

2.4e+00

5.0e-01

2.0e-01

cases:0.85%

controls:1.12%

cases:0.55%

controls:0.48%

cases:0.25%

controls:0.05%

—

cases:0.35%

controls:0.03%

cases:0.72%

controls:0.44%

cases:1.50%

controls:1.23%

215

1977

18920

1983

19044

1989

19125

—

1982

19109

1938

18691

202

1711

16228

Urgent procedure
ZXD05 [2001311386]

-3.2e-02

4.5e-01

2.4e+00

—

6.9e-01

3.4e-01

cases:2.61%

controls:2.69%

cases:0.90%

controls:0.57%

cases:0.80%

controls:0.07%

—

cases:0.72%

controls:0.36%

cases:1.96%

controls:1.41%

515

1942

18620

110

1976

19025

1978

19121

—

1938

18705

231

1703

16199

ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]

3.3e-01

4.2e-01

—

2.4e+00

2.4e-01

2.0e-01

cases:3.46%

controls:2.52%

cases:1.40%

controls:0.93%

—

cases:1.26%

controls:0.12%

cases:1.28%

controls:1.01%

cases:5.18%

controls:4.27%

483

1925

18652

177

1966

18958

—

1964

19093

189

1927

18584

701

1647

15729

Bacterial infection, unspecified
A49.9 [45590816]

2.9e-01

6.0e-01

—

1.0e+50

2.4e+00

1.2e+00

5.9e-02

cases:0.70%

controls:0.53%

cases:0.40%

controls:0.22%

—

cases:0.25%

controls:0.00%

cases:0.40%

controls:0.04%

cases:0.51%

controls:0.15%

cases:0.69%

controls:0.65%

101

1980

19034

1986

19093

—

1989

19135

1981

19108

1942

18745

107

1725

16323

Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]

-1.9e-01

-3.1e-02

—

2.4e+00

8.0e-01

4.3e-01

cases:1.20%

controls:1.45%

cases:0.50%

controls:0.52%

—

cases:0.50%

controls:0.05%

cases:0.92%

controls:0.42%

cases:1.78%

controls:1.17%

277

1970

18858

1984

19036

—

1979

19106

1934

18695

192

1706

16238

Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]

-1.6e-01

6.5e-01

—

2.4e+00

1.1e+00

-2.3e-01

cases:0.50%

controls:0.59%

cases:0.50%

controls:0.26%

—

cases:0.55%

controls:0.05%

cases:0.67%

controls:0.21%

cases:0.69%

controls:0.86%

112

1984

19023

1984

19085

—

1978

19105

1939

18733

142

1725

16288

Physiotherapy
R4110 [2001310233]

1.6e-02

-2.4e-03

—

1.7e+00

5.5e-01

7.0e-01

cases:3.16%

controls:3.11%

cases:1.05%

controls:1.06%

—

cases:0.90%

controls:0.17%

cases:1.64%

controls:0.95%

cases:4.15%

controls:2.11%

595

1931

18540

202

1973

18933

—

1971

19082

179

1920

18594

346

1665

16084

EKG study
11524-6 [3013512]

-1.3e-01

4.2e-02

1.3e+00

—

1.1e+00

1.3e-01

2.0e-01

cases:3.86%

controls:4.38%

cases:2.41%

controls:2.31%

cases:0.95%

controls:0.27%

—

cases:0.70%

controls:0.24%

cases:2.36%

controls:2.08%

cases:6.45%

controls:5.36%

838

1917

18297

442

1946

18693

1975

19084

—

1975

19069

391

1906

18382

112

880

1625

15550

Gas panel - Venous blood
24339-4 [3000991]

2.6e-01

2.4e-01

—

2.3e+00

7.7e-01

2.8e-01

cases:1.15%

controls:0.89%

cases:0.55%

controls:0.43%

—

cases:0.75%

controls:0.08%

cases:0.87%

controls:0.40%

cases:1.73%

controls:1.31%

170

1971

18965

1983

19052

—

1974

19100

1935

18697

216

1707

16214

Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]

-1.4e-01

8.0e-01

—

2.3e+00

1.1e+00

5.2e-01

cases:0.40%

controls:0.46%

cases:0.45%

controls:0.20%

—

cases:0.70%

controls:0.07%

cases:0.56%

controls:0.20%

cases:1.04%

controls:0.62%

1986

19047

1985

19096

—

1975

19101

1941

18736

102

1719

16328

Respiratory and circulatory monitoring
WX700 [2001310817]

6.5e-02

4.6e-01

—

1.0e+50

2.3e+00

9.0e-01

5.2e-01

cases:1.40%

controls:1.32%

cases:0.60%

controls:0.38%

—

cases:2.61%

controls:0.00%

cases:0.60%

controls:0.06%

cases:0.77%

controls:0.31%

cases:1.67%

controls:1.00%

252

1966

18883

1982

19062

—

1942

19135

1977

19103

1937

18714

165

1708

16265

tinzaparin; parenteral
B01AB10 [21600981]

3.4e-02

—

2.3e+00

5.5e-01

-1.4e-01

cases:0.55%

controls:0.53%

—

cases:0.60%

controls:0.06%

cases:0.46%

controls:0.27%

cases:0.75%

controls:0.86%

102

1983

19033

—

1977

19103

1943

18723

141

1724

16289

Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]

—

-1.0e+50

—

2.3e+00

7.4e-01

—

cases:0.00%

controls:0.05%

—

cases:0.31%

controls:0.03%

cases:0.35%

controls:0.16%

—

1994

19125

—

1946

18767

1731

16403

Oxygen content in Venous blood
19220-3 [3011648]

2.3e+00

—

9.0e-01

cases:0.30%

controls:0.03%

—

cases:0.40%

controls:0.16%

1988

19129

—

1730

16403

Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]

-3.7e-02

5.4e-01

—

2.2e+00

8.8e-01

1.9e-02

cases:1.10%

controls:1.14%

cases:0.75%

controls:0.44%

—

cases:0.85%

controls:0.09%

cases:0.92%

controls:0.38%

cases:1.44%

controls:1.41%

219

1972

18916

1979

19051

—

1972

19097

1934

18701

232

1712

16198

Melaena
K92.1 [45533624]

3.9e-01

2.1e+00

—

2.2e-01

cases:0.30%

controls:0.20%

cases:0.40%

controls:0.05%

—

cases:0.29%

controls:0.23%

1988

19096

1986

19126

—

1732

16392

Specific gravity of Urine by Test strip
5811-5 [3000330]

2.5e-01

9.7e-01

2.1e+00

—

1.1e+00

5.4e-01

3.8e-01

cases:0.65%

controls:0.51%

cases:0.70%

controls:0.27%

cases:0.40%

controls:0.05%

—

cases:0.25%

controls:0.08%

cases:0.56%

controls:0.33%

cases:1.78%

controls:1.23%

1981

19038

1980

19084

1986

19126

—

1984

19099

1941

18711

202

1706

16228

pantoprazole; oral, parenteral
A02BC02 [21600097]

2.5e-01

3.2e-01

5.2e-01

—

8.6e-01

3.8e-01

3.3e-01

cases:14.14%

controls:11.38%

cases:8.43%

controls:6.27%

cases:2.16%

controls:1.30%

—

cases:2.97%

controls:1.28%

cases:8.30%

controls:5.85%

cases:15.66%

controls:11.73%

282

2177

1712

16958

168

1199

1826

17936

248

1951

18887

—

244

1930

18871

162

1098

1790

17675

272

1927

1465

14503

Multiple adjuvant cytostatic therapy
WB113 [2001310629]

6.4e-02

-1.0e+50

—

-1.0e+50

—

2.1e+00

cases:0.35%

controls:0.33%

cases:0.00%

controls:0.14%

cases:0.00%

controls:0.03%

—

cases:0.00%

controls:0.03%

—

cases:0.40%

controls:0.05%

1987

19072

1994

19108

1994

19129

—

1989

19110

—

1730

16422

Urology
34 [38004474]

-7.0e-03

2.9e-01

2.3e-01

—

9.9e-01

6.9e-01

4.3e-01

cases:3.11%

controls:3.13%

cases:2.26%

controls:1.70%

cases:0.40%

controls:0.32%

—

cases:0.85%

controls:0.32%

cases:3.02%

controls:1.54%

cases:4.61%

controls:3.06%

599

1932

18536

326

1949

18809

1986

19074

—

1972

19054

289

1893

18484

502

1657

15928

Sacro-iliac joint MRI examination with high intensity magnet
NA6BG [2001307059]

—

2.1e+00

—

cases:0.35%

controls:0.04%

—

1731

16423

Osmolality of Urine
2695-5 [3026782]

5.3e-02

2.5e-01

2.1e+00

—

9.4e-01

4.3e-01

4.4e-01

cases:3.36%

controls:3.19%

cases:1.50%

controls:1.18%

cases:1.05%

controls:0.14%

—

cases:0.40%

controls:0.16%

cases:1.38%

controls:0.91%

cases:3.34%

controls:2.17%

611

1927

18524

225

1964

18910

1973

19109

—

1981

19085

170

1925

18603

357

1679

16073

Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]

-1.7e-01

3.3e-02

—

1.0e+50

2.0e+00

8.8e-01

6.7e-01

cases:0.50%

controls:0.60%

cases:0.35%

controls:0.34%

—

cases:0.35%

controls:0.00%

cases:0.35%

controls:0.05%

cases:0.61%

controls:0.26%

cases:1.38%

controls:0.71%

114

1984

19021

1987

19070

—

1987

19135

1982

19106

1940

18725

117

1713

16313

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]

5.2e-01

—

2.0e+00

—

7.7e-01

cases:0.35%

controls:0.21%

—

cases:0.35%

controls:0.05%

—

cases:0.29%

controls:0.13%

1987

19095

—

1982

19106

—

1732

16408

Thoracal epidural anesthesia
WX302 [2001310795]

-1.8e-01

—

1.0e+50

—

2.0e+00

7.3e-01

cases:0.30%

controls:0.36%

—

cases:0.35%

controls:0.00%

—

cases:0.51%

controls:0.07%

cases:0.40%

controls:0.19%

1988

19066

—

1987

19135

—

1942

18760

1730

16398

Immunization
WW200 [2001310599]

2.9e-01

—

2.0e+00

cases:0.30%

controls:0.22%

—

cases:0.58%

controls:0.08%

1988

19092

—

1727

16417

Telehealth
OMOP5556618 [722455]

2.3e-02

-6.1e-02

-1.5e-02

2.0e+00

4.2e-01

3.8e-02

7.5e-02

cases:20.26%

controls:19.89%

cases:6.52%

controls:6.90%

cases:1.15%

controls:1.17%

cases:0.45%

controls:0.06%

cases:1.36%

controls:0.89%

cases:6.30%

controls:6.08%

cases:13.18%

controls:12.34%

404

3805

1590

15330

130

1320

1864

17815

224

1971

18911

1985

19123

171

1962

18944

123

1142

1829

17631

229

2028

1508

14402

oxazepam; oral
N05BA04 [21604569]

2.6e-01

3.6e-01

8.7e-01

—

4.1e-02

6.2e-01

4.6e-01

cases:4.36%

controls:3.39%

cases:2.56%

controls:1.80%

cases:1.20%

controls:0.51%

—

cases:0.45%

controls:0.43%

cases:3.18%

controls:1.73%

cases:5.87%

controls:3.77%

648

1907

18487

345

1943

18790

1970

19038

—

1980

19032

325

1890

18448

102

620

1635

15810

Supine thorax X-ray examination
GD1QA [2001303648]

3.5e-02

1.3e-01

—

1.9e+00

5.3e-01

2.6e-01

cases:0.75%

controls:0.73%

cases:0.35%

controls:0.31%

—

cases:0.35%

controls:0.05%

cases:0.67%

controls:0.39%

cases:1.32%

controls:1.02%

139

1979

18996

1987

19076

—

1982

19105

1939

18699

168

1714

16262

Pharmacy visit
OMOP4822462 [581458]

-6.8e-02

9.0e-02

2.4e-01

6.2e-01

1.0e+00

6.9e-02

4.0e-02

cases:63.84%

controls:65.39%

cases:61.69%

controls:59.55%

cases:34.90%

controls:29.62%

cases:2.66%

controls:1.44%

cases:54.20%

controls:29.52%

cases:64.45%

controls:62.85%

cases:80.48%

controls:79.84%

1273

12513

721

6622

1230

11394

764

7741

696

5668

1298

13467

276

1941

18859

1078

5642

911

13473

1258

11798

694

6975

1398

13118

339

3312

theophylline; oral, parenteral, rectal
R03DA04 [21603332]

7.8e-01

1.4e+00

—

1.9e+00

1.0e+00

cases:0.35%

controls:0.16%

cases:0.35%

controls:0.09%

—

cases:0.46%

controls:0.07%

cases:0.69%

controls:0.26%

1987

19104

1987

19118

—

1943

18760

1725

16388

Digestive symptom/complaint other
D29 [2002000327]

1.9e+00

—

cases:0.45%

controls:0.07%

—

1985

19122

—

fluconazole; oral, parenteral
J02AC01 [21603080]

3.8e-02

1.4e-01

—

1.3e+00

5.6e-01

2.8e-01

cases:4.91%

controls:4.74%

cases:1.60%

controls:1.40%

—

cases:0.70%

controls:0.19%

cases:2.51%

controls:1.44%

cases:6.45%

controls:4.97%

907

1896

18228

267

1962

18868

—

1975

19079

271

1903

18502

112

817

1625

15613

Endometriosis of pelvic peritoneum
N80.3 [45606506]

6.8e-01

1.4e+00

—

1.9e+00

1.0e+00

cases:0.45%

controls:0.23%

cases:0.35%

controls:0.08%

—

cases:0.61%

controls:0.10%

cases:0.63%

controls:0.23%

1985

19091

1987

19119

—

1940

18755

1726

16393

Other malignant neoplasm of kidney, except renal pelvis
C64.88 [2000501096]

—

-1.0e+50

1.9e+00

1.3e+00

—

cases:0.00%

controls:0.04%

cases:0.41%

controls:0.06%

cases:0.46%

controls:0.12%

—

1989

19107

1944

18761

1729

16410

macrogol; oral
A06AD15 [21600575]

6.5e-02

2.3e-01

—

1.9e+00

4.0e-01

3.5e-01

cases:0.80%

controls:0.75%

cases:0.50%

controls:0.40%

—

cases:0.40%

controls:0.06%

cases:0.56%

controls:0.38%

cases:1.27%

controls:0.89%

144

1978

18991

1984

19059

—

1981

19103

1941

18702

147

1715

16283

pH of Venous blood
2746-6 [3012544]

5.3e-01

6.2e-01

1.6e+00

—

1.9e+00

1.7e-01

5.1e-02

cases:1.76%

controls:1.05%

cases:0.95%

controls:0.52%

cases:0.35%

controls:0.07%

—

cases:0.40%

controls:0.06%

cases:0.61%

controls:0.52%

cases:1.73%

controls:1.64%

200

1959

18935

1975

19036

1987

19121

—

1981

19103

1940

18676

270

1707

16160

Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]

-2.2e-01

1.6e-01

1.8e+00

1.0e+50

1.5e+00

2.6e-02

-4.2e-02

cases:0.55%

controls:0.68%

cases:0.35%

controls:0.30%

cases:0.35%

controls:0.06%

cases:0.35%

controls:0.00%

cases:0.25%

controls:0.06%

cases:0.41%

controls:0.40%

cases:1.21%

controls:1.26%

131

1983

19004

1987

19078

1987

19124

1987

19135

1984

19104

1944

18698

207

1716

16223

Base excess in Venous blood by calculation
1927-3 [3002032]

4.8e-01

5.9e-01

1.5e+00

—

1.8e+00

1.5e-01

6.9e-02

cases:1.60%

controls:1.00%

cases:0.95%

controls:0.53%

cases:0.35%

controls:0.08%

—

cases:0.40%

controls:0.07%

cases:0.56%

controls:0.48%

cases:1.78%

controls:1.67%

191

1962

18944

101

1975

19034

1987

19120

—

1981

19102

1941

18682

274

1706

16156

Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]

4.7e-01

6.4e-01

1.5e+00

—

1.8e+00

2.6e-01

7.6e-02

cases:1.60%

controls:1.01%

cases:0.95%

controls:0.51%

cases:0.35%

controls:0.08%

—

cases:0.40%

controls:0.07%

cases:0.67%

controls:0.52%

cases:1.84%

controls:1.71%

194

1962

18941

1975

19038

1987

19120

—

1981

19102

1939

18676

281

1705

16149

Psychiatric treatment plan, extended/prolonged
ICB02 [2001304099]

1.8e+00

—

cases:0.40%

controls:0.07%

—

1986

19122

—

Capsular endoscopy
UJF92 [2001305032]

—

-1.0e+50

—

-1.0e+50

1.7e+00

—

cases:0.00%

controls:0.03%

—

cases:0.00%

controls:0.04%

cases:0.52%

controls:0.09%

—

1994

19129

—

1952

18766

1728

16415

alprazolam; oral
N05BA12 [21604577]

5.6e-01

8.2e-01

—

1.2e+00

9.3e-01

8.0e-01

cases:1.15%

controls:0.66%

cases:0.85%

controls:0.38%

—

cases:0.35%

controls:0.11%

cases:0.92%

controls:0.37%

cases:1.67%

controls:0.76%

127

1971

19008

1977

19063

—

1982

19094

1934

18704

125

1708

16305

Malignant tumour
130 [2001600128]

4.7e-01

—

1.7e+00

8.8e-02

cases:0.55%

controls:0.34%

—

cases:0.41%

controls:0.07%

cases:0.35%

controls:0.32%

1983

19069

—

1944

18759

1731

16378

sulfadiazine and trimethoprim
J01EE02 [21602962]

-1.3e-01

7.9e-01

—

1.7e+00

9.1e-01

2.5e-01

cases:1.55%

controls:1.77%

cases:1.15%

controls:0.53%

—

cases:0.30%

controls:0.06%

cases:1.38%

controls:0.56%

cases:3.51%

controls:2.75%

339

1963

18796

101

1971

19034

—

1983

19104

105

1925

18668

452

1676

15978

Other and unspecified ovarian cysts
N83.2 [45539066]

6.4e-01

5.0e-01

—

1.0e+50

—

1.7e+00

1.6e-01

cases:1.40%

controls:0.75%

cases:0.55%

controls:0.33%

—

cases:0.45%

controls:0.00%

—

cases:1.02%

controls:0.19%

cases:0.98%

controls:0.83%

143

1966

18992

1983

19071

—

1985

19135

—

1932

18737

137

1720

16293

Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]

-1.8e-01

3.6e-02

1.7e+00

—

1.1e+00

1.9e-01

2.9e-01

cases:3.46%

controls:4.12%

cases:1.55%

controls:1.50%

cases:0.50%

controls:0.09%

—

cases:0.45%

controls:0.15%

cases:1.64%

controls:1.35%

cases:5.07%

controls:3.84%

788

1925

18347

287

1963

18848

1984

19117

—

1980

19086

254

1920

18519

631

1649

15799

Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]

3.0e-01

6.2e-01

1.7e+00

1.0e+50

1.3e+00

5.8e-01

4.5e-01

cases:2.71%

controls:2.03%

cases:1.50%

controls:0.82%

cases:0.50%

controls:0.09%

cases:0.60%

controls:0.00%

cases:0.35%

controls:0.10%

cases:1.28%

controls:0.72%

cases:3.57%

controls:2.29%

388

1940

18747

156

1964

18979

1984

19117

1982

19135

1982

19096

136

1927

18637

377

1675

16053

codeine and paracetamol
N02AJ06 [1123647]

1.8e-01

4.0e-01

2.4e-01

2.1e+00

8.9e-01

2.7e-01

3.9e-01

cases:11.94%

controls:10.18%

cases:5.02%

controls:3.43%

cases:0.85%

controls:0.67%

cases:0.25%

controls:0.03%

cases:1.61%

controls:0.67%

cases:4.41%

controls:3.41%

cases:12.55%

controls:8.83%

238

1948

1756

17187

100

657

1894

18478

129

1977

19006

1989

19129

128

1957

18987

641

1866

18132

218

1450

1519

14980

Voice symptom/complaint
R23 [2002000892]

1.6e+00

—

-1.0e+50

—

cases:0.40%

controls:0.08%

—

cases:0.00%

controls:0.05%

—

1986

19120

—

1952

18763

—

Wrist and hand MRI examination with high intensity magnet
ND1BG [2001307586]

—

-1.0e+50

—

1.6e+00

—

cases:0.00%

controls:0.05%

—

cases:0.46%

controls:0.09%

—

1994

19126

—

1729

16415

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

-3.4e-02

4.1e-02

6.5e-01

—

1.3e+00

3.3e-01

3.0e-01

cases:6.32%

controls:6.52%

cases:3.36%

controls:3.23%

cases:0.90%

controls:0.48%

—

cases:1.56%

controls:0.42%

cases:4.25%

controls:3.11%

cases:9.27%

controls:7.04%

126

1248

1868

17887

618

1927

18517

1976

19044

—

1958

19034

583

1869

18190

161

1156

1576

15274

Short blood count panel - Blood
55429-5 [40758558]

2.8e-02

2.4e-01

7.9e-01

—

1.6e+00

2.5e-01

cases:4.56%

controls:4.44%

cases:2.81%

controls:2.23%

cases:0.95%

controls:0.43%

—

cases:1.96%

controls:0.40%

cases:2.51%

controls:1.97%

cases:5.41%

controls:4.26%

850

1903

18285

427

1938

18708

1975

19052

—

1950

19039

370

1903

18403

700

1643

15730

Clarification/discussion RFE/demand
-48 [2002000119]

1.6e+00

-1.0e+50

—

cases:0.55%

controls:0.11%

cases:0.00%

controls:0.03%

—

1983

19113

1994

19130

—

Internal Medicine
11 [38004456]

1.6e-01

3.3e-01

4.4e-01

—

8.3e-01

4.0e-01

2.1e-01

cases:14.59%

controls:12.70%

cases:6.77%

controls:4.94%

cases:1.20%

controls:0.78%

—

cases:1.61%

controls:0.71%

cases:6.51%

controls:4.45%

cases:15.95%

controls:13.34%

291

2430

1703

16705

135

946

1859

18189

149

1970

18986

—

136

1957

18979

127

836

1825

17937

277

2192

1460

14238

Laparoscopic cholecystectomy
JKA21 [2001305294]

2.8e-01

—

1.5e+00

2.5e-02

cases:0.75%

controls:0.57%

—

cases:0.67%

controls:0.14%

cases:0.52%

controls:0.51%

109

1979

19026

—

1939

18746

1728

16347

nizatidine; oral, parenteral
A02BA04 [21600085]

1.5e+00

—

7.3e-01

cases:0.55%

controls:0.12%

—

cases:0.81%

controls:0.39%

1983

19112

—

1723

16366

Infiltration anesthesia
WX110 [2001310767]

1.3e-02

2.8e-02

5.4e-01

—

1.5e+00

3.0e-01

1.1e-01

cases:16.35%

controls:16.17%

cases:6.62%

controls:6.45%

cases:1.25%

controls:0.73%

—

cases:3.57%

controls:0.80%

cases:7.79%

controls:5.89%

cases:16.81%

controls:15.34%

326

3094

1668

16041

132

1234

1862

17901

140

1969

18995

—

153

1918

18962

152

1106

1800

17667

292

2521

1445

13909

Medication/prescr/renewal
-50 [2002000121]

1.5e+00

—

cases:0.50%

controls:0.11%

—

1984

19114

—

Neutrophils/Leukocytes in Blood
26511-6 [3018010]

7.6e-02

3.4e-01

6.1e-01

—

8.0e-01

3.7e-01

2.2e-01

cases:9.33%

controls:8.71%

cases:6.72%

controls:4.87%

cases:1.55%

controls:0.85%

—

cases:2.01%

controls:0.92%

cases:6.81%

controls:4.79%

cases:11.40%

controls:9.34%

186

1666

1808

17469

134

932

1860

18203

162

1963

18973

—

175

1949

18940

133

899

1819

17874

198

1535

1539

14895

Ileoscopy through colon
UJF30 [2001305028]

9.3e-02

9.6e-01

—

1.5e+00

5.2e-01

cases:1.00%

controls:0.91%

cases:0.65%

controls:0.25%

—

cases:0.97%

controls:0.22%

cases:1.44%

controls:0.86%

175

1974

18960

1981

19087

—

1933

18731

141

1712

16289

Basophils/Leukocytes in Blood
30180-4 [3022096]

9.2e-02

3.8e-01

5.6e-01

—

7.6e-01

3.3e-01

2.2e-01

cases:9.23%

controls:8.48%

cases:6.92%

controls:4.84%

cases:1.50%

controls:0.86%

—

cases:1.96%

controls:0.93%

cases:6.51%

controls:4.78%

cases:11.28%

controls:9.28%

184

1623

1810

17512

138

927

1856

18208

165

1964

18970

—

177

1950

18938

127

897

1825

17876

196

1524

1541

14906

Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]

1.3e-01

4.1e-01

—

1.4e+00

4.7e-01

9.3e-02

cases:2.26%

controls:1.99%

cases:1.45%

controls:0.97%

—

cases:0.55%

controls:0.13%

cases:1.28%

controls:0.80%

cases:2.53%

controls:2.31%

380

1949

18755

186

1965

18949

—

1978

19090

151

1927

18622

380

1693

16050

Pure hypercholesterolaemia
E78.01 [2000501514]

-8.4e-02

-2.0e-01

—

1.4e+00

-2.4e-02

1.1e-01

cases:1.30%

controls:1.42%

cases:0.70%

controls:0.86%

—

cases:0.70%

controls:0.17%

cases:1.02%

controls:1.05%

cases:2.94%

controls:2.64%

271

1968

18864

164

1980

18971

—

1975

19083

197

1932

18576

434

1686

15996

Cathetrisation of artery
TPH07 [2001309747]

-1.7e-01

6.0e-01

—

1.0e+50

2.1e+00

1.4e+00

6.9e-01

cases:0.60%

controls:0.72%

cases:0.35%

controls:0.19%

—

cases:0.65%

controls:0.00%

cases:0.25%

controls:0.03%

cases:0.77%

controls:0.19%

cases:1.09%

controls:0.55%

137

1982

18998

1987

19098

—

1981

19135

1984

19109

1937

18738

1718

16339

Laparoscopy
JAH01 [2001304475]

1.1e+00

1.7e+00

—

1.0e+50

—

1.4e+00

cases:0.60%

controls:0.19%

cases:0.25%

controls:0.05%

—

cases:1.35%

controls:0.00%

—

cases:0.69%

controls:0.17%

1982

19098

1989

19126

—

1967

19135

—

1725

16402

Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]

5.9e-02

6.0e-01

1.3e+00

—

1.4e+00

3.7e-01

3.1e-01

cases:0.90%

controls:0.85%

cases:1.10%

controls:0.61%

cases:0.30%

controls:0.08%

—

cases:0.50%

controls:0.13%

cases:1.02%

controls:0.71%

cases:2.01%

controls:1.49%

163

1976

18972

116

1972

19019

1988

19120

—

1979

19091

133

1932

18640

245

1702

16185

Cardiac arrhythmia NOS
K80 [2002000607]

-4.3e-01

-1.0e+50

—

1.3e+00

3.0e-01

cases:0.35%

controls:0.54%

cases:0.00%

controls:0.17%

—

cases:0.56%

controls:0.15%

cases:0.98%

controls:0.72%

103

1987

19032

1994

19103

—

1941

18745

119

1720

16311

Other specified counselling
Z71.8 [45581061]

2.6e-01

3.2e-01

9.2e-01

—

1.3e+00

3.8e-01

1.0e-01

cases:4.41%

controls:3.45%

cases:2.61%

controls:1.91%

cases:0.55%

controls:0.22%

—

cases:0.70%

controls:0.19%

cases:2.97%

controls:2.05%

cases:6.51%

controls:5.92%

660

1906

18475

366

1942

18769

1983

19093

—

1975

19079

385

1894

18388

113

973

1624

15457

Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]

3.7e-01

8.5e-01

—

1.3e+00

5.8e-01

cases:1.15%

controls:0.80%

cases:0.75%

controls:0.32%

—

cases:0.97%

controls:0.26%

cases:1.50%

controls:0.85%

153

1971

18982

1979

19073

—

1933

18724

139

1711

16291

esomeprazole; oral, parenteral
A02BC05 [21600100]

3.2e-01

2.7e-01

3.1e-01

—

5.8e-01

4.5e-01

4.9e-01

cases:7.22%

controls:5.33%

cases:3.76%

controls:2.89%

cases:0.80%

controls:0.59%

—

cases:0.96%

controls:0.54%

cases:4.20%

controls:2.73%

cases:7.08%

controls:4.46%

144

1019

1850

18116

553

1919

18582

113

1978

19022

—

103

1970

19012

512

1870

18261

123

732

1614

15698

Colonoscopy Study observation
28023-0 [3022145]

1.9e-01

5.7e-01

—

1.2e+00

3.2e-01

cases:1.60%

controls:1.33%

cases:0.95%

controls:0.54%

—

cases:1.43%

controls:0.43%

cases:2.19%

controls:1.60%

254

1962

18881

104

1975

19031

—

1924

18693

263

1699

16167

Post-traumatic stress disorder
F43.1 [45595909]

2.8e-01

8.4e-01

—

1.1e+00

1.2e+00

cases:0.35%

controls:0.27%

cases:0.35%

controls:0.15%

—

cases:0.41%

controls:0.13%

cases:0.98%

controls:0.29%

1987

19084

1987

19106

—

1944

18748

1720

16382

Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 [3037551]

-1.2e-01

—

-1.0e+50

—

1.2e+00

4.8e-01

cases:0.70%

controls:0.79%

—

cases:0.00%

controls:0.06%

—

cases:0.82%

controls:0.25%

cases:1.21%

controls:0.75%

151

1980

18984

—

1994

19123

—

1936

18727

123

1716

16307

Type 2 diabetes mellitus, without complications
E11.9 [45561952]

-2.5e-01

-1.1e-01

3.7e-01

—

1.2e+00

3.4e-01

-1.8e-01

cases:2.11%

controls:2.69%

cases:1.20%

controls:1.34%

cases:0.30%

controls:0.21%

—

cases:0.80%

controls:0.24%

cases:1.90%

controls:1.35%

cases:2.71%

controls:3.22%

515

1952

18620

256

1970

18879

1988

19095

—

1973

19069

254

1915

18519

529

1690

15901

Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]

-1.2e-01

2.6e-02

1.2e+00

—

9.4e-01

1.7e-01

-9.0e-02

cases:2.96%

controls:3.32%

cases:1.96%

controls:1.91%

cases:0.90%

controls:0.27%

—

cases:0.70%

controls:0.28%

cases:2.36%

controls:2.00%

cases:5.01%

controls:5.45%

636

1935

18499

365

1955

18770

1976

19083

—

1975

19062

376

1906

18397

896

1650

15534

nedocromil; inhalant
R03BC03 [21603299]

4.0e-01

-1.0e+50

—

-1.0e+50

1.2e+00

cases:0.35%

controls:0.24%

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.04%

cases:0.75%

controls:0.23%

1987

19090

1994

19123

—

1952

18765

1724

16393

Sentinel node biopsy
PJA12 [2001309627]

2.5e-01

—

-1.0e+50

1.2e+00

cases:0.65%

controls:0.51%

—

cases:0.00%

controls:0.07%

cases:0.81%

controls:0.24%

1981

19038

—

1952

18760

1723

16390

cefuroxime; oral, parenteral
J01DC02 [21602884]

6.6e-01

1.0e+00

—

1.2e+00

1.8e-01

cases:1.10%

controls:0.57%

cases:0.45%

controls:0.16%

—

cases:0.72%

controls:0.22%

cases:1.50%

controls:1.25%

110

1972

19025

1985

19104

—

1938

18731

206

1711

16224

Extensive global examination
SPAT1360 [2001700461]

4.8e-01

—

6.9e-01

1.2e+00

cases:0.80%

controls:0.50%

—

cases:0.31%

controls:0.15%

cases:0.86%

controls:0.27%

1978

19040

—

1946

18744

1722

16385

moxifloxacin; oral, parenteral
J01MA14 [21603021]

5.6e-01

1.1e+00

—

1.1e+00

cases:0.70%

controls:0.40%

cases:0.30%

controls:0.10%

—

cases:0.98%

controls:0.32%

1980

19058

1988

19115

—

1720

16378

Tear of meniscus, current
S83.2 [45555441]

1.1e+00

—

1.3e-01

cases:0.80%

controls:0.26%

—

cases:0.52%

controls:0.46%

1978

19085

—

1728

16355

mesalazine; oral, rectal
A07EC02 [21600664]

2.5e-01

4.5e-01

7.8e-01

—

1.1e+00

6.0e-01

6.2e-01

cases:1.05%

controls:0.83%

cases:1.05%

controls:0.67%

cases:0.50%

controls:0.23%

—

cases:0.70%

controls:0.24%

cases:1.23%

controls:0.68%

cases:1.55%

controls:0.84%

158

1973

18977

129

1973

19006

1984

19091

—

1975

19070

127

1928

18646

138

1710

16292

Acute tonsillitis, unspecified
J03.9 [45576942]

2.3e-02

—

1.1e+00

cases:0.40%

controls:0.39%

—

cases:1.21%

controls:0.41%

1986

19060

—

1716

16363

More than three and less than five hours
ZXE20 [2001311408]

1.1e-01

—

1.0e+50

—

1.3e+00

1.1e+00

cases:1.15%

controls:1.03%

—

cases:0.30%

controls:0.00%

—

cases:0.36%

controls:0.10%

cases:0.92%

controls:0.31%

197

1971

18938

—

1988

19135

—

1945

18754

1721

16379

Pediatric Medicine
37 [38004477]

-7.3e-01

-7.0e-01

4.2e-01

—

1.8e+00

-7.4e-01

-4.1e-01

cases:2.61%

controls:5.25%

cases:0.70%

controls:1.40%

cases:0.30%

controls:0.20%

—

cases:1.01%

controls:0.17%

cases:0.51%

controls:1.07%

cases:1.61%

controls:2.40%

1005

1942

18130

268

1980

18867

1988

19097

—

1969

19083

200

1942

18573

394

1709

16036

Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]

9.7e-01

—

1.0e+00

cases:0.55%

controls:0.21%

—

cases:0.86%

controls:0.30%

1983

19095

—

1722

16380

Ultrasound measurement of residual urine
KC1EE [2001305918]

-3.6e-02

8.0e-01

—

1.0e+00

3.8e-01

cases:0.90%

controls:0.94%

cases:0.65%

controls:0.29%

—

cases:0.72%

controls:0.26%

cases:0.98%

controls:0.67%

179

1976

18956

1981

19079

—

1938

18725

110

1720

16320

Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]

-1.7e-01

—

1.0e+00

cases:0.30%

controls:0.36%

—

cases:1.04%

controls:0.37%

1988

19067

—

1719

16369

Examination and observation for other specified reasons
Z04.8 [45552063]

3.6e-01

4.9e-01

—

1.0e+00

8.1e-02

cases:1.60%

controls:1.13%

cases:0.60%

controls:0.37%

—

cases:1.02%

controls:0.37%

cases:1.27%

controls:1.17%

216

1962

18919

1982

19064

—

1932

18704

192

1715

16238

Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]

-1.4e-01

4.0e-01

—

1.0e+00

1.4e-02

cases:0.75%

controls:0.86%

cases:0.45%

controls:0.30%

—

cases:0.77%

controls:0.28%

cases:1.21%

controls:1.19%

165

1979

18970

1985

19077

—

1937

18721

196

1716

16234

Body CT examination
JN4AD [2001310897]

1.3e-01

1.0e+00

—

5.6e-01

4.4e-01

cases:0.50%

controls:0.44%

cases:0.80%

controls:0.29%

—

cases:0.61%

controls:0.35%

cases:1.09%

controls:0.71%

1984

19051

1978

19079

—

1940

18707

116

1718

16314

nortriptyline; oral, parenteral
N06AA10 [21604697]

5.8e-01

1.0e+00

—

7.2e-01

2.7e-01

cases:1.30%

controls:0.74%

cases:0.75%

controls:0.28%

—

cases:0.51%

controls:0.25%

cases:0.86%

controls:0.66%

141

1968

18994

1979

19082

—

1942

18726

108

1722

16322

Dysuria
R30.0 [45592416]

2.6e-01

—

1.3e+00

9.8e-01

cases:0.35%

controls:0.27%

—

cases:0.26%

controls:0.07%

cases:0.92%

controls:0.35%

1987

19083

—

1947

18760

1721

16373

Moderate depressive episode without somatic syndrome
F32.10 [2000501980]

1.4e-01

5.8e-01

1.2e+00

—

9.4e-01

1.8e-01

cases:1.00%

controls:0.87%

cases:0.55%

controls:0.31%

cases:0.25%

controls:0.08%

—

cases:0.97%

controls:0.38%

cases:1.21%

controls:1.01%

167

1974

18968

1983

19076

1989

19120

—

1933

18701

166

1716

16264

Sleep apnoea
G47.3 [45562094]

3.7e-01

4.1e-01

3.3e-01

—

9.2e-01

3.7e-01

cases:3.91%

controls:2.74%

cases:2.76%

controls:1.84%

cases:0.55%

controls:0.40%

—

cases:0.96%

controls:0.38%

cases:2.97%

controls:2.07%

cases:5.12%

controls:3.61%

524

1916

18611

353

1939

18782

1983

19059

—

1970

19042

389

1894

18384

593

1648

15837

Sprain and strain of other and unspecified parts of knee
S83.6 [45579536]

7.8e-01

—

8.9e-01

cases:0.60%

controls:0.28%

—

cases:1.04%

controls:0.43%

1982

19082

—

1719

16360

Biopsy of endometrium
LCA06 [2001306551]

6.5e-02

5.1e-01

-1.0e+50

—

8.2e-01

8.7e-01

cases:1.05%

controls:0.99%

cases:0.45%

controls:0.27%

cases:0.00%

controls:0.03%

—

cases:0.41%

controls:0.18%

cases:1.32%

controls:0.56%

189

1973

18946

1985

19083

1994

19130

—

1944

18739

1714

16338

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]

-7.7e-02

2.3e-01

—

4.4e-01

8.7e-01

cases:0.55%

controls:0.60%

cases:0.30%

controls:0.24%

—

cases:0.26%

controls:0.17%

cases:1.27%

controls:0.54%

114

1983

19021

1988

19089

—

1947

18742

1715

16342

Concussion
S06.0 [45582805]

2.8e-01

3.4e-01

—

5.0e-01

8.6e-01

cases:1.05%

controls:0.79%

cases:0.35%

controls:0.25%

—

cases:0.36%

controls:0.22%

cases:1.73%

controls:0.74%

152

1973

18983

1987

19087

—

1945

18732

121

1707

16309

celecoxib
L01XX33 [21603805]

2.9e-01

7.7e-01

—

6.3e-01

8.6e-01

cases:1.10%

controls:0.83%

cases:0.45%

controls:0.21%

—

cases:0.36%

controls:0.19%

cases:1.50%

controls:0.64%

158

1972

18977

1985

19095

—

1945

18737

105

1711

16325

celecoxib; oral
M01AH01 [21603992]

2.9e-01

7.7e-01

—

6.3e-01

8.6e-01

cases:1.10%

controls:0.83%

cases:0.45%

controls:0.21%

—

cases:0.36%

controls:0.19%

cases:1.50%

controls:0.64%

158

1972

18977

1985

19095

—

1945

18737

105

1711

16325

Pulmonary Disease
29 [38004472]

3.0e-01

4.4e-01

3.9e-01

—

3.7e-01

2.7e-01

4.2e-01

cases:6.82%

controls:5.12%

cases:3.86%

controls:2.53%

cases:0.65%

controls:0.44%

—

cases:0.75%

controls:0.52%

cases:3.48%

controls:2.69%

cases:8.12%

controls:5.47%

136

980

1858

18155

484

1917

18651

1981

19050

—

100

1974

19015

505

1884

18268

141

899

1596

15531

amitriptyline and psycholeptics
N06CA01 [21604789]

1.4e-01

-2.6e-01

-1.0e+50

—

-1.0e+50

4.3e-01

8.6e-01

cases:0.95%

controls:0.83%

cases:0.25%

controls:0.32%

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.06%

cases:0.36%

controls:0.23%

cases:1.44%

controls:0.61%

159

1975

18976

1989

19073

1994

19124

—

1989

19104

1945

18729

101

1712

16329

chondroitin sulfate
M01AX25 [21604013]

5.3e-01

8.4e-01

1.2e+00

—

5.0e-01

cases:1.71%

controls:1.01%

cases:1.00%

controls:0.43%

cases:0.30%

controls:0.09%

—

cases:0.77%

controls:0.47%

cases:1.78%

controls:1.09%

194

1960

18941

1974

19052

1988

19117

—

1937

18685

179

1706

16251

Acute stress reaction
P02 [2002000799]

6.2e-01

—

8.4e-01

cases:0.65%

controls:0.35%

—

cases:1.61%

controls:0.70%

1981

19068

—

115

1709

16315

prednisone; oral
H02AB07 [21602735]

3.7e-01

8.6e-01

—

8.0e-01

8.4e-01

cases:1.10%

controls:0.77%

cases:0.55%

controls:0.24%

—

cases:0.46%

controls:0.21%

cases:1.84%

controls:0.80%

147

1972

18988

1983

19090

—

1943

18734

132

1705

16298

prednisone
A07EA03 [21600655]

3.7e-01

8.6e-01

—

8.0e-01

8.4e-01

cases:1.10%

controls:0.77%

cases:0.55%

controls:0.24%

—

cases:0.46%

controls:0.21%

cases:1.84%

controls:0.80%

147

1972

18988

1983

19090

—

1943

18734

132

1705

16298

Depressive episode
F32 [45595904]

2.6e-01

9.1e-01

—

-1.0e+50

8.0e-01

8.3e-01

cases:0.70%

controls:0.54%

cases:0.35%

controls:0.14%

—

cases:0.00%

controls:0.05%

cases:0.46%

controls:0.21%

cases:1.21%

controls:0.53%

104

1980

19031

1987

19108

—

1989

19106

1943

18734

1716

16343

Differential panel, method unspecified - Blood
69738-3 [42870588]

8.4e-02

2.9e-01

2.4e-01

—

8.1e-01

3.6e-01

2.5e-01

cases:6.07%

controls:5.61%

cases:4.31%

controls:3.26%

cases:0.80%

controls:0.63%

—

cases:1.41%

controls:0.63%

cases:4.66%

controls:3.31%

cases:7.83%

controls:6.21%

121

1073

1873

18062

623

1908

18512

121

1978

19014

—

121

1961

18994

621

1861

18152

136

1020

1601

15410

duloxetine; oral
N06AX21 [21604749]

5.8e-01

8.0e-01

6.3e-01

—

7.9e-01

6.9e-01

5.2e-01

cases:1.76%

controls:0.99%

cases:1.25%

controls:0.57%

cases:0.35%

controls:0.19%

—

cases:0.40%

controls:0.18%

cases:1.13%

controls:0.57%

cases:2.13%

controls:1.27%

189

1959

18946

109

1969

19026

1987

19099

—

1981

19080

107

1930

18666

209

1700

16221

fluocortolone
C05AA08 [21601612]

2.3e-01

—

9.1e-01

7.9e-01

cases:1.05%

controls:0.84%

—

cases:0.41%

controls:0.17%

cases:1.38%

controls:0.63%

161

1973

18974

—

1944

18742

104

1713

16326

FEV1
20150-9 [3024653]

2.4e-01

4.6e-01

—

-1.0e+50

5.9e-01

7.6e-01

cases:1.60%

controls:1.27%

cases:0.70%

controls:0.44%

—

cases:0.00%

controls:0.05%

cases:0.72%

controls:0.40%

cases:1.50%

controls:0.71%

243

1962

18892

1980

19050

—

1989

19106

1938

18698

116

1711

16314

Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]

2.4e-01

4.6e-01

—

-1.0e+50

5.9e-01

7.6e-01

cases:1.60%

controls:1.27%

cases:0.70%

controls:0.44%

—

cases:0.00%

controls:0.05%

cases:0.72%

controls:0.40%

cases:1.50%

controls:0.71%

243

1962

18892

1980

19050

—

1989

19106

1938

18698

116

1711

16314

FEV1/FVC
19926-5 [3011505]

2.4e-01

4.6e-01

—

-1.0e+50

5.9e-01

7.6e-01

cases:1.60%

controls:1.27%

cases:0.70%

controls:0.44%

—

cases:0.00%

controls:0.05%

cases:0.72%

controls:0.40%

cases:1.50%

controls:0.71%

243

1962

18892

1980

19050

—

1989

19106

1938

18698

116

1711

16314

Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24111-7 [3011371]

5.0e-01

7.5e-01

1.1e+00

1.0e+50

1.6e+00

5.0e-01

4.8e-01

cases:2.36%

controls:1.45%

cases:1.35%

controls:0.64%

cases:0.25%

controls:0.08%

cases:0.45%

controls:0.00%

cases:0.35%

controls:0.07%

cases:0.97%

controls:0.59%

cases:3.17%

controls:1.99%

277

1947

18858

123

1967

19012

1989

19119

1985

19135

1982

19102

111

1933

18662

327

1682

16103

meloxicam; oral, parenteral, rectal
M01AC06 [21603965]

2.5e-01

2.3e-01

—

-1.0e+50

4.1e-02

7.5e-01

cases:3.26%

controls:2.55%

cases:1.00%

controls:0.80%

—

cases:0.00%

controls:0.07%

cases:0.67%

controls:0.64%

cases:3.80%

controls:1.84%

488

1929

18647

153

1974

18982

—

1989

19101

120

1939

18653

302

1671

16128

oxycodone; oral, parenteral
N02AA05 [21604260]

-3.2e-01

2.0e-01

—

5.0e-01

7.4e-01

cases:0.60%

controls:0.83%

cases:0.60%

controls:0.49%

—

cases:0.72%

controls:0.44%

cases:2.07%

controls:1.00%

158

1982

18977

1982

19041

—

1938

18691

165

1701

16265

Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]

2.2e-01

7.3e-01

-1.0e+50

—

-5.9e-02

8.1e-02

cases:3.66%

controls:2.97%

cases:1.65%

controls:0.80%

cases:0.00%

controls:0.10%

—

cases:0.77%

controls:0.82%

cases:3.34%

controls:3.09%

569

1921

18566

154

1961

18981

1994

19115

—

153

1937

18620

507

1679

15923

doxycycline; oral, parenteral
J01AA02 [21602800]

1.5e-01

3.8e-01

2.6e-03

—

4.7e-01

3.0e-01

2.9e-01

cases:12.79%

controls:11.17%

cases:5.27%

controls:3.65%

cases:0.35%

controls:0.35%

—

cases:0.50%

controls:0.31%

cases:5.48%

controls:4.13%

cases:17.73%

controls:13.90%

255

2137

1739

16998

105

698

1889

18437

1987

19068

—

1979

19055

107

775

1845

17998

308

2283

1429

14147

gabapentin; oral
N02BF01 [955005]

5.0e-01

5.7e-01

2.8e-01

—

3.5e-01

6.6e-01

3.9e-01

cases:2.66%

controls:1.63%

cases:1.71%

controls:0.97%

cases:0.40%

controls:0.30%

—

cases:0.50%

controls:0.36%

cases:2.05%

controls:1.07%

cases:3.68%

controls:2.53%

312

1941

18823

185

1960

18950

1986

19077

—

1979

19047

201

1912

18572

415

1673

16015

valaciclovir; oral
J05AB11 [21603137]

3.0e-01

2.1e-01

—

4.7e-01

6.6e-01

cases:1.76%

controls:1.31%

cases:0.75%

controls:0.61%

—

cases:0.87%

controls:0.55%

cases:2.53%

controls:1.33%

250

1959

18885

117

1979

19018

—

103

1935

18670

218

1693

16212

Urinary tract infection, site not specified
N39.0 [45548665]

6.4e-01

8.6e-01

—

4.0e-01

1.9e-01

cases:1.81%

controls:0.96%

cases:0.80%

controls:0.34%

—

cases:0.67%

controls:0.45%

cases:1.61%

controls:1.33%

184

1958

18951

1978

19070

—

1939

18689

219

1709

16211

diclofenac; oral, parenteral, rectal
M01AB05 [21603945]

2.8e-01

3.0e-01

4.2e-01

—

7.8e-02

2.1e-01

3.5e-01

cases:12.54%

controls:9.78%

cases:4.31%

controls:3.22%

cases:0.65%

controls:0.43%

—

cases:0.45%

controls:0.42%

cases:4.20%

controls:3.43%

cases:14.05%

controls:10.29%

250

1871

1744

17264

617

1908

18518

1981

19053

—

1980

19035

643

1870

18130

244

1691

1493

14739

ezetimibe; oral
C10AX09 [21601896]

4.9e-01

6.2e-01

5.7e-01

—

7.5e-01

5.0e-01

4.1e-01

cases:1.65%

controls:1.02%

cases:1.91%

controls:1.03%

cases:0.55%

controls:0.31%

—

cases:0.70%

controls:0.33%

cases:2.05%

controls:1.25%

cases:3.11%

controls:2.08%

195

1961

18940

198

1956

18937

1983

19075

—

1975

19051

235

1912

18538

341

1683

16089

salbutamol; inhalant
R03AC02 [21603256]

2.2e-01

2.8e-01

4.3e-01

-1.0e+50

2.3e-01

3.5e-01

2.6e-01

cases:12.79%

controls:10.50%

cases:6.47%

controls:4.96%

cases:1.20%

controls:0.78%

cases:0.00%

controls:0.07%

cases:0.96%

controls:0.76%

cases:7.12%

controls:5.15%

cases:14.05%

controls:11.21%

255

2010

1739

17125

129

950

1865

18185

150

1970

18985

1994

19122

146

1970

18969

139

966

1813

17807

244

1842

1493

14588

Spinalanesthesia
WX320 [2001310799]

1.6e-01

1.3e-01

—

-1.0e+50

4.9e-01

5.9e-01

cases:2.26%

controls:1.94%

cases:0.85%

controls:0.75%

—

cases:0.00%

controls:0.08%

cases:0.77%

controls:0.47%

cases:2.94%

controls:1.66%

371

1949

18764

144

1977

18991

—

1989

19100

1937

18684

272

1686

16158

tizanidine; oral
M03BX02 [21604116]

2.8e-01

2.7e-01

2.0e-01

—

2.1e-01

2.7e-01

3.0e-01

cases:12.14%

controls:9.42%

cases:4.21%

controls:3.25%

cases:0.60%

controls:0.49%

—

cases:0.50%

controls:0.41%

cases:4.00%

controls:3.09%

cases:12.72%

controls:9.74%

242

1802

1752

17333

622

1910

18513

1982

19041

—

1979

19037

580

1874

18193

221

1600

1516

14830

roxithromycin; oral
J01FA06 [21602974]

5.8e-01

2.3e-01

—

-1.0e+50

1.2e-01

4.2e-01

cases:3.51%

controls:2.00%

cases:0.60%

controls:0.48%

—

cases:0.00%

controls:0.05%

cases:0.72%

controls:0.64%

cases:4.09%

controls:2.72%

382

1924

18753

1982

19043

—

1989

19106

120

1938

18653

447

1666

15983

Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]

3.2e-01

5.5e-01

—

5.8e-01

1.3e-01

cases:3.21%

controls:2.36%

cases:1.91%

controls:1.11%

—

cases:2.10%

controls:1.19%

cases:3.05%

controls:2.69%

452

1930

18683

213

1956

18922

—

223

1911

18550

442

1684

15988

Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]

-2.9e-01

3.2e-01

—

-2.2e-01

5.7e-01

cases:1.35%

controls:1.80%

cases:0.90%

controls:0.66%

—

cases:0.36%

controls:0.45%

cases:2.42%

controls:1.38%

344

1967

18791

126

1976

19009

—

1945

18689

227

1695

16203

lansoprazole; oral
A02BC03 [21600098]

4.3e-01

6.2e-01

9.3e-01

—

6.3e-01

4.6e-01

5.7e-01

cases:3.26%

controls:2.14%

cases:1.71%

controls:0.93%

cases:0.45%

controls:0.18%

—

cases:0.35%

controls:0.19%

cases:1.43%

controls:0.91%

cases:3.28%

controls:1.89%

409

1929

18726

177

1960

18958

1985

19101

—

1982

19079

171

1924

18602

310

1680

16120

Bilateral
ZXA10 [2001311348]

5.5e-01

-3.0e-01

—

3.4e-01

cases:2.31%

controls:1.35%

cases:0.30%

controls:0.41%

—

cases:0.36%

controls:0.26%

cases:1.32%

controls:0.94%

258

1948

18877

1988

19057

—

1945

18725

155

1714

16275

Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]

-1.2e-01

4.4e-01

—

8.9e-02

5.4e-01

cases:2.36%

controls:2.64%

cases:1.50%

controls:0.97%

—

cases:0.77%

controls:0.70%

cases:3.63%

controls:2.14%

506

1947

18629

186

1964

18949

—

132

1937

18641

352

1674

16078

Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]

9.8e-02

3.3e-01

-1.0e+50

—

6.3e-01

5.3e-01

cases:2.16%

controls:1.96%

cases:1.25%

controls:0.90%

cases:0.00%

controls:0.08%

—

cases:1.49%

controls:0.79%

cases:3.45%

controls:2.06%

375

1951

18760

173

1969

18962

1994

19119

—

149

1923

18624

338

1677

16092

Throat symptom/complaint
R21 [2002000891]

1.3e-01

4.0e-01

—

-2.8e-02

5.2e-01

cases:3.86%

controls:3.40%

cases:1.25%

controls:0.85%

—

cases:0.92%

controls:0.95%

cases:4.84%

controls:2.94%

651

1917

18484

162

1969

18973

—

178

1934

18595

483

1653

15947

Knee symptom/complaint
L15 [2002000639]

-1.7e-01

-4.2e-02

—

-1.0e+50

3.9e-01

4.9e-01

cases:1.86%

controls:2.18%

cases:0.80%

controls:0.84%

—

cases:0.00%

controls:0.14%

cases:1.28%

controls:0.87%

cases:4.49%

controls:2.81%

418

1957

18717

160

1978

18975

—

1989

19089

164

1927

18609

462

1659

15968

Otolaryngology
4 [38004449]

1.9e-01

1.6e-02

-5.3e-01

-1.0e+50

1.7e-01

4.5e-01

2.8e-01

cases:9.13%

controls:7.69%

cases:2.71%

controls:2.67%

cases:0.25%

controls:0.42%

cases:0.00%

controls:0.03%

cases:0.55%

controls:0.47%

cases:4.10%

controls:2.65%

cases:9.44%

controls:7.28%

182

1472

1812

17663

510

1940

18625

1989

19054

1994

19129

1978

19026

498

1872

18275

164

1196

1573

15234

Pain in joint
M25.5 [45586941]

1.5e-01

5.7e-01

—

-5.8e-02

4.3e-01

cases:3.56%

controls:3.08%

cases:2.06%

controls:1.18%

—

cases:1.13%

controls:1.19%

cases:6.33%

controls:4.19%

590

1923

18545

225

1953

18910

—

224

1930

18549

110

689

1627

15741

orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]

1.5e-01

3.6e-01

—

1.1e-01

4.3e-01

cases:5.87%

controls:5.08%

cases:2.21%

controls:1.56%

—

cases:1.69%

controls:1.51%

cases:6.74%

controls:4.47%

117

972

1877

18163

298

1950

18837

—

284

1919

18489

117

735

1620

15695

orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]

1.5e-01

3.6e-01

—

1.1e-01

4.3e-01

cases:5.87%

controls:5.08%

cases:2.21%

controls:1.56%

—

cases:1.69%

controls:1.51%

cases:6.74%

controls:4.47%

117

972

1877

18163

298

1950

18837

—

284

1919

18489

117

735

1620

15695

Cough
R05 [2002000886]

4.3e-01

1.6e-02

—

6.8e-01

1.5e-01

cases:4.06%

controls:2.69%

cases:0.90%

controls:0.89%

—

cases:1.38%

controls:0.71%

cases:3.34%

controls:2.90%

515

1913

18620

170

1976

18965

—

133

1925

18640

476

1679

15954

fluticasone, combinations
R01AD58 [43534837]

2.4e-01

5.2e-02

1.8e-02

—

6.1e-01

3.5e-01

3.7e-01

cases:4.76%

controls:3.79%

cases:2.06%

controls:1.95%

cases:0.35%

controls:0.34%

—

cases:0.45%

controls:0.25%

cases:2.82%

controls:2.00%

cases:6.10%

controls:4.30%

726

1899

18409

374

1953

18761

1987

19069

—

1980

19068

376

1897

18397

106

706

1631

15724

azelastine; nasal
R01AC03 [21605035]

2.3e-01

5.2e-02

1.8e-02

—

6.1e-01

3.5e-01

3.7e-01

cases:4.76%

controls:3.80%

cases:2.06%

controls:1.95%

cases:0.35%

controls:0.34%

—

cases:0.45%

controls:0.25%

cases:2.82%

controls:2.00%

cases:6.10%

controls:4.30%

728

1899

18407

374

1953

18761

1987

19069

—

1980

19068

376

1897

18397

106

707

1631

15723

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

814

4181

2.21

78.67

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1460

10260

1.69

49.88

2.8

2.7

58.93

60.38

u/l

0.11

1375

9555

(3032080) INR in Blood by Coagulation assay

1821

14202

1.55

36.68

13.1

13.6

1.19

1.22

inr

1.90

1557

11781

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2109

16993

1.55

36.62

5.9

6.8

11.06

11.32

umol/l

0.40

2040

16256

(3023368) Bacteria identified in Blood by Culture

1169

8439

1.56

32.20

4.4

4.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1529

11776

1.50

30.81

4.0

3.6

34.82

58.74

ng/l

1.62

1016

7735

(3041096) Erythrocytes [Presence] in Urine by Automated

1259

9535

1.48

26.46

3.5

3.2

0.15

0.14

estimate

0.02

413

2774

(3031040) Bacteria [#/volume] in Urine by Automated count

2422

20774

1.47

26.42

4.8

4.4

1236.41

2081.98

e6/l

0.29

278

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1853

15144

1.44

25.94

2.8

2.7

—

estimate

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2782

24903

1.45

21.26

8.4

76.62

77.97

u/l

1.17

2667

23794

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1613

13173

1.39

21.01

3.8

3.6

0.02

0.08

estimate

0.99

438

2892

(3044640) Blood type and Crossmatch panel - Blood

1321

10440

1.41

20.81

2.3

2.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1150

8882

1.42

20.59

3.3

3.2

0.37

0.39

e6/l

0.15

854

6455

(3037467) Urinalysis macro (dipstick) panel - Urine

2505

22080

1.40

20.26

4.8

4.4

2.40

3.49

—

(3009261) Glucose [Presence] in Urine by Test strip

2053

17548

1.38

19.75

3.9

3.8

0.06

0.10

estimate

0.17

499

3340

(3026782) Osmolality of Urine

814

5945

1.47

19.48

2.9

522.89

531.80

mosm/kgh2o

0.44

730

5217

(3013826) Glucose [Moles/volume] in Serum or Plasma

2175

18857

1.36

18.60

5.5

5.1

6.77

6.64

mmol/l

1.63

2097

17818

(3021601) Nitrite [Presence] in Urine by Test strip

2012

17250

1.36

18.39

3.9

3.8

0.00

estimate

1.08

518

3498

(3035350) Ketones [Presence] in Urine by Test strip

2032

17455

1.36

18.31

3.9

3.8

2.80

5.16

estimate

0.34

521

3572

(3002582) Erythrocytes [#/volume] in Urine

1287

10312

1.38

18.01

3.3

68.20

90.10

e6/l

0.45

995

7818

(3000850) Epithelial cells [#/volume] in Urine

928

7091

1.41

17.06

2.6

2.7

6.22

5.76

e6/l

0.46

843

6459

(3013650) Neutrophils [#/volume] in Blood by Automated count

2168

18959

1.34

16.55

9.2

10.0

4.61

4.02

e9/l

16.79

1914

16514

(40761536) Microorganisms panel - Urine sediment

394

2560

1.60

15.98

3.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3393

32074

1.60

15.88

17.9

15.2

26.19

22.81

mg/l

6.00

3006

26201

(3029937) Albumin [Presence] in Urine by Test strip

1158

9385

1.34

14.26

3.9

0.01

0.00

estimate

0.14

479

3280

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

217

1275

1.75

12.92

2.4

2.3

6660.62

5497.72

u/l

0.18

511

(3018095) Leukocytes [#/volume] in Urine

1422

11994

1.30

12.79

4.0

3.9

132.90

94.72

e6/l

0.47

1058

8340

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2556

23298

1.30

12.40

3.5

3.3

46.85

45.97

u/l

0.18

2445

22124

(3019550) Sodium [Moles/volume] in Serum or Plasma

3414

32626

1.51

11.73

19.8

17.1

139.60

139.73

mmol/l

2.63

3379

32031

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

978

7949

1.31

11.29

2.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3417

32713

1.50

11.07

20.0

17.3

3.97

3.96

mmol/l

0.28

3379

32049

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3282

31186

1.42

11.05

16.4

14.4

83.67

83.85

ml/min/173m2

0.20

3064

28840

(3023511) Choriogonadotropin [Units/volume] in Urine

120

630

1.93

10.32

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

571

4352

1.37

10.08

2.7

3.2

4.43

4.65

e9/l

0.45

521

3861

(3042936) Bacteria identified in Isolate by Culture

602

4628

1.36

10.06

2.0

2.1

—

(3026008) Bacteria identified in Urine by Culture

1100

9192

1.28

10.05

3.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1795

15902

1.25

9.87

8.0

7.3

1.21

mmol/l

0.47

1527

13859

(3015736) pH of Urine

1599

13994

1.25

9.78

3.4

3.3

6.17

6.20

0.52

975

8013

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2623

24283

1.27

9.64

4.7

4.4

11.61

11.27

mm/h

0.62

2466

22929

(3002030) Lymphocytes/Leukocytes in Blood

1803

16033

1.24

9.40

6.9

6.7

28.25

28.15

0.14

1731

15256

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1165

9910

1.25

8.95

2.2

224.25

217.56

u/l

0.06

1100

9436

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

291

2013

1.48

8.82

3.5

3.6

5.13

5.16

kpa

0.29

280

1941

(3009343) pH of Capillary blood

283

1952

1.49

8.71

3.3

3.6

7.42

0.53

238

1613

(3019069) Monocytes/Leukocytes in Blood

1752

15624

1.23

8.60

7.1

6.8

8.66

8.76

0.93

1668

14714

(3022096) Basophils/Leukocytes in Blood

1746

15586

1.22

8.42

7.1

6.8

0.68

0.69

0.36

1661

14635

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

637

5062

1.31

8.38

3.0

2.62

2.64

e6/l

0.02

286

2417

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

316

2247

1.44

8.32

1.7

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

142

846

1.71

8.15

1.8

—

(3021589) Normoblasts [#/volume] in Blood

1656

14735

1.22

8.15

13.4

11.2

0.00

e9/l

0.17

1416

12005

(3018010) Neutrophils/Leukocytes in Blood

1761

15775

1.22

8.07

6.8

6.6

57.19

57.05

0.20

1714

15122

(3006504) Eosinophils/Leukocytes in Blood

1740

15587

1.22

7.92

7.0

6.7

2.89

2.86

0.26

1658

14662

(3037522) Nuclear Ab [Titer] in Serum

632

5057

1.30

7.86

1.4

380.15

526.01

titre

2.67

133

1078

(3017181) Myelocytes/Leukocytes in Blood

401

3003

1.38

7.84

4.9

4.6

0.86

0.90

0.11

118

883

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1599

14240

1.21

7.63

7.2

6.6

1.21

mmol/l

0.64

1496

13268

(3006315) Basophils [#/volume] in Blood

1886

17069

1.21

7.61

6.8

6.6

0.04

e9/l

0.81

1686

14761

(3013115) Eosinophils [#/volume] in Blood

1940

17613

1.21

7.55

6.9

6.8

0.20

0.19

e9/l

1.40

1760

15504

(3019198) Lymphocytes [#/volume] in Blood

1921

17427

1.21

7.53

6.8

6.6

2.03

1.91

e9/l

0.87

1746

15463

(3025159) Blasts/Leukocytes in Blood

390

2928

1.37

7.50

5.1

4.8

0.11

0.26

0.57

105

718

(3001604) Monocytes [#/volume] in Blood

1880

17030

1.21

7.45

6.8

6.6

0.59

0.57

e9/l

2.28

1682

14746

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

681

5556

1.28

7.24

2.9

1.30

1.00

e6/l

0.56

332

2908

(3022145) Colonoscopy Study observation

495

3874

1.32

7.22

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

189

1249

1.54

7.16

2.3

1.9

1.40

2.01

ug/l

0.62

166

1122

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

242

1688

1.46

7.07

3.0

3.4

1.92

1.84

mmol/l

0.14

179

1258

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2337

21685

1.21

6.93

3.3

3.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

333

2470

1.38

6.90

4.3

4.1

1.23

mmol/l

0.14

297

2145

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2893

27427

1.24

6.88

21.0

18.5

13.53

13.55

0.35

2866

27059

(3003694) ABO and Rh group [Type] in Blood

1110

9629

1.22

6.70

1.5

—

(36660697) Celiac disease serology panel - Serum

372

2823

1.35

6.68

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

377

2869

1.35

6.65

5.1

4.7

0.14

0.11

0.28

749

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

407

3142

1.33

6.52

3.8

3.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1017

8774

1.22

6.44

3.3

3.1

1321.58

1127.42

ng/l

0.48

862

7465

(3002179) Metamyelocytes/Leukocytes in Blood

376

2875

1.34

6.43

4.8

4.4

0.47

0.70

2.08

115

844

(3014051) Protein [Presence] in Urine by Test strip

1106

9631

1.21

6.36

3.0

2.8

0.16

0.02

0.42

186

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

791

6664

1.24

6.28

1.4

1.3

24.02

29.15

iu/ml

1.09

257

2051

(3048689) Calprotectin [Mass/mass] in Stool

564

4571

1.28

6.28

2.5

2.6

120.20

128.03

ug/g

0.24

445

3703

(3024561) Albumin [Mass/volume] in Serum or Plasma

1588

14319

1.19

6.18

5.2

35.81

36.08

g/l

1.14

1505

13499

(1616796) Gas panel - Central venous blood

113

685

1.67

6.17

4.1

3.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

941

8093

1.22

6.10

1.4

1.3

1.19

1.81

u/ml

1.95

263

2242

(40768797) Stomach Pathology biopsy report

569

4639

1.27

6.02

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

876

7503

1.22

5.89

1.7

1.8

1.21

1.14

mg/l

0.23

676

5787

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3167

30475

1.25

5.72

6.5

6.0

39.13

38.84

mmol/mol

1.08

2990

28855

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3516

34332

1.38

5.43

21.9

19.1

77.25

75.80

umol/l

1.63

3489

33972

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

316

2418

1.34

5.39

2.3

2.4

22.86

21.56

au/ml

0.10

283

(3033658) Prothrombin time (PT) actual/Normal

968

8435

1.20

5.37

4.0

4.1

90.04

91.46

1.06

952

8245

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

135

888

1.54

5.31

1.2

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

409

3250

1.29

5.31

2.6

32.94

55.01

u/l

0.86

357

2783

(40760892) CBC W Ordered Manual Differential panel - Blood

903

7826

1.20

5.31

5.2

4.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2706

25696

1.19

5.30

4.9

4.4

14.64

14.66

pmol/l

0.13

2509

23916

(3047181) Lactate [Moles/volume] in Blood

141

939

1.52

5.25

6.3

6.4

1.24

1.33

mmol/l

0.73

130

822

(3026493) Urate [Moles/volume] in Serum or Plasma

1003

8793

1.19

5.18

2.7

2.6

335.75

335.97

umol/l

0.03

890

7907

(1761868) Lipid panel - Serum or Plasma

1534

13947

1.17

5.09

3.3

3.0

—

(3035933) Granulocytes/Leukocytes in Blood

112

721

1.57

4.88

3.7

3.4

56.08

57.96

0.87

112

721

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

440

3585

1.26

4.66

4.2

4.6

234.06

242.78

u/l

0.59

415

3424

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

290

2244

1.32

4.61

1.2

1.3

57.06

55.51

au/ml

0.05

159

(3003327) Ova and parasites identified in Stool by Light microscopy

172

1238

1.41

4.35

1.6

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

394

3198

1.26

4.32

2.6

2.3

377.97

378.33

nmol/l

0.01

372

2964

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1529

14020

1.15

4.31

2.1

95.54

96.62

pmol/l

0.41

813

7512

(40768804) Tissue Pathology biopsy report

1468

13423

1.15

4.30

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

478

3968

1.23

4.29

2.2

2.8

8.31

7.91

umol/l

0.12

424

3495

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3118

30151

1.20

4.24

5.8

5.3

1.80

1.87

mu/l

2.33

2914

28258

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

139

2.24

4.24

1.1

240.64

189.16

iu/ml

0.18

139

(3004588) Protein electrophoresis panel - Serum or Plasma

263

2042

1.31

4.10

2.7

2.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

212

1596

1.35

4.10

3.0

2.8

0.62

0.04

212

1587

(3018418) pH of Serum or Plasma

1072

9609

1.16

4.07

4.8

4.3

7.40

0.54

811

6883

(3005719) IgG [Mass/volume] in Serum or Plasma

340

2736

1.27

4.02

2.6

2.9

10.39

10.64

g/l

0.44

315

2541

(3002032) Base excess in Venous blood by calculation

369

2999

1.26

4.01

4.5

3.8

1.86

1.84

mmol/l

0.04

325

2601

(3052592) Norovirus Ag [Presence] in Stool

3.90

3.99

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

249

1932

1.31

3.92

2.3

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

183

1358

1.37

3.89

5.3

5.4

1.61

1.63

0.15

175

1285

(3000012) Reticulocyte production index

411

1.67

3.89

2.3

2.1

0.98

0.92

0.24

291

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

711

6190

1.18

3.86

1.3

11.15

10.49

u/ml

0.09

283

2503

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1745

16231

1.14

3.86

3.4

3.1

124.25

119.26

ug/l

0.24

1645

15328

(3012544) pH of Venous blood

380

3117

1.24

3.82

4.6

3.8

7.38

0.47

211

1774

(3014111) Lactate [Moles/volume] in Serum or Plasma

348

2830

1.25

3.78

8.8

8.0

1.46

1.33

mmol/l

0.99

348

2772

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

132

933

1.43

3.74

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

982

8794

1.16

3.73

1.8

1.7

20.09

20.20

nmol/l

0.08

821

7574

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3157

30647

1.19

3.68

4.4

4.2

1.37

1.30

mmol/l

4.62

2944

28689

(3022313) Gas panel - Capillary blood

182

1363

1.35

3.67

3.3

3.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

426

1.63

3.66

1.4

1.3

6.98

7.20

mmol/l

0.28

377

(40758558) Short blood count panel - Blood

1110

10042

1.15

3.65

6.1

6.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

806

7122

1.17

3.64

1.5

2.30

2.41

g/l

0.96

493

4548

(3020491) Glucose [Moles/volume] in Blood

225

1.88

3.63

2.0

1.8

6.51

6.75

mmol/l

0.27

149

(3007853) Bacteria identified in Skin by Aerobe culture

464

3909

1.21

3.61

1.8

1.7

—

(3025941) Bacteria identified in Stool by Culture

239

1866

1.30

3.61

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

109

750

1.47

3.58

2.6

2.3

132.22

130.32

g/l

0.38

586

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1281

11722

1.14

3.54

3.3

3.4

29.95

34.77

u/l

2.05

1215

11124

(3004789) Transferrin [Mass/volume] in Serum or Plasma

590

5093

1.19

3.53

3.0

2.6

2.36

2.33

g/l

0.47

539

4739

(3020630) Protein [Mass/volume] in Serum or Plasma

314

2544

1.26

3.53

3.1

2.8

66.41

66.78

g/l

0.43

287

2378

(3016879) Cocaine [Presence] in Urine

177

1334

1.34

3.44

3.1

2.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

636

1.49

3.37

3.6

4.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

310

2523

1.25

3.36

1.2

132.00

146.49

u/ml

0.25

102

977

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

202

1561

1.31

3.32

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

289

2338

1.26

3.31

2.3

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1228

0.67

3.31

1.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

861

7701

1.15

3.28

3.8

1.02

1.21

kg/l

0.50

586

5121

(3014271) Vancomycin [Susceptibility]

109

2.21

3.25

2.6

2.9

—

(3000330) Specific gravity of Urine by Test strip

197

1523

1.31

3.23

3.1

3.2

1.02

ratio

0.20

182

1374

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3293

32155

1.20

3.23

5.2

4.9

1.43

1.46

mmol/l

4.93

3086

30345

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

143

1056

1.37

3.20

3.0

3.6

25.05

24.92

mmol/l

0.23

138

979

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3306

32315

1.19

3.08

5.3

5.0

4.70

mmol/l

0.07

3123

30672

(3042631) Mycobacterium sp identified in Specimen

407

1.58

3.07

1.9

2.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

345

2871

1.22

3.06

7.7

8.2

9.09

9.46

mmol/l

0.51

333

2767

(3022948) Iron [Moles/volume] in Serum or Plasma

623

5468

1.17

3.05

3.1

2.6

13.91

13.62

umol/l

0.45

588

5129

(1001926) Buprenorphine [Presence] in Urine by Screen method

150

1131

1.34

2.96

3.4

2.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

405

3437

1.20

2.94

2.2

2.7

1.80

0.01

358

3102

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1617

15143

1.12

2.92

2.6

2.5

76.55

76.78

nmol/l

0.11

1475

13973

(3027008) Opiates [Presence] in Urine

186

1449

1.30

2.92

3.0

2.0

—

(3027944) Amphetamines [Presence] in Urine

184

1432

1.30

2.91

3.2

2.1

—

(3022621) pH of Urine by Test strip

315

2618

1.22

2.85

2.8

2.5

6.16

6.08

0.85

205

1728

(3028300) Cannabinoids [Presence] in Urine

186

1455

1.29

2.84

3.1

2.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

558

4884

1.17

2.83

2.0

2.1

29.56

29.59

0.03

547

4747

(3000570) Elastase.pancreatic [Mass/mass] in Stool

134

1001

1.35

2.82

1.3

1.4

264.32

286.90

ug/g

0.67

583

(3011412) CD3 cells [#/volume] in Blood

337

1.61

2.82

2.5

2.3

1471.73

1233.11

e6/l

0.46

299

(3003329) Lymphocytes/Leukocytes in Synovial fluid

283

1.67

2.82

1.9

1.6

33.40

32.14

0.08

168

(3009508) Creatinine [Moles/volume] in Urine

1208

11144

1.12

2.81

3.7

3.5

7.75

mmol/l

0.02

999

9569

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

583

5134

1.16

2.73

2.0

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

184

1446

1.29

2.72

3.1

2.1

—

(3012501) Base excess in Blood by calculation

626

1.43

2.69

3.9

4.5

2.52

2.48

mmol/l

0.04

417

(3020911) Cortisol [Moles/time] in 24 hour Urine

105

2.10

2.68

1.6

1.5

67.00

413.52

nmol/24h

0.70

105

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

534

4683

1.16

2.64

3.1

2.6

23.45

23.48

0.02

501

4386

(3015171) Extractable nuclear Ab [Units/volume] in Serum

177

1391

1.29

2.63

1.3

0.19

1.23

u/ml

—

112

(3023520) Reticulocytes [#/volume] in Blood

312

2614

1.21

2.62

2.6

2.7

71.83

70.93

e9/l

0.15

235

1898

(3007930) Methemoglobin/Hemoglobin.total in Blood

162

1259

1.30

2.62

5.7

5.8

0.88

0.89

0.14

155

1187

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

731

6564

1.14

2.60

1.8

1.7

71335918.74

36716528.95

pmol/l

0.52

614

5597

(3028026) IgM [Mass/volume] in Serum or Plasma

262

2160

1.23

2.58

2.0

1.9

1.22

1.38

g/l

0.63

245

2002

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3469

34136

1.21

2.56

12.8

11.9

26.87

26.86

u/l

0.01

3384

33332

(3045424) Erythrocytes [Presence] in Urine

203

1630

1.26

2.54

2.3

2.2

0.09

0.01

estimate

0.68

538

(44806420) Estimation of glomerular filtration rate

395

1.53

2.53

2.5

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

178

0.34

2.53

1.0

1.1

—

(4024509) Urine culture

184

1461

1.27

2.53

2.0

—

(3004451) EKG impression Narrative

186

1.78

2.52

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

681

6100

1.14

2.51

3.9

3.7

241.58

441.28

ng/l

1.73

487

4482

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

185

1474

1.27

2.48

2.0

39.87

39.38

u/l

0.11

162

1349

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

270

2245

1.22

2.46

3.3

3.5

4.46

4.52

pmol/l

0.41

239

2020

(3045414) Leukocytes [Presence] in Urine

370

3169

1.19

2.46

2.1

0.00

0.01

estimate

1.06

691

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

129

984

1.32

2.41

3.9

3.8

33.26

58.30

mg/l

1.27

108

837

(3046861) Legionella sp Ag [Presence] in Urine

5.01

2.40

1.2

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

985

1.32

2.40

3.9

3.8

36.87

58.24

mg/l

2.07

110

837

(3035285) Chloride [Moles/volume] in Venous blood

305

1.58

2.38

2.1

2.5

106.10

105.57

mmol/l

0.39

299

(3041354) Potassium [Moles/volume] in Venous blood

305

1.58

2.38

2.1

2.5

3.92

4.05

mmol/l

1.91

299

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

600

1.41

2.37

1.3

180.00

426.00

titre

—

(3037756) Immunofixation for Serum or Plasma

617

1.40

2.37

2.1

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

330

1.55

2.35

2.1

5.1

6.70

7.37

mmol/l

0.66

280

(3015377) Calcium [Moles/volume] in Serum or Plasma

1195

11113

1.11

2.33

3.1

3.6

2.35

mmol/l

0.28

1078

10215

(3000492) Spirometry study

407

3531

1.17

2.33

1.5

—

(3007461) Platelets [#/volume] in Blood

3569

35255

1.25

2.32

26.5

22.9

254.29

254.27

e9/l

0.01

3524

34639

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

604

1.40

2.29

1.9

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.95

2.28

3.2

2.6

—

(3035941) MCH [Entitic mass]

3569

35261

1.25

2.27

26.4

22.8

30.31

0.04

3547

34945

(3011288) Drugs identified in Urine by Screen method Nominal

130

1003

1.31

2.26

2.3

3.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3569

35262

1.25

2.26

26.4

22.8

90.91

90.94

0.13

3547

34945

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3569

35264

1.25

2.24

27.1

23.3

40.65

41.02

0.99

3547

34931

(3026361) Erythrocytes [#/volume] in Blood

3569

35266

1.24

2.23

26.5

22.9

4.52

e12/l

0.42

3513

34553

(3010813) Leukocytes [#/volume] in Blood

3569

35268

1.24

2.21

26.5

22.9

6.90

6.66

e9/l

4.58

3517

34552

(3006245) CD3-CD19+ cells/cells in Blood

128

1.88

2.21

2.2

2.1

11.33

8.60

0.67

121

(3000963) Hemoglobin [Mass/volume] in Blood

3569

35273

1.24

2.17

26.7

23.0

135.95

136.20

g/l

0.50

3546

34961

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

117

897

1.31

2.15

1.7

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

729

6625

1.12

2.14

2.1

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3325

32668

1.16

2.14

5.9

5.6

2.79

2.77

mmol/l

0.37

3130

30869

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

190

1549

1.24

2.13

2.3

—

(3016502) Oxygen saturation in Arterial blood

376

3267

1.17

2.13

9.8

8.5

95.37

95.79

0.49

365

3169

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

259

1.59

2.12

2.2

2.1

11.73

15.13

1.51

254

(3012565) Volume of 24 hour Urine

167

1.74

2.11

1.4

2.4

2173.54

1876.97

0.67

154

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.56

2.07

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

206

1.66

2.07

1.1

0.89

1.14

u/l

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1510

14277

1.10

2.05

2.1

1.9

1.45

1.40

mmol/l

1.30

1229

12225

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

652

1.36

2.04

1.5

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

451

3992

1.15

2.00

1.5

—

(3042517) Benzodiazepines panel - Urine

2.82

2.00

7.1

2.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

360

1.48

2.00

2.3

2.4

0.85

1.38

g/24h

0.94

215

(3003458) Phosphate [Moles/volume] in Serum or Plasma

471

4183

1.14

1.99

7.3

6.5

1.03

1.04

mmol/l

0.23

446

3908

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

215

1791

1.21

1.98

2.4

3.6

36.44

63.21

u/ml

1.52

205

1733

(1175426) CD3 cells/Lymphocytes in Blood

272

1.55

1.97

2.3

2.1

73.98

73.80

0.02

258

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

337

1.49

1.96

2.1

2.3

25.83

18.88

mg/l

0.39

132

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

119

928

1.29

1.95

2.1

10.87

11.62

mg/l

0.49

112

875

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

141

1124

1.26

1.95

2.2

2.3

319.21

456.42

ug/l

0.89

133

1060

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3166

31041

1.13

1.95

5.1

4.9

5.92

5.88

mmol/l

1.14

2965

28949

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

163

1322

1.24

1.94

1.7

1.6

14.57

13.80

u/ml

0.06

327

(3016650) Hepatitis A virus Ab [Presence] in Serum

624

1.35

1.93

1.1

—

(4062490) Immunoglobulin typing, IgG

363

1.47

1.93

1.2

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

113

878

1.30

1.91

4.0

3.5

1.56

3.41

ratio

1.90

484

(3049717) Cytology report of Urine Cyto stain

136

1085

1.26

1.88

2.7

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1115

10431

1.10

1.87

4.4

4.2

11.19

7.73

mg/mmol

1.12

688

6575

(3033705) Calcium.ionized [Moles/volume] in Venous blood

300

1.51

1.87

2.2

2.5

1.20

1.19

mmol/l

0.24

294

(3012095) Magnesium [Moles/volume] in Serum or Plasma

602

5453

1.12

1.87

3.5

3.6

0.82

mmol/l

0.35

576

5172

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

236

1.57

1.87

2.4

2.6

216.16

215.05

e6/l

0.01

205

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.09

1.86

1.5

1.1

—

(3011985) Renin [Units/volume] in Plasma

467

1.40

1.84

1.5

1.4

37.15

55.94

mu/l

0.67

416

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

229

1.58

1.84

2.5

580.42

545.39

e6/l

0.16

187

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

261

1.54

1.84

2.2

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

3.53

1.83

1.0

1.1

7.16

8.10

mmol/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

286

1.51

1.81

2.4

2.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

385

1.43

1.81

1.2

1.4

—

nmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

242

2059

1.19

1.80

1.5

1.4

23.22

29.24

iu/l

2.35

206

1757

(3010838) Calcium [Moles/time] in 24 hour Urine

591

1.34

1.77

2.0

5.63

5.13

mmol/24h

0.58

530

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

215

1815

1.20

1.75

12.8

10.9

16.29

16.13

0.30

209

1751

(3002173) Hemoglobin [Mass/volume] in Arterial blood

350

3077

1.15

1.73

10.3

9.0

123.41

122.61

g/l

0.28

342

3010

(3027456) Digoxin [Moles/volume] in Serum or Plasma

499

1.37

1.72

3.6

3.4

0.77

0.81

nmol/l

0.43

416

(3028192) IgG subclass 2 [Mass/volume] in Serum

364

1.43

1.72

1.2

1.4

3.03

2.96

g/l

0.10

259

(3024139) IgG subclass 3 [Mass/volume] in Serum

364

1.43

1.72

1.2

1.4

0.33

0.39

g/l

1.06

258

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

148

1207

1.24

1.71

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

1.70

0.0

2.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

365

1.43

1.70

1.2

1.4

7.24

6.54

g/l

0.62

259

(3034274) Bile acid [Moles/volume] in Serum --fasting

399

1.41

1.69

2.5

2.1

7.18

5.32

umol/l

0.44

288

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

906

8439

1.10

1.66

2.4

2.3

2.73

2.76

mg/l

0.09

788

7352

(40768793) Breast Pathology biopsy report

829

0.73

1.65

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

228

1.54

1.64

1.2

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

127

1.74

1.64

2.2

2.1

31.55

30.38

0.12

122

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

749

1.29

1.62

4.5

5.9

1115.75

503.52

iu/ml

0.28

(3039000) Anion gap in Blood by calculation

644

1.31

1.61

8.2

7.6

11.10

11.47

mmol/l

0.55

580

(3012516) Albumin [Mass/volume] in Urine

1093

10279

1.09

1.61

3.7

3.5

50.94

43.45

mg/l

0.54

673

6579

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

270

1.49

1.61

1.0

1.2

104.20

109.80

pmol/l

0.42

270

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

270

1.49

1.61

2.0

2.2

19.96

19.04

nmol/l

0.20

256

(3006571) Granulocytes/Leukocytes in Synovial fluid

378

1.41

1.60

1.5

1.7

67.07

59.81

0.67

234

(3018572) Chloride [Moles/volume] in Blood

645

1.31

1.60

8.2

7.6

105.39

105.22

mmol/l

0.12

581

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2725

27877

0.92

1.56

21.1

19.0

332.85

332.53

g/l

1.08

2714

27727

(3027801) Oxygen [Partial pressure] in Arterial blood

409

3662

1.13

1.56

9.4

8.1

11.87

12.59

kpa

2.60

390

3529

(3043410) Blood group antigens tested for on Red Blood Cells

1.85

1.55

2.2

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

425

3817

1.13

1.55

1.9

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

432

1.37

1.54

1.3

227.29

323.92

pmol/l

2.46

369

(3005322) IgE [Units/volume] in Serum or Plasma

272

2371

1.16

1.54

1.4

1.3

364.21

210.26

u/ml

0.33

258

2204

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

192

1.57

1.54

1.8

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.98

1.53

1.8

1.3

1.47

47.38

ug/l

—

(3028707) Methadone [Presence] in Urine by Screen method

615

1.31

1.52

5.3

2.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

114

917

1.25

1.52

1.1

3.02

4.67

eliau/ml

—

127

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

408

3661

1.13

1.51

9.4

8.2

5.09

5.11

kpa

0.14

389

3530

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

460

1.35

1.50

1.2

1.4

0.61

4.46

nmol/l

0.50

443

(3035320) C reactive protein [Mass/volume] in Body fluid

259

1.47

1.48

2.8

2.5

27.20

29.97

mg/l

0.18

181

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

620

1.30

1.45

1.1

22.34

16.74

au/ml

0.32

162

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

236

1.49

1.44

2.5

0.98

0.72

e9/l

0.38

226

(3009677) Dengue virus Ab [Presence] in Serum

3.13

1.44

1.2

1.0

—

(3019977) pH of Arterial blood

406

3660

1.12

1.41

9.4

8.2

7.43

7.42

2.66

224

2014

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

197

1.53

1.40

1.8

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

296

1.42

1.39

1.6

1.4

1.22

1.23

promille

0.02

236

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1005

9476

1.08

1.38

5.8

5.0

2.30

2.52

ug/l

0.27

899

8654

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

133

1103

1.21

1.37

1.9

1.8

1.18

1.19

g/l

0.10

127

1061

(4198724) Urine methamphetamine measurement

135

1.63

1.35

3.5

3.3

—

(3000991) Gas panel - Venous blood

306

2719

1.14

1.35

11.5

9.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

460

4188

1.11

1.34

1.8

1.6

—

(3003396) Base excess in Arterial blood by calculation

401

3624

1.12

1.34

9.5

8.1

0.82

0.95

mmol/l

0.26

336

2982

(3023430) Cat dander IgE Ab [Units/volume] in Serum

540

1.30

1.33

1.1

3.73

4.04

u/ml

0.05

240

(3032057) Clostridioides difficile [Presence] in Stool

2.04

1.32

1.6

1.9

—

(40768443) Skin Pathology biopsy report

171

1457

1.18

1.32

1.3

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

113

1.68

1.31

1.3

1.5

14.47

15.58

pmol/l

0.28

(4027681) Cerebrospinal fluid IgG ratio and IgG index

217

1.48

1.30

1.3

1.2

0.55

0.58

ratio

0.22

128

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.10

1.30

15.3

11.4

4.88

5.34

mmol/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

155

1312

1.19

1.30

2.1

1.6

280.01

288.82

mu/l

0.18

144

1201

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

242

1.45

1.30

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

164

1396

1.18

1.29

1.7

1.6

23.33

16.35

iu/ml

—

(3010503) CD19 cells [#/volume] in Blood

218

1.47

1.28

2.7

2.4

106.16

262.90

e6/l

0.70

209

(3015076) Soybean IgE Ab [Units/volume] in Serum

210

1.48

1.27

1.1

1.0

0.23

0.27

u/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

179

1537

1.17

1.27

1.9

1.7

0.33

0.32

mg/l

0.16

748

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

129

1077

1.20

1.26

3.0

2.5

0.46

1.07

g/l

2.25

107

943

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

355

3199

1.12

1.26

3.9

4.3

7.04

22.17

ug/l

2.30

282

2561

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

124

1032

1.21

1.25

2.4

2.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

124

1033

1.21

1.24

1.2

1.3

94.44

126.34

titre

—

101

(3035947) Staphylolysin Ab [Units/volume] in Serum

139

1.59

1.23

1.1

—

3.90

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

898

1.22

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

610

1.27

1.22

1.3

1.7

0.62

0.77

g/l

0.72

477

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

619

1.27

1.22

1.7

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

391

1.33

1.21

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

1.72

1.21

2.3

2.0

0.21

0.17

e9/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

647

1.26

1.20

4.2

3.7

128.92

699.18

u/ml

0.80

601

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

289

1.39

1.19

1.2

34.26

43.16

mg/l

1.46

241

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

250

0.60

1.18

1.9

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

165

1.52

1.17

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

534

1.28

1.17

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

282

1.39

1.16

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

411

3756

1.11

1.14

4.8

4.7

31.48

31.86

0.32

300

2579

(3002523) Influenza virus A Ag [Presence] in Specimen

688

1.24

1.14

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

688

1.24

1.14

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

274

2449

1.13

2.3

8.17

7.80

ug/l

0.07

244

2201

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

397

3625

1.11

1.13

1.9

1.8

—

(3044007) Cell count panel - Peritoneal fluid

111

0.45

1.12

1.0

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

195

1706

1.15

1.12

1.1

102.22

130.13

titre

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.8

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

144

1231

1.18

1.11

3.2

2.4

7.22

7.34

g/l

0.39

128

1148

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

1.43

1.11

1.8

1.5

—

(40768800) Prostate Pathology biopsy report

566

1.26

1.10

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.38

1.09

1.2

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

119

1003

1.19

1.08

1.7

2.1

2.95

9.49

iu/l

0.65

431

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

443

4078

1.10

1.07

2.3

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

598

5580

1.09

1.07

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

169

1.48

1.07

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

524

4864

1.09

1.06

1.8

1.7

1178.81

1151.42

nmol/l

0.28

397

3772

(3008152) Bicarbonate [Moles/volume] in Arterial blood

219

1941

1.14

1.05

7.5

7.0

24.71

24.47

mmol/l

0.44

210

1857

(4094501) Cardiovascular stress test using bicycle ergometer

119

1007

1.19

1.05

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

652

1.23

1.03

1.1

3.08

1.56

u/ml

0.73

324

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

125

1064

1.18

1.03

1.9

1.8

0.24

0.23

g/l

0.32

119

1021

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

926

1.19

1.03

1.2

1.1

3.80

4.29

0.30

130

(3017509) Phencyclidine [Presence] in Urine

2.06

1.02

4.3

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.74

1.02

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.69

1.01

1.3

1.2

23.34

12.71

pmol/l

—

(3018133) Calcium [Moles/volume] in Urine

1.81

0.98

1.7

2.5

2.78

3.06

mmol/l

0.24

(3014599) Egg white IgE Ab [Units/volume] in Serum

223

1.39

0.98

1.1

1.0

0.34

0.80

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

142

1230

1.16

0.96

3.2

2.4

3.55

3.73

g/l

1.02

127

1150

(3024522) Salmonella sp identified in Specimen by Organism specific culture

389

1.29

0.96

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

1054

1.17

0.96

3.2

2.4

9.54

10.35

g/l

1.51

106

966

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

142

1231

1.16

0.95

3.2

2.4

4.27

4.24

g/l

0.22

127

1148

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

607

5699

1.08

0.94

3.3

3.1

0.80

0.73

ug/l

0.56

392

3504

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.89

0.94

1.4

1.2

3.27

5.00

nmol/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

158

1.46

0.93

1.0

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

217

1.39

0.93

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

409

1.28

0.93

1.3

0.18

nmol/l

0.06

322

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

269

1.34

0.92

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

690

1.21

0.91

1.2

2.1

1.01

0.88

nmol/l

1.13

588

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.14

0.91

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

201

1.40

0.91

1.6

2.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

118

1.53

0.90

2.1

1.9

2.26

1.74

ratio

0.53

111

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

119

1023

1.17

0.90

2.1

2.5

3.71

3.62

g/l

0.25

114

967

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

279

1.33

0.90

1.1

228.10

283.18

mg/l

2.32

243

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

288

1.32

0.89

1.1

1.3

1.32

0.95

u/ml

0.15

158

(3025468) Yersinia sp identified in Specimen by Organism specific culture

368

1.28

0.88

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

169

0.59

0.88

2.2

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

169

0.59

0.88

2.1

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

169

0.59

0.88

2.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

169

0.59

0.88

2.2

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

129

0.54

0.88

2.6

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

129

0.54

0.88

2.7

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

129

0.54

0.88

2.6

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

521

1.23

0.87

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.86

0.87

1.0

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

102

871

1.18

0.85

3.1

3.3

1.78

1.68

index

0.07

467

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

370

1.27

0.85

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

399

3703

1.09

0.84

2.2

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

1161

1.15

0.84

3.3

2.5

2.79

2.92

g/l

1.14

117

1080

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

651

1.20

0.84

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

108

929

1.17

0.83

3.0

2.4

0.00

0.03

g/l

2.26

845

(3014133) Dog dander IgE Ab [Units/volume] in Serum

588

1.21

0.83

1.1

3.70

3.33

u/ml

0.09

288

(3005988) Vibrio sp identified in Specimen by Organism specific culture

372

1.27

0.82

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

627

1.20

0.80

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

282

0.71

0.79

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

282

0.71

0.79

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

282

0.71

0.79

1.7

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.82

0.79

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.67

0.78

2.0

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.67

0.78

4.3

7.7

10.56

10.50

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

216

1.35

0.78

2.7

2.8

39.36

42.94

0.50

116

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

384

1.25

0.78

1.5

1.4

—

(3034426) Prothrombin time (PT)

122

0.57

0.77

1.3

1.2

29.71

28.52

—

122

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

502

1.22

0.77

1.1

0.13

0.22

u/ml

0.38

167

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

0.15

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

267

2446

1.10

0.77

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

280

0.71

0.76

1.6

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.77

0.76

1.0

—

(1002224) Polysomnography panel

206

1866

1.11

0.75

1.1

—

(4212803) Bone marrow aspirate examination

2.08

0.74

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

123

1080

1.14

0.74

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

116

1.47

0.74

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

116

1.47

0.74

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

698

1.18

0.74

1.1

4.35

4.44

u/ml

0.02

364

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

208

0.67

0.74

1.4

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

0.72

1.6

1.3

39.60

48.12

umol/l

—

(40765096) Chromosome analysis panel by Banding

106

0.57

0.72

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

169

1518

1.12

0.72

2.3

1.8

3.77

6.91

iu/ml

1.11

360

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.75

0.71

1.0

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

0.70

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

126

1.43

0.70

2.8

2.7

47.83

137.82

au/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

592

1.19

0.69

3.6

2.8

2916.00

1421.24

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

230

1.31

0.69

1.1

1.0

0.42

1.69

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

152

1.38

0.69

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

278

2569

1.09

0.68

2.4

2.5

0.40

0.41

e6/l

0.03

267

2437

(3020393) Adenovirus Ag [Presence] in Stool

1.85

0.68

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

593

1.18

0.68

1.2

—

(3024263) Appearance of Synovial fluid

161

1.37

0.68

2.5

1.8

—

(21494814) CD8 cells/Lymphocytes in Specimen

144

1.39

0.67

2.3

2.0

27.30

30.34

0.41

144

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

724

1.16

0.67

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

340

3174

1.08

0.66

2.5

2.3

0.22

0.21

g/l

0.21

323

2975

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.79

0.66

1.0

1.3

19.00

2955.57

u/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.79

0.66

2.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.79

0.66

1.4

2.2

4.02

2.66

mg/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

241

1.29

0.65

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

110

970

1.14

0.65

3.5

3.2

0.40

0.34

iu/ml

0.86

520

(3034092) Cytoplasmic Ig cells/cells in Blood

1.59

0.65

6.1

9.5

0.21

0.18

—

(4281824) Cell count and differential, peritoneal fluid

358

1.23

0.65

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

154

1.37

0.65

1.0

1.4

151.62

163.67

mmol/24h

0.23

154

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

270

0.74

0.64

1.5

13.15

12.50

umol/l

0.11

253

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

260

1.27

0.63

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

323

1.24

0.63

1.4

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

112

1.43

0.63

1.0

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

269

0.74

0.63

1.2

1.4

195.27

196.09

pmol/l

0.01

269

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

381

0.79

0.63

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.52

0.62

1.2

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

360

1.22

0.62

1.9

2.0

15.27

24.58

ug/l

1.83

354

(21494755) Public health laboratory ask at order entry panel

387

3641

1.07

0.62

1.3

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.60

0.61

1.0

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.60

0.61

1.0

1.2

31.81

49.24

mg/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

352

1.22

0.61

1.0

1.1

—

titre

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.4

—

338.81

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

3.4

—

0.65

—

(3044290) Cell count panel - Cerebral spinal fluid

723

1.15

0.60

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

245

1.27

0.59

1.4

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.16

—

(21494890) Protein electrophoresis panel - 24 hour Urine

290

1.24

0.59

3.3

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

670

0.85

0.58

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.72

0.57

1.3

1.5

—

(3000494) Fungus identified in Specimen by Culture

439

4161

1.06

0.57

1.5

—

(3008898) HLA-B27 [Presence]

147

1333

1.11

0.57

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

494

1.18

0.56

5.7

6.1

383.98

362.17

umol/l

0.62

440

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.46

0.56

1.1

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

194

1.29

0.55

1.8

1.5

11.00

13.20

u/l

1.49

187

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

131

1183

1.11

0.55

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

635

1.15

0.55

2.9

3.4

23.09

24.92

mg/l

0.19

436

(3008401) Mugwort IgE Ab [Units/volume] in Serum

673

1.15

0.54

1.1

0.82

0.96

u/ml

0.14

284

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

198

1827

1.09

0.54

1.1

—

(3016750) Collection duration of Urine

186

1.29

0.54

2.7

2.3

488.84

489.26

min

0.01

137

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

151

1377

1.10

0.53

1.8

1.56

1.55

g/l

0.02

127

1198

(3036071) Salmonella sp Ab [Titer] in Serum

125

1.36

0.53

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

497

1.17

0.53

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.49

0.53

1.1

—

(3006462) Nitrate [Presence] in Urine

134

1.34

0.53

2.2

2.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

196

1.28

0.52

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

100

893

1.12

0.52

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

271

0.77

0.52

1.0

1.1

—

(4211845) Urine protein measurement

152

1.32

0.52

2.0

2.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

152

1.32

0.52

1.4

1.7

3.67

3.55

u/field

0.02

110

(40765089) Chromosome analysis panel - Blood by G-banded

0.61

0.51

1.2

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

667

1.14

0.51

1.5

1.4

142.33

154.50

au/ml

0.34

192

(3019832) Treponema pallidum Ab [Presence] in Serum

361

3415

1.06

0.51

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

296

1.22

0.51

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

465

4433

1.06

0.51

1.8

1.56

1.46

1.43

404

3937

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

352

1.20

0.50

1.1

—

(3045142) Bone marrow Pathology biopsy report

362

1.19

0.49

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

658

0.86

0.49

1.5

1.21

1.26

0.26

468

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.56

0.49

1.1

48.00

61.04

ug/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

301

2838

1.07

0.48

1.5

—

(3019225) pH of Specimen

305

2877

1.07

0.48

3.8

4.1

7.37

7.35

0.61

222

2109

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

671

1.14

0.48

1.5

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

118

1070

1.11

0.48

1.5

1.4

9.84

10.19

u/l

0.11

871

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.52

0.48

1.0

9.37

6.20

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

531

1.15

0.47

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.47

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

272

1.22

0.47

1.5

1.3

2.40

2.11

mmol/l

0.25

255

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

197

1832

1.08

0.47

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

687

0.87

0.47

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

117

1064

1.10

0.46

4.5

3.1

1.53

1.49

mg/l

0.24

109

991

(40768441) Liver Pathology biopsy report

264

1.21

0.45

1.1

1.4

—

(3016228) CD19 cells/cells in Blood

147

1.29

0.45

2.2

2.0

7.42

8.04

0.12

140

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

219

1.23

0.45

1.1

1.09

1.05

ratio

0.82

179

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

761

1.12

0.44

1.4

1.5

—

(4034850) Laboratory test

1010

0.90

0.44

11.6

9.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

895

1.11

0.44

3.2

2.4

0.00

g/l

-0.00

791

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.37

0.44

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

820

1.11

0.43

1.1

1.99

2.02

u/ml

0.01

428

(3027923) C peptide [Moles/volume] in Serum or Plasma

202

1.24

0.43

1.2

1.5

1.17

1.33

nmol/l

0.46

152

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

193

1.25

0.43

2.4

2.0

75.13

109.36

ng/l

2.00

193

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.35

0.43

1.0

1.1

85.57

89.77

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.35

0.43

1.0

1.2

88.29

93.40

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

250

2356

1.07

0.43

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

294

1.19

0.42

1.5

1.4

27725.65

111731.04

e6/l

1.28

197

(3023199) Leukocytes [#/volume] in Pleural fluid

338

0.83

0.42

1.9

1.4

994.16

2228.26

e6/l

2.03

238

(42529406) Shigella sp [Presence] in Stool by Culture

899

1.10

0.41

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.52

0.41

1.6

1.2

6.00

5.96

mmol/l

—

(3019174) dRVVT (LA screen)

1.52

0.41

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.4

—

198.25

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

0.20

—

(40763590) HLA-DQ beta [Type]

0.00

0.40

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.40

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.40

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.40

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.33

0.40

1.3

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

141

1.28

0.40

1.2

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

15.08

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.36

0.40

1.2

39.99

37.80

g/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.43

0.39

1.2

1.1

102.40

89.60

titre

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

260

1.19

0.39

1.0

1.1

11.48

8.22

iu/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

106

0.66

0.39

1.1

1.7

8.65

8.85

ug/l

—

106

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

226

0.80

0.39

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

801

0.90

0.38

1.5

1.02

1.21

ratio

1.74

487

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

801

0.90

0.38

1.5

0.90

0.94

ratio

0.50

483

(44790049) Parainfluenza type 3 nucleic acid detection

431

0.86

0.38

1.3

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

431

0.86

0.38

1.3

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

431

0.86

0.38

1.3

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

431

0.86

0.38

1.3

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

114

1048

1.09

0.38

1.3

7.75

6.48

u/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.36

0.38

5.1

6.6

6.21

5.39

kpa

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

800

0.90

0.38

1.5

1.01

1.14

ratio

0.79

482

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

401

1.15

0.38

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

192

0.78

0.38

1.0

1.1

1905.67

1448.99

miu/ml

1.24

192

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.35

0.37

1.1

1.4

42.20

29.86

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

308

1.17

0.37

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

861

0.90

0.37

1.5

51.52

61.09

ug/l

1.27

707

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

134

1.27

0.36

2.4

2.1

9.63

9.31

mg/l

0.08

115

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

403

1.14

0.36

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

688

1.11

0.35

2.9

2.5

134.43

118.86

ug/min

0.11

418

(3017569) Oxygen content in Arterial blood

171

1.23

0.35

1.9

2.3

15.88

16.39

0.33

171

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

117

1.28

0.35

2.1

127.33

165.09

1.38

110

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

123

1325

0.93

0.35

1.7

5.49

4.63

mg/l

0.19

968

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.40

0.35

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

126

0.71

0.35

1.3

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.33

1.0

—

(3023410) Appearance of Cerebral spinal fluid

349

1.15

0.33

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

567

1.11

0.33

1.5

1.4

28.53

27.37

u/l

0.10

472

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

701

1.10

0.33

1.7

1.6

—

(40768795) Lymph node Pathology biopsy report

318

0.85

0.33

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.30

0.33

1.8

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

123

1145

1.08

0.32

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

337

3509

0.96

0.32

6.4

6.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

109

1175

0.93

0.32

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

426

1.13

0.32

2.0

2.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

303

2903

1.05

0.32

2.5

2.4

13.27

13.43

nmol/l

0.13

270

2662

(3004775) Volume in Urine collected for unspecified duration

229

1.18

0.32

2.8

2.4

641.10

622.88

0.11

159

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

192

1.20

0.32

1.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

789

0.91

0.31

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

887

1.08

0.31

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.72

0.30

1.4

1.6

0.43

0.50

e9/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

573

5569

1.03

0.30

1.8

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.30

0.30

1.0

1.1

0.02

0.07

u/ml

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

129

1.24

0.30

1.2

0.32

0.30

g/l

—

109

(44813793) Dust mix specific IgE antibody measurement

240

1.17

0.30

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

889

1.08

0.30

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

166

1.21

0.29

2.0

2.1

205.70

158.63

umol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.25

0.29

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

148

1.22

0.29

2.4

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

669

1.09

0.29

1.6

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

139

1.22

0.29

2.4

4.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

109

0.73

0.29

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

834

1.08

0.28

1.7

11073.04

12297.45

e6/l

0.12

576

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

112

1.25

0.28

1.3

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.29

0.28

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

183

0.82

0.27

1.6

2.0

7.62

8.17

mmol/l

0.41

183

(3037692) Legionella sp identified in Specimen by Organism specific culture

121

0.74

0.27

1.0

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

846

1.08

0.27

1.3

4.54

3.24

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

635

0.91

0.26

1.4

0.41

0.38

nmol/l

0.13

489

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.26

1.4

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

424

1.11

0.26

1.2

1.5

3.28

3.58

ug/l

0.20

377

(3008536) Aspergillus sp Ab [Presence] in Serum

0.68

0.26

2.2

2.0

—

(3008295) Osmolality of Serum or Plasma

377

1.12

0.25

1.5

1.4

278.13

279.11

mosm/kgh2o

0.09

298

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

830

0.93

0.25

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

330

1.12

0.25

1.1

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

416

1.11

0.24

1.7

1.6

—

(40768446) Kidney Pathology biopsy report

142

1.20

0.24

2.0

1.6

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.28

0.24

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

274

1.13

0.24

1.1

25.41

16.95

u/ml

0.74

119

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

852

1.07

0.23

1.3

1.2

42.53

49.23

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

514

1.09

0.23

1.1

4.42

2.95

—

(3004616) Nuclear Ab [Presence] in Serum

447

1.10

0.23

1.4

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

400

0.90

0.22

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.25

0.22

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.25

0.22

1.8

1.2

—

0.83

—

(3020650) Glucose [Presence] in Urine

125

1.20

0.22

1.7

1.9

0.00

0.05

estimate

0.80

125

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

845

0.93

0.22

1.7

1.6

—

(3016038) Potassium [Moles/volume] in Urine

200

1.15

0.22

1.0

1.2

29.96

35.13

mmol/l

0.93

179

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

116

1.21

0.22

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

178

0.84

0.22

1.0

1.1

—

(4035726) Immunohistochemistry procedure

292

2828

1.04

0.21

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

122

1158

1.06

0.21

3.0

3.7

560.74

1617.35

u/ml

0.58

109

1007

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

229

1.14

0.21

1.6

2.1

1.50

1.46

u/field

0.03

124

(3025018) Bordetella pertussis Ab [Titer] in Serum

248

1.13

0.21

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.19

0.21

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

8.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

25.80

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

111

1051

1.06

0.21

1.3

19.58

8.10

u/ml

0.32

148

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

6.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

0.78

0.21

3.7

3.8

9.75

10.36

kpa

—

102

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

0.78

0.21

3.7

3.8

5.18

4.88

kpa

—

102

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.24

0.21

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.20

0.0

3.4

—

100.93

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.20

0.0

1.2

—

4932.78

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

0.63

—

(3014007) Fractional oxyhemoglobin in Arterial blood

219

2114

1.04

0.20

12.7

10.1

93.75

94.11

0.35

219

2105

(3024471) HLA-A [Type]

111

0.81

0.20

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

791

1.06

0.19

1.4

2549.26

1332.94

e6/l

0.31

626

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

791

1.06

0.19

1.3

1.2

3.66

3.69

mmol/l

0.14

751

(44806071) Cardiolipin IgM antibody measurement

1.20

0.19

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.20

0.19

2.0

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

416

0.91

0.19

2.0

1.6

623.36

348.46

mu/l

0.52

334

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

579

1.07

0.18

1.2

2.17

3.31

u/ml

0.82

199

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

223

1.12

0.18

1.0

1.1

2.50

3.57

nmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.19

0.18

2.1

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

464

1.08

0.17

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

279

0.90

0.17

1.5

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

289

0.90

0.17

2.0

1.4

39914.00

86019.68

e6/l

0.72

167

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

243

2359

1.03

0.17

5.4

4.0

102.51

88.23

ng/l

1.16

219

2086

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

110

1.18

0.17

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

142

1476

0.96

0.16

1.6

915.19

1032.64

mu/l

0.77

113

1225

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

778

1.06

0.16

1.4

1.3

19.31

37.93

e6/l

0.61

581

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

158

1.14

0.16

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

766

7553

1.02

0.16

4.6

4.1

22.01

21.53

0.33

372

3428

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.77

0.15

1.0

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

216

1.11

0.15

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

293

1.09

0.15

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

106

1015

1.05

0.15

2.1

2.4

184.64

189.87

0.24

101

969

(3002619) Bacteria identified in Specimen by Culture

1.13

0.15

1.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

154

1488

1.04

0.15

1.2

1.1

1.47

1.53

g/l

2.53

154

1488

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

317

0.91

0.15

4.8

5.5

29.81

72.27

u/ml

—

106

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.08

0.14

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

111

1066

1.04

0.14

3.2

3.4

461.48

468.34

mg/l

0.01

469

(3001019) Free T4 and TSH panel - Serum or Plasma

202

1963

1.03

0.14

1.6

1.7

—

(4133840) Spirometry

0.78

0.14

1.0

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

124

1195

1.04

0.14

1.4

1.3

175.31

220.25

miu/ml

0.86

575

(4146454) Self-monitoring of blood glucose

324

1.08

0.14

3.4

2.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.19

0.14

3.1

2.2

16.60

16.53

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

122

1.15

0.13

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

305

1.08

0.13

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

201

0.90

0.13

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

354

1.07

0.13

1.1

1.2

—

33.89

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

354

1.07

0.13

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

364

1.07

0.13

1.1

—

(3024932) HLA-DR beta [Type]

109

0.83

0.13

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

374

1.07

0.13

1.1

—

87.48

—

(3044927) Protein electrophoresis panel - Urine

277

1.08

0.12

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

560

0.95

0.12

1.0

1.1

14025.50

19501.01

iu/ml

0.09

120

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

127

0.87

0.12

1.1

—

5.12

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

314

3200

0.98

0.12

1.7

3.57

3.50

mmol/l

0.49

205

2203

(3051611) Lipemic interference index of Serum or Plasma

298

1.07

0.11

2.8

3.4

13.50

12.99

index

0.10

183

(3023183) Ammonium ion [Moles/volume] in Plasma

739

1.04

0.11

3.0

30.38

36.49

umol/l

1.90

675

(3018333) Ribosomal P Ab [Presence] in Serum

279

1.08

0.11

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

134

1.12

0.11

1.3

1.2

775.00

1059.26

titre

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

544

1.05

0.10

1.5

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

271

2662

1.02

0.10

2.7

2.6

64.55

68.85

ml/min/173m2

0.92

110

1105

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.14

0.10

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.09

0.09

1.4

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

320

1.06

0.09

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.06

0.09

2.2

2.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.06

0.09

1.2

1.5

2300006.96

718926.54

nmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

174

1.09

0.09

1.2

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

1.04

0.09

4.0

2.8

15.66

14.84

ml/dl

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.04

0.09

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

452

0.95

0.09

1.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

301

1.06

0.09

2.5

3.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.13

0.09

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

553

0.96

0.09

1.6

1.4

60.64

61.78

mmol/l

0.07

449

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

143

1397

1.02

0.09

1.1

0.74

0.62

ratio

1.32

176

(3024869) Neuronal Ab [Presence] in Serum

1.07

0.08

1.2

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

175

1.09

0.08

1.4

1.5

28.21

29.32

umol/l

0.25

160

(3020891) Body temperature

142

1452

0.98

0.08

4.8

4.4

36.95

36.92

°c

0.62

142

1441

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

876

0.97

0.08

1.7

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

185

1.08

0.08

1.3

1.2

132.36

132.28

nmol/l

0.00

185

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

568

1.04

0.08

1.2

2.71

4.66

u/ml

1.66

254

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.09

0.08

1.7

3.0

3.29

4.76

ug/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.09

0.08

1.0

0.86

1.23

u/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

174

1707

1.02

0.08

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

303

1.06

0.07

1.0

1.1

—

(3017704) Immunofixation for Urine

166

1.08

0.07

1.7

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.84

0.07

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.82

0.07

4.5

3.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

313

1.05

0.07

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.81

0.07

1.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

176

1.08

0.07

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

1.10

0.07

2.4

2.3

—

(3025130) Human papilloma virus identified in Specimen

570

0.96

0.07

1.8

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

304

1.05

0.07

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

118

1.10

0.07

3.4

1.8

40.45

40.97

g/l

0.14

118

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.05

0.07

1.7

1.6

19.44

26.46

—

(3042733) HLA Ab [Presence] in Serum

122

0.90

0.07

5.6

5.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.12

0.06

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

104

0.87

0.06

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

104

0.87

0.06

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

104

0.87

0.06

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

104

0.87

0.06

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

532

1.03

0.06

1.5

58.68

58.76

ug/l

0.01

532

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

626

6216

1.01

0.06

2.7

2.9

2.45

2.44

mmol/l

0.62

549

5574

(3038026) Centromere Ab [Units/volume] in Serum

256

1.06

0.06

1.2

1.1

—

42.43

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

416

0.96

0.06

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

711

1.03

0.06

1.2

262.27

269.99

u/ml

0.10

435

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

182

0.93

0.05

1.4

1.2

7.00

9.58

mm/h

1.10

182

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

129

1.09

0.05

2.4

3.3

1.71

1.19

0.40

129

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

395

0.96

0.05

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

100

1.10

0.05

1.0

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

941

1.02

0.05

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

586

0.97

0.05

1.8

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

297

1.04

0.05

1.2

—

63.63

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

159

1.07

0.05

1.2

1.1

—

(3036489) Thrombin time

130

1319

0.99

0.04

1.7

2.0

21.32

20.79

0.26

114

1156

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

150

1.07

0.04

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

150

1.07

0.04

1.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

646

1.02

0.04

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

432

4294

1.01

0.04

2.0

3.65

3.50

ratio

1.28

327

3292

(4268621) Lupus anticoagulant assay

402

0.97

0.04

2.4

2.3

—

(4195642) Thrombophilia screening test

543

0.98

0.04

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1.04

0.04

1.0

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

418

1.03

0.03

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

995

0.98

0.03

1.4

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

1.07

0.03

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

601

0.98

0.02

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

601

0.98

0.02

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

291

1.03

0.02

1.7

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

131

1298

1.01

0.02

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

272

1.03

0.02

2.7

2.9

17.01

64.87

mg/l

1.33

197

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

368

0.98

0.01

1.4

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

133

1.05

0.01

1.1

1.2

—

0.12

g/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

223

2241

0.99

0.01

2.5

2.9

182.86

177.27

ng/l

0.06

197

2040

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

1.04

0.01

1.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

174

1.03

0.00

45.6

37.6

6.58

7.55

ug/l

1.72

157

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

566

0.99

0.00

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

185

1.03

0.00

8.3

7.2

29.60

54.66

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

502

1.00

0.00

1.1

4.95

3.16

eliau/ml

0.21

243

(3004809) Band form neutrophils/Leukocytes in Blood

495

0.99

0.00

3.5

3.4

0.48

1.50

5.75

443

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

118

1182

1.00

0.00

1.6

1.5

0.10

7.02

iu/ml

0.60

201

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

341

1.00

0.00

1.4

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

106

1.04

0.00

1.0

1.2

16.54

16.64

umol/l

0.03

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

124

0.97

0.00

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

126

1.03

0.00

2.8

2.7

0.62

mmol/l

0.09

126

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

303

0.99

0.00

3.4

4.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

127

1.02

0.00

1.2

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

247

1.01

0.00

2.0

1.4

290.88

378.12

u/l

0.63

237

(3025577) Chromium [Mass/volume] in Blood

177

1.02

0.00

2.0

2.2

2.25

2.69

ug/l

0.30

155

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

279.89

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

190

1.00

-0.00

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.00

-0.00

4.0

3.2

44.12

43.34

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2629.43

—

(21494434) Karyotype in Bone marrow

270

1.00

-0.00

1.0

1.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.90

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.90

-0.00

1.0

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.00

-0.00

8.0

6.3

5.38

7.61

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.3

—

0.32

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.95

-0.00

1.7

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

200

1.00

-0.00

6.4

7.4

16.78

188.22

ug/l

0.86

124

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

6.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.89

-0.00

1.1

1.3

—

(4015189) Microbial culture of sputum

1.01

-0.00

1.1

2.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.95

-0.00

1.7

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

620

1.00

-0.00

1.5

1.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

43.09

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3033099) Centromere Ab [Titer] in Serum

0.89

-0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.88

-0.00

1.2

76.60

66.54

ug/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

-0.00

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

299.71

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

48.25

—

(40762814) Titanium [Mass/volume] in Blood

1.02

-0.00

2.0

2.5

—

4.33

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.95

-0.00

1.7

1.1

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

74.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_APPENDOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_APPENDOTH	1.152 [0.93, 1.43]	0.2
Birth year	0.992 [0.98, 1.0]	0.062

During the follow-up period (1.1.1998 — 31.12.2019), 155 out of 3277 females with K11_APPENDOTH died.

Males

Parameter	HR [95% CI]	p-value
K11_APPENDOTH	1.066 [0.88, 1.3]	0.52
Birth year	0.991 [0.98, 1.0]	0.089

During the follow-up period (1.1.1998 — 31.12.2019), 202 out of 3197 males with K11_APPENDOTH died.

Mortality risk

Mortality risk for people of age

years, who have K11_APPENDOTH.

N-year risk	Females	Males
1	0.088%	0.285%
5	0.562%	1.552%
10	1.442%	3.661%
15	2.692%	6.828%
20	4.667%	11.537%

Relationships between endpoints

↥

Index endpoint: K11_APPENDOTH – Other appendicitis

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other appendicitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints